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Abstract
Nowadays, wound dressings are complex materials that, behind the mechanical protection, are 
also capable of interacting with the injury tissue. These complex products improve the healing 
process by maintaining suitable conditions, allowing skin to establish integrity with appropriate 
cosmetic results. The incidence of chronic wounds related with diseases, population ageing, and 
tissue infection caused by multi-resistant strains of bacteria, has been increasing. Thus, the 
wound dressing research is now focused on the development of new materials with higher 
specificity in order to improve the quality of patients’ life. One of the directions is the use of 
natural materials for wound dressing’s production for the development of a friendlier product. 
Hydrogels have been successfully used as wound dressings. They gather favourable properties 
for wound healing, such as good biocompatibility and ability to maintain the proper 
environmental humidity, which facilitate the ready removal of the material with minimal pain. 
However, hydrogels lack the capacity to load and control the release of bioactive molecules. 
Thus, the incorporation of cyclodextrins on the hydrogels allowed the improvement of the 
polymeric network ability to protect and modulate the release of bioactive molecules. Additionally, 
cyclodextrins are capable of complex with a wide range of molecules, due to their micro-
heterogeneous environment (hydrophilic outside and hydrophobic cavity). Moreover, plants have 
been used as source for new therapeutic agents able to enhance the healing process. 
Polyphenolics, one of the groups of bioactive molecules, has been described as anti-oxidant, 
anticarcinogenic, anti-inflammatory and antimicrobial. However, their application by the 
pharmaceutical industry is limited by polyphenolics lower solubility and stability to environmental 
stress. Thus, cyclodextrins has been proposed as viable carrier for the maintenance of bioactive 
molecules’ structural integrity and bioactivity. 
Therefore, the present thesis reports the work developed to obtain a wound dressing, using 
natural compounds, capable of preventing infection of the injury tissues. 
The first step was to select phenolic compounds from natural extracts obtained from Portuguese 
wild plants. Gallic and caffeic acid revelled to be the most efficient antibacterial agents against 
bacteria commonly isolated from skin and soft tissue infections (Klebsiella pneumoniae, 
Staphylococcus epidermidis and Staphylococcus aureus). Besides, gallic acid has shown very low 
cytotoxicity, for concentrations lower than 0.01 mg.mL-1. 
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In order to enhance gallic and caffeic acids solubility and stability, their encapsulation by 
cyclodextrins was evaluated. The inclusion complexes obtained were stable and capable of 
destroying the bacteria used. Although, gallic and caffeic acid had similar molecular structure, 
the cyclodextrins encapsulation behaviour was different. In the case of gallic acid, the 
hydroxypropyl-β-cyclodextrin formed a more stable inclusion complex at pH 3 (when compared 
with β-cyclodextrin and methyl-β-cyclodextrin) as well as presented a better antibacterial activity. 
Moreover, gallic acid carboxylic group was positioned towards the smaller cyclodextrins ’cavity 
and hydroxyl groups were placed near the wider opening. The gallic acid neutral form, positioned 
inside the cyclodextrins, preserved gallic acid antibacterial activity. Otherwise, the caffeic acid 
carboxylic group was project to the water phase and the aromatic part inside the cyclodextrins 
cavity. Additionally, the native cyclodextrin was better for the encapsulation of this phenolic at pH 
5 and it antibacterial activity was enhanced by the inclusion complex formation. 
Hence, the incorporation of gallic and caffeic acid in a polymeric network was, also, studied. A 
hydrogel based on cyclodextrins and hydroxypropyl methylcellulose, using 1,4-butanediol 
diglycidyl ether as cross-linking agent, was synthetized. Only the β-cyclodextrin and 
hydroxypropyl-β-cyclodextrin permitted the formation of hydrogels with good mechanical 
properties. Both networks behaved with superabsorbent materials and were capable of loading 
and release gallic and caffeic acid by a control mechanism. The differences between the 2 
phenolic acids found in the study of the inclusion complexes were similar to the load hydrogels. 
The gel with hydroxypropyl-β-cyclodextrin had better properties regarding the gallic acid and the 
gel with β-cyclodextrin was more suitable in the caffeic acid case. Thus, cyclodextrins were the 
major mechanism involved on the load and release of the gallic and caffeic acid. Furthermore, 
the phenolic acids antibacterial activity and effect on the fibroblasts proliferation was maintained 
after their incorporation on the hydrogels. 
In conclusion, the work developed proved that natural antibacterial agents can be used to control 
the growth of the most common bacteria isolated from infected wounds, and their incorporation 
in cyclodextrins-based hydrogels preserved the selected phenolics biological activities. Thus, the 
hydrogels synthesised could be useful as natural antibacterial agent’s delivery systems device for 
the treatment of wound infections. 
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Sumário
Atualmente, os pensos utilizados no tratamento de feridas são materiais complexos que 
oferecem proteção mecânica e promovem cicatrização, mantendo as condições mais favoráveis 
para o restabelecimento da integridade da pele. A incidência de feridas crónicas como 
consequência de doenças, do envelhecimento da população e de infeções provocadas por 
bactérias multirresistentes, tem aumentado nos últimos anos. Esta evolução obrigou a indústria 
a direcionar os seus esforços para o desenvolvimento de materiais com maior especificidade, 
contribuindo para melhorar a qualidade de vida dos pacientes. 
Os hidrogéis reúnem propriedades que favorecem a cicatrização de feridas, nomeadamente 
biocompatibilidade e capacidade para manter a humidade, o que facilita a remoção dos 
dispositivos com reduzido trauma ou dor para o paciente. Por isso mesmo, têm sido aplicados 
com sucesso no tratamento de feridas crónicas. Contudo, a sua capacidade para adsorver e 
libertar fármacos de um modo controlado é reduzida. Assim, a incorporação de ciclodextrinas 
em matrizes poliméricas tem sido investigada de modo a melhorar a capacidade dos hidrogéis 
para proteger e modular a libertação de biomoléculas. As ciclodextrinas apresentam, ainda, a 
vantagem de conseguirem encapsular uma grande variedade de moléculas, pois possuem uma 
superfície externa hidrofílica e uma cavidade hidrofóbica. 
A procura de novos agentes antimicrobianos tem crescido nos últimos anos como consequência 
do decréscimo de eficiência dos antibióticos contra bactérias multirresistentes. As plantas 
possuem uma gama alargada de moléculas, por exemplo polifenólicos, capazes de promoverem 
a cicatrização e prevenirem infeções. Os polifenólicos têm sido descritos como antioxidante, anti-
carcinogénico, anti-inflamatório e antimicrobiano. No entanto, a sua utilização pela indústria 
farmacêutica é limitada, devido à sua baixa solubilidade e estabilidade. Assim sendo, a 
encapsulação de compostos polifenólicos com ciclodextrinas tem sido proposta como opção 
viável, pois a sua integridade estrutural e a bioatividade são preservadas após inclusão. 
A presente tese resume o trabalho desenvolvido na conceção de um penso para o tratamento de 
feridas com compostos naturais, capaz de melhorar a cicatrização e de prevenir infeções. 
Inicialmente, procedeu-se à seleção de compostos fenólicos obtidos a partir de extratos de 
plantas do Nordeste português. Os ácidos gálico e cafeico foram os compostos polifenólicos que 
apresentaram maior eficiência no controle da proliferação de bactérias, normalmente isoladas de 
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feridas infetadas (Klebsiella pneumoniae, Staphylococcus epidermidis and Staphylococcus 
aureus). Além do mais, o ácido gálico apresentou reduzida citotoxicidade para concentrações 
abaixo de 0.01 mg.mL-1. 
No sentido de melhorar as propriedades de estabilidade e solubilidade dos ácidos gálico e 
cafeico procedeu-se ao estudo da sua encapsulação com ciclodextrinas. Os complexos de 
inclusão obtidos demostraram ser estáveis e capazes de manter a atividade antibacteriana dos 
fenólicos. Apesar dos ácidos gálico e cafeico apresentarem uma estrutura molecular semelhante, 
o comportamento de encapsulação com ciclodextrinas divergiu. No caso do ácido gálico, a 
hidroxipropil-β-ciclodextrina permitiu a formação de complexos mais estáveis a pH 3 e com 
melhor atividade antibacteriana. E, supõe-se que o ácido gálico encapsulado apresente o grupo 
carboxílico orientado para a abertura mais pequena da ciclodextrina e os grupos hidroxilos 
voltados para o interior da cavidade. Pelo contrário, o grupo carboxílico do ácido cafeico estará 
projetado para fora da ciclodextrina e a parte aromática para o interior da cavidade. Além disso, 
a β-ciclodextrina foi a mais eficiente na complexação do ácido cafeico a pH 5 e observou-se um 
reforço das propriedades antibacterianas deste fenólico depois da inclusão. 
Após a confirmação da complexação dos ácido fenólicos pelas ciclodextrinas com preservação 
das propriedades antibacterianas, estudou-se a incorporação dos ácidos gálico e cafeico num 
hidrogel. Para tal, produziu-se uma matriz polimérica utilizando ciclodextrinas e hidroxipropil 
metil celulose como monómeros e 1,4-butanediol diglicidil éter como agente de reticulação. A 
formação de hidrogéis com propriedades mecânicas aceitáveis só foi confirmada com a 
utilização da β-ciclodextrina e da hidroxipropil-β-ciclodextrina. Em ambos os casos obteve-se 
materiais superabsorventes, em que as ciclodextrinas desempenharam um papel crucial na 
capacidade de modelar a adsorção e a libertação dos ácidos fenólicos. Além disso, a atividade 
antibacteriana e o efeito sobre a proliferação de fibroblastos manteve-se após incorporação dos 
ácidos fenólicos nos hidrogéis. 
Em conclusão, o trabalho desenvolvido demostrou ser possível utilizar ácidos fenólicos de origem 
natural para controlar o crescimento das bactérias normalmente isoladas de feridas infetadas. 
Comprovou-se, ainda, a possibilidade de incorporação destes compostos antimicrobianos em 
hidrogéis com ciclodextrinas mantendo as suas propriedades biológicas. Assim sendo, os 
hidrogéis antibacterianos sintetizados poderão ser úteis na prevenção e tratamento de infeções 
em feridas. 
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Thesis Preamble
 
Scope 
Wounds result from skin injury caused by mechanical, thermal, chemical, electric or by the 
presence of an underlying medical or physiological disorder. Normally, the human body is 
capable of restore the skin integrity with minimal scar, by a complex and interactive cascade of 
events. However, in some situations the normal healing process is interrupted as result of 
physical factors like age, nutritional status or local factors such as infections, tissue ischaemia, 
haematomas, foreign bodies or mechanical pressure. In these situations, medical treatment is 
necessary. Additionally, wounds related to pathologies diseases such as diabetes mellitus, 
chronic venous, arterial insufficiency, and immunological or dermatological diseases have 
increased, in the last years. This demand for an effective management of the different types of 
wounds induced the commercialization of a wide range of wound dressings. 
Wound dressings evolved from simple plan textile strips to engineered composite materials with 
different layers and, even, with medical substances inside. At this point, the wound dressings 
research aims to develop a wound dressing capable of improving the healing process by 
maintaining the favourable conditions for the re-establishment of the skin integrity to achieve the 
best function and cosmetic results. Thus, wound dressings have been used as platforms for the 
sustained delivery of therapeutic agents for a desired period of time. This feature has been 
particularly important regarding the control of wounds infections. In fact, the deposition and 
proliferation of microorganisms, such as Staphylococcus aureus, Staphylococcus epidermidis, 
Escherichia coli, Pseudomonas aeruginosa and Candida species, on the injury tissues lead to 
wound infection, inducing tissue inflammation and triggering the immune response. Therefore, 
wound infections can prolong or impair the wound healing process, resulting in tissue morbidity 
and, ultimately, on sepsis and dead. 
The population ageing associated with the emergence of multi-resistant strains of bacteria, 
resultant from to the widespread use of broad-spectrum antibiotics, has been challenging the 
industry to find new sources of antibacterial agents, as well as new wound dressings more 
specific for each diseases. So, the use of natural materials for wound dressings production has 
gained prominence. 
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Aim 
Considering the facts exposed, the prime goal of the present thesis was to develop a wound 
dressing with the ability to promote the healing process and, also, capable of preventing the 
infection of the injury tissue. Thus, the first aim was the characterization and selection of 
antibacterial agents obtained from Northeast Portuguese plants for the substitution of large-
spectrum antibiotics, normally, used for the treatment of infected wounds. Then, hydrogels based 
on natural monomers were developed and characterized in order to be applied as platforms for 
the delivery of antibacterial agents, for wound dressing proposes. In order to achieve this last 
goal, the encapsulation of natural agents by cyclodextrins was optimized. 
 
Structure 
The present dissertation gathers the scientific work developed to accomplish the goals proposed 
above. It was structured in five chapters, according with the following organization. 
Chapter 1 overviews the state of the art regarding the natural antibacterial agents obtained from 
plants, with specially emphasis on polyphenolic compounds, as well as their encapsulation by 
cyclodextrins for improvement of polyphenols stabilization and solubilisation, to be then 
incorporated in hydrogels for wound care.  
Chapter 2 is focused on the antibacterial activity evaluation of phenolic extracts obtained from 
wild plants collected on Northeast Portugal region. The potential antibacterial activity of phenolic 
compounds obtained from those extracts is, also, described in this chapter. 
Chapter 3 gathers 2 subchapters concerning the evaluation of cyclodextrins encapsulation on the 
gallic acid (3.1) or caffeic acid (3.2) antibacterial activity, respectively. Physiochemical and 
biological characterization of the complexes was used for the evaluation. 
Chapters 4 report the synthesis of cyclodextrin-based hydrogels and their physicochemical 
characterization. The effect of hydrogel functionalization by the gallic acid (chapter 4.1) or caffeic 
acid (chapter 4.2) incorporation is, also, described and characterized. 
Chapter 5 closes the thesis by connecting the most significant conclusions obtained in the 
present work and pointing out relevant paths for future research. 
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Abstract 
Optimal wound dressings should be capable of mechanical wound protection combined with the 
ability to facilitate the healing process, via maintenance of suitable environmental conditions and 
the controlled delivery of bioactive molecules. 
Hydrogels present suitable properties for wound dressing applications such as good 
biocompatibility, together with a high water content, the latter of which is important for the 
maintenance of a moist environment and ready removal from the wound with a minimal level of 
associated pain. However, they have poor properties as drug-delivery systems. Thus, the 
conjugation with cyclodextrins may allow the achievement of an optimal wound dressing material, 
since the hydrogel component will maintain the moist environment required for the healing 
process, and the cyclodextrin moiety has the ability to protect and modulate the release of 
bioactive molecules.  
Cyclodextrins are cyclic oligosaccharides arising from the starch degradation, which can be a 
viable option as encapsulation vehicle. Cyclodextrins are inexpensive, friendly to humans, and 
also capable of improving the biological, chemical and physical properties of bioactive molecules. 
Plants possess a wide range of molecules capable of improve healing: fibre, vitamins, 
phytosterols, and further sulphur-containing compounds, carotenoids, organic acid anions and 
polyphenolics. However, they require an adequate level of protection, from the environmental 
conditions, to prevent losing their structural integrity and bioactivity.  
In the present chapter, cyclodextrins were analysed simultaneous as monomers for hydrogels 
synthesis and as encapsulation agent for antibacterial agents. 
 
Keywords:  Bioavailability, cyclodextrin; drug delivery, hydrogel, infection, inclusion complex; 
polyphenolic, supramolecular structures, wound dressing. 
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Introduction 
 
The skin is the largest human organ, and probably the most heterogeneous, reaching 10% of the 
total body mass [1]. The main function of the skin is to act as a protective barrier against the 
environment, and beyond this physical protection function, skin is also responsible for sensory 
detection, thermoregulation, fluid homeostasis, immune surveillance, and self -healing [2]. 
Normally, the human body is able to restore skin integrity after injury, with a minimal scar, via a 
complex and interactive process. However, this healing process can be interrupted by a series of 
physical factors such as age, nutritional status, or local factors, like infections, tissue ischaemia, 
haematomas, foreign bodies or mechanical pressure. In these situations, medical treatment is 
necessary [3, 4]. Indeed, in the past few years the number of wounds related to diseases such as 
diabetes mellitus, chronic venous disease, arterial insufficiency, and immunological or 
dermatological illnesses have increased. Therefore, in order to improve the life quality of those 
affected, a range of wound-care products have been developed [5–8]. 
Wound dressings cover the wound, providing physical protection against microorganism 
deposition, wound dehydration, and external injuries [9, 10]. Moreover, they can interact with the 
wound and accelerate the healing process, via the release of bioactive molecules, and/or by 
maintaining the moist environment required for effective wound healing [11]. New formulations of 
composite systems containing synthetic and/or biological agents, such as gauzes, foams, films, 
hydrocolloids and hydrogels, have been developed to maintain the favourable environmental 
conditions, and/or to deliver bioactive compounds through the skin and, hence, enhance the 
healing process [6]. 
Hydrogels, composed of polymeric networks with a high water content and biocompatibility 
status, can be used as wound-care coverings, drug delivery systems, dental materials, implants, 
injectable polymeric systems, ophthalmic application systems and hybrid-type organs [4]. 
Additionally, the presence of cyclodextrins (CD) on hydrogels as drug carriers improve the 
properties of the polymeric networks and give rise to an enhanced level of wound healing [12–
14]. 
CDs can serve as vehicles for the protection of bioactive molecules due to their ability to 
encapsulate molecules, a process involving the formation of inclusion complexes (IC). Indeed, 
CDs have the capacity to modify the guest molecule‘s characteristics. For example, they enhance 
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the solubility of lipophilic ‗guests‘, stabilise the ‗guest‘ against derivatizing agents (such as 
oxygen, visible or ultra-violet light, and heat), control volatility and sublimation properties, allow 
the physical isolation of incompatible compounds (via chromatographic separation), permit taste 
modification by masking potentially adverse flavours, control odours and the release of such 
encapsulated compounds. Furthermore, CDs are now readily available, and their price and 
production costs have declined in recent years [15–20]. 
Plants are, virtually, inexhaustible sources of biologically-active compounds, which are their 
defence mechanisms against microorganism, insects and herbivores. Plants bioactive 
compounds have been, widely used by the food, cosmetic and pharmaceutical industries [21–
24]. In the pharmaceutical field, the utilization of natural compounds instead of synthetic ones 
offers many advantages, such as high levels of biocompatibility, low toxicity and good availability. 
Plants‘ bioactive molecules include polyphenolics, alkaloids and polysaccharides, and they, all, 
have well-documented pharmacological properties. However, polyphenolics are currently one of 
the major group of interest in view of their anti-inflammatory, anti-microbial and anti-oxidant 
properties, as well their availability in the human diet [21–24].  
In order to have biological activity, molecules need to be capable of reaching the action site 
without losing integrity and to be able to cross the lipophilic membrane. Plants bioactive 
compounds have restrict application as pharmaceutical products since they have limited water 
solubility, poor bioavailability, and can be easily modified by environmental factors, such as 
temperature, pH and light. Therefore, in order to preserve their structural integrity, these kind of 
molecules need to be protected by a finishing formulation with the capacity to deliver them to the 
physiological targets, without losing any bioactivity [25, 26]. 
The present chapter gathers the state of the art on two main applications of CDs for the 
development of optimal wound dressing. An overview of the CDs as monomers for synthesis of 
hydrogels, improving their drug delivery properties is provided. Additionally, a synthesis of the 
complexes between CDs and plant polyphenolics, with pharmaceutical applications, is also 
discussed. 
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Cyclodextr ins 
 
Cyclodextrins (CDs) are a group of structurally-related cyclic oligosaccharides described for the 
first time by Schardinger [17, 27]. They are produced by the bacterial enzymatic degradation of 
starch [15, 16, 18, 27]. The naturally-occurring CDs (Fig 1.1) are αCD with 6 units, βCD with 7 
units, and γCD with 8 units [17, 28, 29]. These 3 CDs have the same cavity height; however, 
their cavity volume and diameter varies, which determines the classes of molecules (‗guest‘ 
molecules) that will fit better in each CD cavity. βCD is more accessible, with a lower cost price, 
and is, also, the most commonly employed one for commercial proposes [15]. 
 
 
F ig  1.1 Schematic representation of αCD, βCD and γCD (left to right) and schematic representation of the CD 
truncate aspect (Chem3D Pro 12.0 software). 
 
CDs have the shape of a truncated cone (Fig 1.1), mainly in view of the chair conformation of the 
glucopyranoside units [30, 31]. Since their hydroxyl groups (OH) are oriented to the outer 
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molecular surface, CDs have a micro-heterogeneous environment, the outside having hydrophilic 
characteristics and the inner cavity being a hydrophobic environment [16, 18]. Therefore, CDs 
are able to accommodate poorly water-soluble molecules (such as polyphenolics), improving 
molecules' solubility or even polymers forming IC in aqueous solutions [17, 18, 27, 31, 32]. In 
addition to the solubilisation improvement, CDs protect bioactive molecules from side-effects 
caused by environmental conditions (temperature, pH, light) and, hence enhance their shelf -life 
and reduce the concentrations of the agent required to achieve a biological effect [26, 33]. 
Moreover, CDs can modify the behaviour of the encapsulated molecule, specifically by modulate 
the delivery rate (i.e. retarding or prolonging it), which renders the drug formulation with CDs 
‗non-bioequivalent‘ to formulations without CDs [29, 34]. Other advantage of the CDs application 
as carrier is CD‘ ability to eliminate irritant or toxicologica l effects of the active agent, by replace 
some excipients, such as pH regulators, solubilising agents or organic solvents [29, 35–37]. 
 
Cyc lodextr ins‘ Derivatives  
In the last years, physicochemical properties and, consequently, the inclusion capacity of the 
natives CD have been improved by chemical modification of their OH [28]. The CD derivatives 
may help to control the chemical activity of the ‗guest‘ molecule, and chemical modifications of 
CDs enlarge the applications of such molecules. For example, functional groups that act on 
molecular recognition can be added to CDs, enabling their use in enzyme mimetization, targeted 
drug delivery, or analytical chemistry applications [15, 19]. 
CD derivatives can be manufactured by aminations, esterifications or etherifications of the 
primary or secondary OH from naturally occurring CDs [27]. Each CDs‘ glucopyranose unit has 3 
reactive OH with different ratio of reactivity and function, in the case of βCD it is possible to 
change 21 OH by chemical or enzymatic reaction [31]. The βCD derivatives (Table 1.1) are, 
normally, distributed based in their interaction with the water molecules, i.e, hydrophilic, 
hydrophobic or ionisable derivatives. The first group (hydrophilic) has better solubility in water 
and are suitable for IC formation with poor water soluble ―guest‖ molecules. The DMβCD, 
TMβCD, hydroxyalkylated CDs, such as HPβCD, and branched CDs, like G1βCD, are some 
examples of hydrophilic CD derivatives. The hydrophobic derivatives, for example DeβCD, are 
capable of decrease and modulate the release rate of water soluble molecules. The ionisable CDs 
CMβCD, CMEβCD, and SBEβCD, can enhance the dissolution rate, the inclusion capacity and, 
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also, the decrease of the side effects of some molecules [27, 28]. The HPβCD and the SBEβCD 
are the most used derivatives on the pharmaceutical industry, their low toxicity and high solubility 
make them suitable for oral and parental application (Table 1.1) [27, 37, 38] 
 
Table 1.1 Common βCD derivatives 
CD‘Derivative  Characteristic  
Hydrophilic derivatives   
MβCD  Soluble in cold water and in organic solvents,  
DMβCD surface active, hemolytic  
TMβCD  
DMAβCD Soluble in water, low hemolytic  
Hydroxyalkylated βCD  
2HEβCD Amorphous mixture with different degrees of substitution,  
2HPβCD highly water-soluble (50%), low toxicity  
3HPβCD  
3HPβCD  
2,3-DHPβCD  
Branched βCD  
G1βCD Highly water-soluble (50%), low toxicity  
G2βCD  
GUGβCD  
Hydrophobic derivatives   
AlkylatedβCD  
DEβCD Poorly water-soluble, soluble in organic solvents, surface-active  
TEβCD  
AcylatedβCD (C2—C18)   
TAβCD Poorly water-soluble, soluble in organic solvents  
TVβCD Film formation  
Ionaizable derivatives   
AnionicβCD pKa=3 to 4, soluble at pH 4 
CMEβCD  
 
Inc lusion Complex Formation Process 
There are several methods for the formation of ICs between CDs and bioactive molecules, and 
the selection of the process is clearly based on the properties of the guest molecule, the facilities 
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available and the cost involved [36]. The most common methods are neutralization, slurry, 
solution, co-precipitation, kneading, and grinding method [39]. 
The process of inclusion of the ‗guest‘ into the CD occurs at the supramolecular level, and hence 
there is a substitution of enthalpy-rich water molecules from the central cavity, by the lipophilic 
‗guest‘ or moiety, no covalent bonds are broken or formed between the IC compounds [18, 36]. 
The IC is maintained via hydrophobic forces and van der Waals interactions, and, also, by other 
factors like the release of ring strain, modifications in solvent surface, tensions and hydrogen-
bonds which render the IC complex more energetically-stable [15, 18]. IC generation represents 
a three-dimensional fit between the CD and the ‗guest‘ molecule, and on the specific local 
interactions between the CDs‘ surface groups and the guest molecule [17]. The inclusion process 
is dynamic and the ‗guest‘ molecule-CD interactions are required to reach equilibrium in order to 
stabilize the IC [16, 40]. The IC is very stable, and possesses a long shelf-life at ambient 
temperature and under dry conditions. However, it can be disrupted by increases in temperature, 
or by exposure of the complex to water, which can replace the ‗guest‘ molecule within the CD  
cavity [16]. However, this may be helpful when the goal is to achieve a controlled release of the 
‗guest‘, for example a drug. 
The CD encapsulation of the bioactive molecule induces alterations on the physicochemical 
characteristics of both agents. Therefore, it is possible to assess the stoichiometry of the 
complexes and their stability constant (K) by analysing the modifications on the solubility, 
chemical reactivity and stability, UV-Vis absorbency, drug retention and permeability [36, 41, 42]. 
The stoichiometry of the IC represents the number of molecules that interact with the CD, in 
most part of the cases the 1:1 IC is observed, however the same CD can interact with 2 or more 
molecules (1:2) or one guest can complex with more than one CD (2:1), not so frequent. The 
variable, K, also known as equilibrium constant or binding constant, needs to be determined by 
experimental methods and is a parameter that represents the thermodynamic equilibrium 
between the free and the complexes molecules [43]. Moreover, thermodynamic parameters, 
such as enthalpy (∆H), entropy (∆S) and free Gibbs energy (∆G), must be, also, considered as 
important parameters on the evaluation of the complexation process, since the temperature 
influences the selectivity of the binding between CD and the bioactive molecule [41, 44].  
Therefore, in order to assess the K value and the stoichiometry of the complex, evaluation of the 
IC concentrations and the equilibrium concentrations of the CD and the bioactive molecule needs 
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to be assessed based on experimental methods. Continuous variation, slope ratio and mole ratio 
are some of the methods used, and the parameters are measured based on alterations on one or 
more physicochemical properties of the guest, for example UV-Vis absorbency spectrum or NMR 
(nuclear magnetic resonance) [42, 44]. 
 
Applications 
The main interest in CDs lies in their ability to encapsulate ‗guest‘ molecules and, hence, modify 
their physiochemical characteristics [15, 16]. In fact, CDs can enhance the solubility of lipophilic 
‗guests‘, stabilise the ‗guest‘ molecule against potentially damaging agents (such as oxygen, 
visible or ultra-violet light, and heat), control their volatilities and sublimation properties, allow the 
physical isolation of incompatible compounds (via chromatographic separation), permit taste 
modifications by ‗masking‘ flavours, control odours, and attenuate the release of bioactive 
compounds [17–19]. 
Besides the improvement of some characteristics of the ‗guest‘ molecule, ICs have low cost and 
good availability, which make them useful for pharmaceutical applications, analytical sciences, 
separation processes, and catalysis. They are also of much value to the cosmetic, textile, food 
and packaging industries [17, 18, 20]. 
The food industry has used CDs to form ICs with lipids, flavours and colourings. They are very 
helpful for flavour protection and delivery, and also have the ability to remove some unhealthy 
compounds (e.g. cholesterol), and, also, improve the textural properties of some foods [27]. 
CDs are widely used in cosmetic, personal care products, and toiletries, such as toothpastes, 
skin creams, softeners and tissues. Additionally, antimicrobial agents can be added to 
toothpastes as ICs [15, 17, 27]. Moreover, ICs are used as chemical stabilisers to prolong the 
action of active compounds, to decrease local irritation, or, alternatively, to mask unpleasant 
odours [45]. CDs are used to improve perfume fragrance, enhance the effect of room fresheners 
by suppressing the volatilities of their odour molecules, and also to control the release of 
fragrances in detergent formulations. 
In the pharmaceutical industry, CDs are used as drug carriers to enhance the solubility, stability 
and bioavailability of the bioactive molecules [46]. They have a high level of biocompatibility and 
are approved by FDA (Food and Drug Administration), thus CDs are friendly to humans, indeed 
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they may only be harmful at extremely high concentrations [16, 28, 42, 47]. CDs are capable of 
encapsulating a wide range of molecules such as straight or branched aliphatic chains, 
aldehydes, ketones, alcohols, organic acids, fatty acids, aromatics, gases, and polar compounds 
like halogens, oxyacids and amines [15].  
The pharmaceutical industry possesses a wide range of products with CDs, where they are used 
as active ‗carriers‘. Usually, the drugs involved must be able to reach the cellular membrane 
without a corresponding loss of integrity, and also be hydrophobic enough to cross it. Therefore, 
CDs can be used to facilitate drug delivery processes by the maintenance of hydrophobic drugs 
in solution, and deliver them into cell membranes, enhancing their level of penetration via 
substitution of the drug by blood serum or tissue biomolecules in the cavity [15, 28, 48]. 
Moreover, CDs are used as solubilizers and stabilisers, and are able to reduce local irritation, a 
phenomenon attributable to their high level of biocompatibility [15, 18, 27, 28, 42, 49]. 
Moreover, CDs have been also applied as monomers for hydrogels wound dressings as drug 
delivery devices [15]. 
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Hydrogels 
 
Hydrogels are tri-dimensional networks of hydrophilic polymers [50], the network confers an 
insoluble behaviour to the polymeric system and allow the hydrogels to absorb from 10-20% (an 
arbitrary lower limit) to up to thousands of times their equivalent weight in water , until the 
process reaches an equilibrium state. Therefore, hydrogels provide the moist environment 
required for an optimal wound healing process [4, 51, 52]. They are mainly employed to dry-to-
moderately draining-wounds, to promote autolytic debridement in necrotic wounds and in 
granulating wounds. 
The characteristics of hydrogels critically depend on the polymers employed and on their 
interactions within the network. Hydrogels are known as either permanent or chemical if their 
network is covalently cross-linked [51–53] or physical/reversible if the network is sustained by 
molecular entanglements and/or secondary attractions, including electrostatic interactions, 
hydrogen-bonding or hydrophobic forces (Van der Waals) (Fig 1.2). The reversible character of 
these hydrogels arises from the disruption of the above network interactions via modifications in 
physical conditions such as ionic strength, pH, temperature, stress or, alternatively, the addition 
of specific solutes [51, 52, 54, 55]. 
 
 
F ig  1.2 Schematic of methods for the formations of the two types of hydrogels, chemical or permanent and physical 
or reversible [51]. 
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Hydrogels can be generated from a wide range of polymers, and they are characterised 
according to the source of these macromolecules: synthetic, natural, or a combination of both 
(Table 1.2) [51]. 
Synthetic polymers allow the control, at the molecular level, of the network structure's properties 
and chemical or biological responses during their design and manufacture [52, 56, 57]. Within 
the synthetic category of hydrogels, those most commonly employed for biomedical applications 
are the neutral ones. These are derivatives of PHEMA [12, 58], PVA [56, 59, 60], or PEG. PEG is 
probably the polymer most investigated and employed for biomaterials purposes, in view of its 
non-toxicity, non-immunogenicity and, also, its approval by the FDA [13, 61]. Immune alterations 
on PEG hydrogels, such as surface modification via covalent bonding with silicone acrylate and 
thiol linkages, adsorption and/or ionic attractions or hydrogen bindings, have been proposed in 
order to facilitate their suitabilities for cell contact [62]. 
Furthermore, an increased extent cell contact can be achieved by the formation of block of co -
polymers such as tri-blocks of PEG with PEO, which confer degradability potentials to PEG 
hydrogels, or tri-blocks of PEG with PLA, or similar polymers that give rise to/ enhance the 
specific properties of PEG hydrogels [56]. 
For example, Molina et al [63] prepared a series of hydrogels from pre-synthesised 
PLA/PEO/PLA triblock polymers via a phase separation technique, involving the introduction of 
low water levels over co-polymers present in a biocompatible organic solvent system, specifically 
PEG-THF. The hydrogels generated in this manner exhibited hydrophilic characteristics which 
were greater than those of corresponding hydrogels produced via the swelling of dry tablets or 
films derived from these co-polymers. Indeed, they were sufficiently soft to permit their trocar 
injection. Moreover, both albumin and fibrinogen could be successfully entrapped in these 
hydrogel formulations, via their pre-mixing with the copolymer solutions prior to gel production. In 
terms of the time-dependent release profiles of these unique formulations, these researchers‘ 
findings were consistent with gel-protein compatibilities and incompatibilities with regard to 
albumin and fibrinogen, respectively [63]. 
As expected, hydrogels from natural sources are ‗friendlier‘ to the user since they are non-toxic, 
biodegradable and biocompatible, but unfortunately lack some of the mechanical properties 
required [64, 65]. The most common natural sources are collagen, hyaluronic acid (HA), 
alginate, agarose and chitosan [53, 66].  
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Table  1.2 Hydrophilic polymers employed for hydrogel production [51]. See Abbreviations for definitions of terms 
Po lymer  
Synthetic 
PEG-PLA-PEG 
PEG-PLGA-PEG 
PEG-PCL-PEG 
PLA-PEG-PLA 
PHB 
P(PF-co-EG) 6 acrylate end groups 
P(PEG/PBO terephthalate) 
PEG-bis-(PLA-acrylate) 
PEG-6CDs 
PEG-g-P(AAm-co-Vamine) 
PAAm 
P(NIPAAm-co-AAc) 
P(NIPAAm-co-EMA) 
PVAc/PVA 
PNVP 
P(MMA-co-HEMA) 
P(AN-co-allyl sulfonate) 
P(biscarboxy-phenoxy-phosphazene) 
P(GEMA-sulfate) 
Natural 
Hidroxyapatite 
Alginic acid 
Pectin 
Carrageenan 
Chondroitin 
Sulfate, 
Dextran sulfate 
Chitosan 
Polylysine 
Collagen (and gelatin) 
Carboxymethyl chitin 
Fibrin 
Dextran 
Agarose 
Pullulan 
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Table 1.2 Hydrophilic polymers employed for hydrogel production [51]. See Abbreviations for definitions of terms 
(continuation) 
Composites 
P(PEG-co-peptides) 
Alginate-g-(PEG-PPO-PEG) 
P(PLGA-co-serine) 
Collagen-acrylate 
Alginate-acrylate 
P(HPMA-g-peptide) 
P(HEMA/Matrigel) 
HA-g-NIPAAm a 
 
The first three sources of these materials are components derivatives of the mammalian 
extracellular matrix (ECM), collagen being its major protein [9], and HA is a polysaccharide 
(consisting of linear repeating glucuronate/N-acetylglucosamine disaccharide units) which has 
unique viscoelastic properties and is present in almost all animal tissues. Agarose, alginate and 
chitosan are isolatable from marine sources and have low toxicities and a high level of 
biocompatibility [56]. 
Collagen-based hydrogels can be synthesised without chemical modifications and, in view of the 
presence of many cell-signal domains, they are suitable for cell growth matrices. In addition, 
collagen is degraded in vivo by enzymes, such as collagenase, which is useful for tissue 
engineering scaffolds or injectable systems. Nevertheless, collagen hydrogels have poor 
mechanical properties, but these may be improved by chemical cross-linking, cross-linking with 
UV light or temperature, or by the generation of admixtures with other polymeric agents [56, 66]. 
HA is a glycosaminoglycan associated with wound healing, and is present at high levels in joints. 
HA hydrogels can be produced via multiple chemical modifications, and their in vivo degradation 
is achievable by enzymes such as hyaluronidase [66–68]. Alginate hydrogels are composed of 
various polymer chains, the structural integrity of which is maintained by ionic bridges and 
divalent cations. The network cross-linking density depends on the particular monomeric units 
and molecular mass of the polymer. The alginate hydrogel degradation occurs by modifications of 
its mechanical properties [69, 70]. Chitosan is composed of linear polysaccharides obtained 
from the partial hydrolysis of chitin and is degraded, in vivo, by lysozymes. Chitosan hydrogels 
maintain the beneficial bioactive properties of chitin, in terms of  biodegradability and bioactivity, 
and provides improvements in water retention capacity over that of chitin [56, 71, 72]. 
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Composite hydrogels arise from the incorporation of natural and synthetic polymers into the 
same network. The ‗natural‘ component of the hydrogel contributes to the high affinity and 
specificity for the cell binding activities of the matrix, and the synthetic part allows the control of 
the mechanical and physical properties of these systems. For example, bioactive molecules can 
be ‗entrapped‘ into the synthetic network and be released by environmental stimuli, act as 
degradable ‗trigger‘, or improve the biocompatibility of the system [56]. 
Currently, there are a number of hydrogels brands available for wound-dressing purposes already 
commercialized, especially in the case of skin substitutes, as reviewed by Boateng et al and Shai 
and Maibach [66, 73]. These skin substitutes involve scaffolds capable of releasing drugs which 
improve the cell growth and promote tissue regeneration. The attractive scaffolding properties of 
bioactive synthetic hydrogels have arisen their exact molecularly-customised biofunctions and 
attenuatable mechanical properties, together with the provision of microenvironments with 
functional properties similar to those of ECMs, which promote cell growth and tissue generation. 
Indeed, a range of design strategies have been examined in order to generate synthetic hydrogels 
with novel bioactive ECM-mimetic attributes, including cell adhesion, binding of growth factors, 
and proteolytic degradation [74]. Moreover, essential knowledge regarding these materials can 
be employed for the development of new wound dressing materials.  
Hydrogels are, also, cheap and effective wound-dressing agents in view of their high level 
biocompatibility, permeability to oxygen, powerful water absorption and moisture retention 
properties (Fig 1.3). Their removal from the wound sites can be made with minimal pain or 
trauma [75, 76]. Moreover, they are semi-transparent, allowing visual observation of the wound 
state without removal of the dressing. Since these hydrogels have soothing and absorption 
characteristics, they are suitable for partial-thickness wounds such as superficial thermal burns, 
friction blisters, chemical peels, derma-abrasion, facial laser resurfacing, and ulcers [53, 77]. 
However, with regard to the bioactive agent delivery systems, hydrogels have a number of 
limitations. Indeed, the capacity of hydrogels to load hydrophobic drugs is restricted, and  the 
release of those molecules, usually, occurs via a rapid non-linear diffusion to the surrounding 
environment [78]. Furthermore, the drug's biological activity may be lost via its interactions with 
solvents, or by phenomena imposed by the environmental conditions required for hydrogel 
production, such as pH and temperature [13]. 
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Fig  1.3 Representation of the most important features of the hydrogel as a wound dressing. 
 
Hydrogels already commercialised included synthetic, natural and composite materials [66, 73]. 
However, to the best of the authors‘ knowledge, there are little or no publications available 
regarding CD-based hydrogels in which the CD species works, simultaneous, as monomers for 
network synthesis and as carriers for wound-dressing applications. 
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Supramolecular Structures of CDs for Drug Delivery Purposes 
 
As referred above, CDs and their derivatives have been employed and studied for molecular 
recognition, drug delivery systems, and, also, as building blocks for nano-structured functional 
materials. Molecular architectures, including oligomers, polypseudorotaxanes, polyrotaxanes, 
nanoparticles, nanocages and hydrogels, have been constructed based on the ability of CDs to 
specifically link (covalently or non-covalently) to other CDs or polymers [15, 18, 79]. These 
nanosize structures are composed by CD aggregates with numerous functional groups, resulting 
in multiple cavities with the capability to interact with various ‗guest‘ molecules. This promotes 
the connection between the ‗guest‘ and the CDs by co-operative binding, which facilitates 
interactions between CDs and the guest's functional groups, and/or the ‗guest‘ itself. Hence, 
supramolecular structures-(SM) mimic the co-operative multimode, multipoint binding often found 
in biological systems. Therefore, SM improve the capacities of CDs' to encapsulate drugs, a 
process which enhances drug bioavailability and bioactivity [80, 81]. 
SM-CDs can be produced by covalently linking several CD cavities on a polymer, or by grafting 
them on a polymer through nucleophilic displacement, condensation or acylation reactions. They 
may also be constructed by the contribution of several covalent interactions which give rise to 
well-organized structures [82]. 
Bioactive CD-Oligomers (O-CD) are composed by CD cavities linked by functional bridges that 
provide additional interactions with the ‗guest‘ molecules, together with the co -operative binding 
of several CD units in order to improve the encapsulation of important bioactive ‗guests‘ [81–85]. 
Polypseudorotaxane and polyrotaxane structures consist of a long-chain molecule (axle 
component) and several CDs (wheel components) [80, 86]. Harada et. al [82], described a 
method to generate both classes of these structures. The production of polypseudorotaxanes (Fig 
1.4 a) involves the entrapment of CDs on polymers or polyelectrolytes, and then stabilising them 
through the use of hydrogen bonds between adjacent CD cavities and further non-covalent 
interactions between the long-chain molecule and the threaded cavities. The polyrotaxanes (Fig 
1.4 b) are obtained from polypseudorotaxanes to which bulk terminals (organic or organometallic 
groupings) were added at the chain ends, in order to prevent the CD‘s detachment [81, 82]. 
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Fig  1.4 Schematic representation of (a) αCD PEG polypseudorotaxanes and (b) αCD PEG polyrotaxanes [87]. 
 
The bioactive two- or three-dimensional supramolecular assemblies are composed by (1) an 
improvement of polypseudorotaxanes with added side-chains, giving the structure a two-
dimensional configuration that enables interactions between SM molecules and the bioactive 
agent; (2) nanostructures of modified CDs with three-dimensional configurations that are 
constructed via covalent and non-covalent linkages with gold, and (3) hydrogels that arise from 
the combination of long polymers and CDs [81, 88].The first two structures have their major 
applications in the DNA field, and since it is outside of the scope of this thesis, only hydrogels will 
be discussed in the next section. 
 
Cyc lodextr in-based Hydrogels 
As noted above, hydrogels possess novel properties, enabling them to be employed as drug 
delivery systems with the ability to improve wound healing, i.e., they have effective 
biocompatibilities and a sufficient water content. However, predominantly, such hydrogels require 
covalent cross-linking or severe environmental conditions in order to achieve a ‗gel‘ state which 
limits their applicability, and, hence, the sorption of drugs is very time-consuming with these 
systems and impairs drug integrity [52, 79]. 
Therefore, the main goal of this research field is the development of a hydrogel capable of 
delivering a drug without an associated cross-linking agent (i.e. one that is integral and has an 
effective level of activity), as well as a requirement to be generated at a suitable temperature and 
pH value for in vivo use. 
The further utilisation of CDs‘ as monomer improve the ‗swelling‘ properties of the hydrogels and 
further assist in protecting the drug trapped inside the cavity (Fig 1.5) [79, 80]. Consequently, 
SM systems composed by polymers and cyclodextrin have been investigated for possible wound 
Chapter 1| General Introduction 
21 
dressing applications, since these systems have the capacity to form spontaneous tri-dimensional 
physical cross-linking macromolecular networks that correspond to a hydrogel [52, 89]. 
To date, there are little or no documented reports available concerning the actions and efficacies 
of CD-based hydrogels for wound dressing purposes. However, Lee et al [90] investigated the 
therapeutic capacity of a hydrogel composed of βCD, PEI and SF, and containing Centella 
asiatica extract and HCA in the healing of pressure sores. In view of its hydrophobic nature, 
HCA‘s release was influenced by its partitioning between the βCD cavity and the bulk water 
phase, and not by the hydrogel‘s swelling capacity. Results obtained revealed that the pressure 
sores treated with this hydrogel system healed within a period of 6 days, compared to a 10 day 
length for control (untreated) pressure sores, and the researchers concluded that the 
βCD/PEI/SF hydrogel containing Centella asiatica extract and HCA diminished the healing time 
required for these sores [90]. 
 
 
F ig  1.5 Schematic representation of the CD-based hydrogel, where CD may have two utilities: (1) monomers and (2) 
a drug carrier. This system improves the capacity of the hydrogel to carrier hydrophobic drugs and avoids the drug 
aggregation (adapted from Peng et al [91]). 
 
CD-based hydrogels result from the ‗threading‘ of CDs onto parts of long polymers or copolymers 
with high molecular masses. The CD-drug complex may be added to the polymer (1) after or 
during gel cross-linking, (2) via grafting, or (3) by direct cross-linking with digylcidyl-ethers. The 
first method is easier to perform but may induce an early liberation of the complex from the 
hydrogel, alleviating the extent of control over the release kinetics. On the other hand, the other 
two strategies permit a better level of modulation of drug release from the system [52]. 
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Chemical supramolecular hydrogels are typically formed from polypseudorotaxanes or 
polyrotaxanes with CDs covalently-linked by cross-linking agents, or by modifications of the 
polymeric backbone. For example, biodegradable polymers with hydrolysable traps have been 
developed for drug or gene delivery applications [92]. 
The first published work with CD-containing polymeric hydrogels described a procedure to build a 
network from the chemical cross-linking of α, β or γCDs with epichlorohydrin (EPH), as a 
biofunctional cross-linking agent [93]. The first study proved that this network was able to form a 
complex with a variety of poorly water-soluble drugs. To enhance the swelling capability, increase 
the drug loading capacity and reduce the toxicity of EPH, the cross-linking reaction was 
performed in the presence of cationic or anionic compounds. For example, Li et al [94] described 
a positively-charged network by cross-linking βCD with EPH in the presence of choline chloride, 
and this resulted in an effective encapsulation, and release of the anti-inflammatory drug 
naproxen and had a lower toxicity when compared with networks without CDs. Negatively-charged 
EPH cross-linking βCD networks containing carboxymethyl groups were also reported. In this 
case, the hydrogels could be loaded with cationic drugs, such as those with microbicidal 
properties, a phenomenon rendering them useful for wound dressing and chewing gum 
formulations of value against mucosal infections. Other cross-linking agents were also described 
for CD-containing polymeric hydrogels, such as diepoxides, alkyleneglycoldi (epoxypropyl) ethers, 
the di-isocyanate hexamethylene diisocyanate, and anhydrides. The use of CD derivatives, such 
as MβCD, SBβCD or HPβCD, has been a helpful strategy, since they are capable of improving 
the capacity of these hydrogel materials to absorb water [18]. 
In order to tailor the mechanical properties of covalently-linked networks, this cross-linking has 
been employed to incorporate water-soluble polymers, such as PVA or hydroxypropyl 
methycellulose (HPMC). Nozaki et al [95] described a procedure to couple pNIPAAm-, (with 
terminal carboxyl acid groups) to amine-functionalised EPH pre-cross-linked by βCD. However, 
the material obtained exhibited a temperature-dependent behaviour. 
Although polymerisation of CDs with low-molecular-mass cross-linking agents demonstrated 
appropriate properties, the coupling of pre-existing networks to modified or unmodified CDs 
achieves an improvement in these properties. For example, CDs can be used as cross-linking 
agents as described by Bibby et al [96]. Their work reported an esterification of CD‘s OH with 
PAA carboxylic acid groups, and generation of an anhydride between PAA chains in this manner 
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led to the formation of a network inducible with temperature. Paradossi et al [97] suggested the 
production of a heterogeneous biocatalyst gel system loaded with copper(II) ions, by cross-linking 
chitosan with an oxidised (aldehyde-containing) CD via reductive amination. A recent work used a 
highly-selective copper(I)-catalysed, 1,3-dipolar cycloaddition (click chemistry) between an alkyne-
modified CD and an azide-functionalised poly(NIPAAm-co-HEMA) during hydrogel generation. The 
improvements offered by this process were an effective control of the gelation rate and the 
reaction conditions [98, 99]. 
Copolymerisation and chemical- or radiation-mediated inductions are also widely used for the 
production of CD/polymer networks. The most common polymers used are vinyl- or 
(meth)acryloyl-modified CD monomers with further vinyl monomers (acrylic acid, 2- HEMA, and 
NIPPAm). γ-CD-PAA systems with pH- dependent swelling properties [100], and βCD-maleic 
anhydride hydrogels with both temperature- and pH-dependent behaviour [101] have been 
described for drug-release materials. 
Moreover, vinyl- substituted polymeric macromers, such as MAH and PLA, the MAH-substituted 
block copolymer of Pluronic F68, and PCL have been employed for the development of hydrogels 
with controlled characteristics via radical polymerisation with CD derivatives [102]. 
Covalently-linked polymer/CD adducts can also be developed by cross-linking CD to reactive 
polymer end-groups, for example end-modified PEG, and these agents have swelling properties 
which depend on the network composition (i.e., the ratio of polymer:CD). Desirable PEG 
characteristics (biocompatibility, non-immunogenicity, and an effective loading capacity for 
hydrophobic drugs) render these hydrogels valuable candidates for biomaterials [103, 104]. 
In order to avoid the adverse effects of using cross-linking agents for hydrogel formation, selected 
systems have been developed in which gelation is induced via complexation between CDs and 
polymer chains [18, 79]. 
Physical supramolecular hydrogels arise from non-covalent interactions, such as (1) electrostatic 
interactions, (2) hydrophobic interactions between amphiphilic polymers, (3) hydrogen-bonding or 
(4) stereo complex formation between polymers with opposite chiralities, which confer 
reversibility behaviour to the network systems. This cross-linking can be performed in aqueous 
environments, whilst the drug is loaded, a process which improves the properties of the network 
[18, 105]. 
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In this case, network generation is a consequence of the CD inclusion of ‗guest‘ molecules, e.g. 
linear polymers. The polymers predominantly used are PEG, PPO and PCL [105]. PEG is 
probably the most widely employed for physical CD-based hydrogels in view of its 
biocompatibility, biodegradability and hydrophilicity, properties which render the network suitable 
for biomedical applications [79]. 
Hydrogels based on α-CD-PEG and its copolymers have been designed, and modifications to 
these materials have been made to improve their physicochemical properties, and, also, their 
biocompatibilities. The triblock of PEG and PPO (PEG-PPO-PEG) has weak physical interactions 
between chains in aqueous environments, an observation ascribable to the hydrophilic behaviour 
of PEG, which renders this copolymer unsuitable for long-term drug release applications. 
However, this can be overcome by using αCD as a ‗trap‘ to the PEG segments, a process which 
changes the hydrophobicity of the copolymer, and hence reduces the effective polymer 
concentration required for gelatinisation, and also confers thermo-reversibility behaviour to the 
copolymer [79]. Moreover, the PEG-PPO-PEG copolymer is not biodegradable, and therefore the 
use of PHB, a natural, optically-active and biodegradable polyester with high crystallinity and 
hydrophobic properties (instead of PEG only on its triblocks), gives rise to a polypseudorotaxane 
with a high self-assembly tendency in aqueous environments. The stability of the copolymer PEG-
PHB-PEG is attributable to complementation of the complexation between the αCD and PEG, with 
hydrophobic interactions between the mid-placed PHB blocks. For these reasons, PEG-PHB-PEG 
is a thyrotrophic and reversible supramolecular hydrogel, and can be employed for the long-term 
release of macromolecular drugs without a requirement for post-application removal [79, 92]. 
Additionally, αCD-PEG-PCL, (where PCL is an amphiphilic biodegradable copolymer) presented a 
similar behaviour to αCD- PEG-PHB-PEG. This is specifically the case for competition between 
complexation of PEG by CD versus hydrophobic PCL, as well as for the reversibility behaviour of 
the hydrogel and its thyrotrophic properties. This shows that it is possible to develop 
supramolecular hydrogels by IC formation with other amphiphilic biopolymers for the purpose of 
drug delivery with a minimal level of adversity to the user [79, 92]. 
The reversible properties of these physical hydrogels result from the entropically-unfavourable 
inclusion of the polymer and the CD via complexation linkages. Therefore, changes in the 
environment, such as temperature and pH values, can induce dissociation of the polymer from 
the CDs [92].  
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Plant-derived bioactive agents 
 
Plant extracts have been used in traditional medicine, and during the past few years many 
studies have proved their beneficial effects on human health. The plant extract‘s bioactivities are 
commonly related with compounds like fibre, vitamins, phytosterols, sulphur-containing 
compounds, carotenoids, organic acid anions, together with polyphenolics [106]. This kind of 
molecules is plants secondary metabolites and includes a wide range of compounds, many of 
which are phenolics or their oxygen-substituted derivatives (Fig 1.6). Polyphenolics confer 
protection to the plant, and are responsible for plant odours (essential oils), plant pigmentation 
(quinines and tannins) or their flavours (e.g., terpenoid capsaicin from chilli peppers) [23].  
Polyphenolics are plant metabolites present in human and animal diets, with a wide range of 
biological activities on human body, such as anti-oxidant, anti-inflammatory, antibacterial and 
antiviral [25, 26, 106–109]. They share a common chemical structure: all have at least one 
aromatic ring, with one or more OH attached. The diversity of phenolic compounds present in 
nature result from variations in the basic chemical skeleton, such as degree of oxidation, 
hydroxylation, methylation, glycosylation, and conjugation with further molecules, particularly 
lipids, proteins, other phenolics, and biomolecular metabolites [25, 110]. 
Therefore, this group of natural bioactive compounds includes a range of molecules from simple, 
single aromatic-ring, low-molecular-mass compounds, to large and complex tannins and 
polyphenolic derivatives. However, they all share two fundamental biological activities (1) radical 
scavenging action and (2) anti-oxidant properties by interaction with proteins and ions [25, 111–
113]. The anti-oxidant activity of lipophilic phenolics and polyphenolics can be attributed to their 
action as chain-terminator for the self-perpetuating autocatalytic lipid peroxidation process, as 
indeed does α-tocopherol (vitamin E). 
Polyphenolics are grouped by the number and arrangement of their carbon atoms (Fig 1.6) 
[110]. Polyphenolics will be sub-divided as flavonoids and non-flavonoids. 
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Fig  1.6 Chemical structures of common plant-derivable bioactive agents (Chem3D Pro 12.0 software). 
 
Flavonoids 
Flavonoids are low-molecular-mass compounds with a flavan nucleus: two aromatic rings 
connected by 3-carbon bridge (C6-C3-C6) [106, 112]. In plants, they are utilised in response to 
microbial infection. However, in animals and humans, flavonoids protect cells against damage 
caused by reactive oxygen species (ROS), and, also, defend skin from damage induced by short 
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wavelengths [33]. Moreover, they have the capacity to inhibit the growth of a wide range of 
bacteria via disruption of bacterial cell walls, following by their complexation with the extracellular 
soluble protein components [23]. Flavonoids, also, exert anti-viral actions due to their favourable 
oxidation potentials [114, 115]. 
The heterogeneity of the flavonoid group arises from the numerous substitutional modifications 
possible on the basic carbon-based skeleton. The presence of OH and sugars are very common, 
and increase their water solubility. However, methyl groups and iso-pentyl units increase their 
lipophilicity [110]. The bioactivities and properties of the flavonoids are critical, and are affected 
by small changes in the chemical structures [23, 116]. Therefore, flavonoids can be divided into 
sub-classes according to the precise nature of their chemical substituents, summarized on Table 
1.3. 
 
Non-Flavonoids 
Non-flavonoids include all the other polyphenolics (Fig. 1.6), from the simplest phenolics and 
phenolic acids to the phenolic complex tannin. This non-flavonoids group incorporates (1) 
phenolic acids, (2) quinines, (3) stilbenes, (4) tannins, and (5) coumarins. 
Although phenolics and phenolic acids are single-substituted phenolic rings, they are capable of 
numerous biological effects. In fact, some authors have related the number of OH on the 
aromatic ring with their antimicrobial activity: the higher is number of OH the higher is the level of 
toxicity exerted to micro-organisms [110]. Phenolic acids include derivatives of benzoic acids, i.e. 
(C1-C6)- hydroxybenzoic acids, and derivatives of cinnamic acid, i.e. (C 3-C6)- hydroxycinnamic acids 
[117, 118]. Gallic, p-hydroxybenzoic, and ellagic acids are representatives of the first group, and 
frequently occur in the form of glucosides. These compounds are water-soluble and sensitive to 
temperature, elevated pH values, oxidation and light [25, 111, 118]. Caffeic, ferulic and p-
coumaric acids belong to the class of hydroxycinnamic acids, and are rarely found in the free 
form; indeed, they are usually present in nature as simple esters with hydroxy carboxylic acids or 
glucoses. The hydroxycinnamic acids are, also, sensitive to oxidation and high pH values, and are 
poorly-soluble in water [25, 110, 111, 119]. Phenolic acids have been described in the literature 
as molecules with effective anti-microbial activity, particularly as fungicides. Their antimicrobial 
activity critically depends on phenolic chemical structure, especially on the number and position 
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of the substitution in the benzene ring, and, also, on the saturated chain length. The microbicidal 
capacity was found to be increased with augmentation of the alkyl chain length [118, 120, 121]. 
 
Table  1.3 Classification, structure and possible substitutions of the major classes of plant-derived flavonoids 
(Chem3D Pro 12.0 software) 
 
Quinones are highly-reactive, oxidised polyphenolic agents containing an aromatic ring (phenol 
group-oxidised) with two ketone substitutions. In plants, they are responsible for the brown 
colouration of the injured fruits, and act as intermediates in the melanin synthesis pathway in 
humans. Furthermore, quinones exert powerful antimicrobial activities, by link ing irreversibly to 
proteins and enzymes of the surface wall and membrane of microorganism, and thereby 
inactivating them. However, this mechanism of action may also be responsible for their 
toxicological actions in humans [23]. 
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Resveratrol serves as a typical representative of the stilbenes group. The members of this group 
are characterized by a C6-C2-C6 structure, and are produced by plants during episodes of stress,  
such as those arising from disease or injury [110, 111, 122]. Stilbenes, specially resveratrol, 
have been established anti-ageing and anti-oxidant [116]. 
Tannins are a group of relatively high-molecular-mass biomolecules capable of tanning leather, or 
precipitation of gelatine from solution. Tannins based on a gallic acid precursor or ‗nucleus‘ can 
be hydrolysable as multiple esters with D-glucose, or based on condensed derivatives from 
flavonoid monomers, also known as proanthocyanidins. Tannins have the capacity to stimulate 
phagocytic cells, and also act as host-mediated tumour suppression or microbicidal agents. The 
latter activity results from the capacity of these agents to reversibly bind to proteins via hydrogen 
bonding and/or hydrophobic interactions (van der Waal‘s forces), or irreversibly via covalent 
bonding processes which inactivate the enzymes and adhesins present on the microbial cell wall 
[23, 111].  
Coumarins include phenolic agents with fused benzene or α-pyrone rings; indeed, the basic 
structure can provide a wide range of substitutional modifications which modulate their biological 
activities. The major bioactivities assigned to this group of compounds are antithrombotic, anti-
inflammatory, anti-allergic, hepatic-protective, antiviral, anticarcinogenic, and vasodilator agents 
[123, 124]. Warfarin, [2-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-4-1], serves as a good example 
of a coumarin-based drug available with good anticoagulant and antiviral properties [23]. 
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Cyclodextr ins and Polyphenolics 
 
The number of currently-available pharmaceutical products based on polyphenolic agents is 
enormous, and its relevance to the global economy is consistently growing. A large number of 
plant extracts and their constituents, already employed in the food industry, have been adapted 
to serve as major active ingredients in both cosmetic and health products. However, the 
effectiveness of these active compounds deepens the preservation of their stability, bioactivity 
and bioavailability [26]. Indeed, limited water solubility, differences in the amounts of extract 
required for bioactive effects, and the rapid oxidation of at least some of these agents, represents 
some of the problems detected during the developmental stages of drugs based on polyphenolics 
[25, 26, 36]. Therefore, new approaches have been developed in order to overcome these 
drawbacks. Indeed, their encapsulation with CD species is one of them. 
A wide range of reports have been published regarding the encapsulation of natural polyphenolic 
agents by CDs, for food and drug delivery proposes. A brief resume of the available published 
work regarding the IC between the most common polyphenolics and CD with pharmaceutical 
applications will be made. The works with IC polyphenolics-CDs are summarized on Table 1.4 
and some of them are analysed with more detail. 
 
Table  1.4 Published works regarding the inclusion of polyphenolics by CDs and derivatives 
 Po lyphenolic CD Improved characteristics Re ferences 
E
ss
e
n
ti
a
l 
O
il
s Eugenol βCD  [125] 
Lavender β-D Solubility [126] 
Mint βCD  [126] 
A
lk
a
lo
id
s 
Curcumin 
αCD 
HPαCD 
βCD 
HPβCD 
RMβCD 
SBEβCD 
HTAβCD 
HPγCD  
Solubility 
Anti-carcinogenic 
Transdermal permeation 
Anti-inflammatory 
Bioavailability 
Photodegradation 
 
[127] 
[128] 
[129] 
[130] 
[131] 
[132] 
[133] 
[134] 
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Table  1.4 Published works regarding the inclusion of polyphenolics by CDs and derivatives (continuation) 
A
lk
a
lo
id
s 
Curcumin γCD  
[135] 
[132] 
P
h
e
n
o
li
c 
a
ci
d
 
Caffeic acid 
βCD 
HPβCD 
Solubility 
[125] 
[136] 
Catechol βCD  
[125] 
[137] 
Chlorogenic acid βCD 
Solubility, Anti-oxidant, 
Antimicrobial 
[49] 
Coumaric acid  βCD Solubility, Anti-oxidant [138] 
Ferulic acid 
αCD 
βCD 
γCD 
Solubility, Photostability, 
Transdermal permeation 
[125] 
[139] 
[140],[141] 
Nerolidylcatechol HPβCD  Solubility [142] 
Rosmarinic acid 
βCD 
HPβCD 
HEβCD 
MβCD 
Solubility 
Anti-oxidant 
 
[143] 
Vanillin βCD  [125] 
S
ti
lb
e
n
e
s 
Resveratrol 
αCD 
βCD 
HPβCD  
MβCD 
DMβCD 
Thermal stability Solubility 
Anti-oxidant 
Anticarcinogenic 
UV degradation 
 
[144] 
[145] 
[146] 
[147] 
[148] 
F
la
vo
n-
3-
ol
s 
Epigallocatechingallate 
βCD 
HPβCD 
DMβCD 
Solubility 
Anti-oxidant 
[149] 
F
la
vo
n
e
 
Apigenin 
DMβCD 
HPβCD 
Solubility [150] 
Baicalein 
αCD 
βCD 
HPβCD  
DMβCD 
γCD 
Solubility 
Thermal Stability 
[151] 
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Table  1.4 Published works regarding the inclusion of polyphenolics by CDs and derivatives (continuation) 
F
la
vo
n
e
 
Chrysin 
βCD 
DMβCD 
HPβCD 
Solubility 
Anti-oxidant 
[152] 
[150] 
Luteolin 
βCD 
MβCD 
DMβCD 
HPβCD 
HEβCD 
G2βCD 
Solubility 
 
[153] 
[150] 
 Rutin 
HPαCD 
βCD 
HPβCD 
γCD 
HPγCD  
Solubility 
Stability 
Anti-oxidant 
Bioavailability 
[154] 
[155] 
[156] 
[157] 
[158] 
F
la
vo
n
o
l 
Catechin βCD 
Solubility, Anti-oxidant, 
Transdermal permeation 
[159], [160], 
[161] 
Galangin 
HPβCD 
DMβCD 
Solubility [162] 
Isoquercetin 
βCD 
HPβCD 
DMβCD 
 [163] 
Kaempferol 
βCD 
G2βCD 
HPβCD 
DMβCD 
Solubility 
Stability 
Thermal Stability 
Anti-oxidant  
[164] 
[165] 
[162] 
[166] 
F
la
vo
n
o
l 
Myricetin 
HPβCD 
DMβCD 
Solubility 
Anti-oxidant  
[162] 
[166] 
Quercetin 
βCD 
HPβCD 
MβCD 
DMβCD 
Solubility 
Anti-oxidant  
Photostability 
[159] 
[158] 
[162] 
[33] 
[166] 
 
 
 
Chapter 1| General Introduction 
33 
Table  1.4 Published works regarding the inclusion of polyphenolics by CDs and derivatives (continuation) 
F
la
va
n
o
n
e
 
Alpinetin HPβCD Solubility, Stability [167] 
Astilbin 
αCD 
βCD 
γCD 
Solubility [168] 
Naringenin 
βCD 
HPβCD 
DMβCD 
TMβCD 
Solubility 
Bioavailability 
 
[169], [170], [47] 
Naringin βCD Solubility [170] 
Hesperetin βCD Solubility [170] 
Hesperidin βCD Solubility [170] 
Is
o
fl
a
va
n
e
 
Daidzein  
βCD 
HPβCD 
RM-βCD  
γCD 
Solubility 
Bioavailability 
[171], [172] 
Genistein 
βCD 
HPβCD 
RMβCD 
γCD 
Solubility 
Bioavailability 
[171], [172] 
Glycitein 
βCD 
HPβCD 
Solubility [171] 
Puerarin G2βCD Solubility [173] 
 
Cyc lodextr ins and Flavonoids 
The majority of the publications in this area of expertise concern the encapsulation of flavonoids 
with βCD and its derivatives in order to improve the flavonoids water solubility and stability.  
The catechin, epicatechin and epigallocatechin-gallate are molecules representative of the flavon-
3-ols subgroup (Table 1.3). These compounds present antidiabetic and antiobesity properties, 
besides the anti-oxidant action [174]. Catechin isolated from grape seed was successfully 
complexed with βCD with a 1:1 stoichiometry [160]. Moreover, the solubility profile of 
epigallocatechin after encapsulation with βCD, HPβCD and DMβCD was described by Folch-Cano 
et al [149]. They observed that the temperature had a different influence on the K, dependent on 
the CD used. In the case of the native CD, the K rise with temperature increase, the opposite was 
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observed for the CD derivatives used in this study. Hence, the DMβCD was the most suitable CD 
for the complexation of epigallocatechin. The authors also described that regardless of all the IC 
had similar geometries, the flavonoid anti-oxidant rings position inside the CD cavity was different 
[149]. 
Rutin is a flavone used in capillary preservation drug with poor solubility. The encapsulation of 
this polyphenol with αCD, βCD, HPβCD and DMβCD was described by different authors in order 
to improve rutin solubility, and, consequently, pharmacological activity [156, 158, 175, 176]. For 
the CDs used, the IC formed was 1:1, this means that each molecule of cyclodextrin was capable 
of interact with one molecule of rutin. Haiyun et al [175], Shuang et al [156] and Sri et al [158] 
achieved similar K for the IC of rutin and βCD (between 260 to 265 M-1). 
Regarding HPβCD, the IC formed was more stable since the constants described were higher 
than the ones for the βCD/rutin. The constant value achieved by Sri et al was a lower than 
Shuang et al, meaning that higher temperatures (28ºC in the first case) are less favourable for 
this IC formation. However, the DMβCD was the CD with higher K (3217.62 M -1) [176]  and the 
αCD with lower capacity to complex with rutin, probably related to the CD‘ cavity size [156]. The 
formation of IC improved rutin solubility and, consequently, it anti-oxidant activity and 
bioavailability. For instances, the complexation of rutin with βCD improved it anti-oxidant 
protection of cells against oxidative stress [154]. The enhance of the oral availability by the 
capsulation of rutin by HPβCD was proved by Miyake et al [155] after administration of the ICs to 
beagle dogs. The stability of rutin can be improved by complexation with HPβCD or HPγCD, the 
hydroxypropyl groups enhanced the interactions stability of the CD with rutin and the analyse of 
NMR showed that the rutin A ring was inside the cavity of HPβCD. The IC protect rutin from 
thermal and UV degradation and, also, increased this phenolic anti-oxidant capacity [157]. 
Chrysin is also a flavone and its pharmaceutical applications are related with its anti-oxidant, anti-
inflammatory and antihypertension capacity. However, as most part of this kind of compounds, 
chrysin has low solubility in water. Therefore, the use of CD as carrier agent improved it activity 
and administration [152]. Chrysin IC with βCD were investigated by Chakraborty et al [152]. The 
complex had the stoichiometry of 1:1 and with a K of 1005 M -1, anti-oxidant activity of the chrysin 
was also improved [152]. Kim et al [150] encapsulate this molecule with HPβCD, DMβCD, 
besides the native CD. They report the same stoichiometry (1:1) for all the CD use and the 
HPβCD had the higher K (1855 M-1) [150]. In both works, authors described that the interaction 
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between the chrysin and the CDs occurs by the A-ring of the flavon, molecular interactions 
already mention for rutin [150, 152]. 
As the most part of flavonoids, quercetin is flavonol with antibacterial, anti-oxidant and antitumor 
properties, but its use on the pharmaceutical field is limited due to their sparingly solubility in 
water [177]. The βCD was used to improve solubility and photo stability of quercetin by several 
authors [158, 177, 178]. Jullian et al [177] and Calabro et al [178] reported a 1:1 stoichiometry 
complex, but Sri et al [158] described a 1:2 complex. As it was mention above, in the same 
equilibrium, it is possible to find different interactions between CD and the guest molecule (1:1 or 
2:1). Moreover, the K values, assessed by these authors, rise with the increase of the 
temperature. Jullian et a. [177] used 30ºC to prepare the βCD/quercetin and had the higher 
stability constant (602 M-1). In the same work, the IC formation with SBEβCD and HPβCD was, 
also, established. The IC for both βCD derivatives with quercetin was 1:1 and the solubility of 
quercetin was enhanced, with K of 4032 and 1419 M -1, respectively, without diminishing its anti-
oxidant property. Moreover, the CD derivatives were more efficient on the solubilisation of  
quercetin than the natural CD and showed better anti-oxidant activity [177]. 
The HPβCD was, also, used by Sri et al [158] and by Mercader-Ros et al [166] to enhance the 
solubility and anti-oxidant properties of the quercetin. In both situations, the K value found was 
lower (321 and 900 M-1) than the mentioned by Jullian et al, as well as the temperature used (28 
and 25ºC) [158, 166]. This means that the temperature is a crucial parameter on 
HPβCD/quercetin IC formation. The anti-oxidant activity of the quercetin was improved by its 
encapsulation by βCD derivatives (HPβCD, SBEβCD, DMβCD and MβCD) [33, 166, 176, 177]. 
The enhacment of quercetin biological activity may be a outcome of the protection from the rapid 
oxidation, by free radicals, conffered by the CDs [166]. Carlotti et al [33], also, reduced the 
photodegradation ratio of the quercetin by its complexation with MβCD. They claimed that  
because quercetin was in an apolar environement inside the CD cavity the photolytic reaction 
was reduced, and the amount of light capable of reach this flavonol was lower, since it had to 
cross the CD molecule [33]. 
Kaempferol is, also, a flavonol with great interest in the pharmaceutical field due to its potent 
anti-oxidant activity [179]. Its behaviour in aqueous environment had been improved by the 
utilization of CDs as encapsulating agents. As the other works described above, the βCD 
derivatives, such as HPβCD, DMβCD and G2βCD, were more suitable for the IC formation with 
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kaempferol than the βCD [162, 164–166]. Additionally, the temperature determines the K 
values, but in this situation IC formation was improved by lower temperatures [165]. The 
beneficial effect of the IC on the anti-oxidant activity of kaempferol was determined by Kim et al 
[162] and Mercader-Ros and et al [166]. 
The naringenin is a flavanone with a similar structure of the rutin, with good anti-oxidant capacity 
and capable of reduce the cholesterol plasma level [180]. The formation of IC between 
naringenin and βCD and its derivatives (HPβCD, DMβCD, MβCD and TMβCD) was analysed by 
several authors [47, 169, 170]. For the CDs mentioned above the stoichiometry of the IC was 
1:1, the HPβCD was the CD with higher stability constant [47]. Yang et al [169] demonstrated 
that the water solubility and thermal stability of this flavonoid was improved when encapsulated 
by β-CD, DMβCD or TMβCD. In fact, the ICs remained stable when exposed to temperatures 
near 225ºC. Based on their analysis of the NMR, they assumed that the C-ring of naringenin was 
interacting with the CDs‘ cavity [169]. The biological effect of the IC HPβCD/naringenin was also 
described. Shulman et al [47] proved that the solubility of the flavonoid was increased 400 times 
when complexated with the HPβCD. Moreover the naringenin transport across the model of the 
gut epithelium (Caco-2 cells) was, also, enhanced as well as it plasma concentration. Therefore, 
the IC HPβCD/naringenin can be used as oral delivery drug for the treatment diabetes and 
dyslipidaemia [47].  
Ficarra et al [170] and Tommasin et al [181] investigated the effect of the βCD and HPβCD IC 
on the solubility of the flavanones hesperetin and hesperidin. In the first work, hesperetin and 
hesperidin were complexed with βCD and improvement on the solubility and chemical stability 
were demonstrated [170]. Tommasin et al [181] demonstrated that the ICs formed was 1:1, and 
the better complextion was observed by HPβCD and hesperetin, based on the higher K values 
(21000 M-1) when compared to the ones assessed for hesperidin (K 90 M-1). The K values 
discrepancy can be justify by the size of the flavanones molecules, the hesperetin is smaller and 
less polar which make it more appropriated to interact with the hydrophobic cavity of the CD 
derivative. Nerveless, the solubility of both flavanones was improved and, consequently, their anti-
oxidant activity. Therefore, the hesperidin and hesperetin application as anti-oxidant and 
anticarcinogenic can be upgraded by the use of HPβCD as drug delivery agent [181]. 
Yang et al [119] used the three native CD and HPβCD for the IC formation with taxifolin, a 
flavanonol able to dilates bloods vessels, enhance microcirculation and cerebral blood flow and 
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prevent platelet aggregation. In this investigation, they proved that the ICs formed enhanced the 
taxifolin water solubility and thermal stability, highlighting their use on healthcare products. 
Moreover, βCD showed better capacity to interact with this flavanonol [119].  
The genistein is an isoflavone used on treatment and prevention of estrogenic related cancers or 
postmenopausal symptoms, due to its great affinity to estrogenic receptors. This polyphenolic 
has, also, anti-inflammatory effects and platelet aggregation inhibition. However, genistein limited 
solubility reduce its applicability in the pharmaceutical industry [172]. The complexation of 
genistein with CD can improve its solubility and enhance its biological effects. Daruházi et al 
[172] tested the IC formation between this isoflavonoid and βCD, γCD, HPβCD and RMβCD. The 
genistein was capable of interact with the 4 CD, but the CD derivatives induced a higher 
influence on the solubility of the compound. The genistein capacity to cross biological 
membranes was, also, improved by the encapsulation with the CDs [172]. Yatsu et al [171] 
assessed the βCD and HPβCD encapsulation capacity of a mixture of daidzein, genistein and 
glycitei. All the isoflavones showed higher affinity to the HPβCD, and the interaction between the 
CD and the bioactive molecules occur by introduction of the B-ring into the CD cavity, besides 
external interactions [171]. 
Based on the works described above, the derivatives of βCD are more appropriate for the 
improvement of the flavonoids solubilisation and stabilization, being the HPβCD the most used. 
These group of flavonoids can interact with CDs by (1) directing the B-ring toward the secondary 
rim of the CD or (2) heading the A-ring toward the secondary rim of the CD [162]. Moreover, 
flavonoids photo and thermal stability upgrade by encapsulation with CDs, as well as their anti-
oxidant activity, since the CDs prevent the oxidation by free radical of the flavonoids. 
 
Cyc lodextr ins and non-f lavonoids 
As referred above, the non-flavonoids had great importance on the pharmaceutical and cosmetic 
industry due to their biological properties. Though, their application is limited because these 
polyphenolics are very susceptible to degradation by environmental factors such as light, 
temperature and pH [110, 182]. In order to overcome this, some works have been published 
regarding the inclusion of non-flavonoids into CD.  
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The ferulic acid is, commonly, used for the preventing UV light induced skin tumour, but it has 
low stability under thermal and physical stress. The IC formation between ferulic acid and αCD 
was investigated by Anselmi et al [140]. Thus, the authors proposed the inclusion of this phenolic 
acid into the αCD, with a K value of 1162 M -1 and equimolecular complexation. Based on their 
results, the α and β unsaturated part of the ferulic acid and part of its aromatic skeleton were 
inside the hydrophobic cavity of the CD. The IC increased the ferulic acid resistance to the 
degradation by UVB and also, decreases it rate release [140]. The same phenolic acid was used 
by Casolaro et al [141] for the complexation with αCD. The stoichiometry of the IC was the same 
and they assumed that the ferulic acid was neutralized inside the CD cavity [141]. The cutaneous 
permeation and distribution through skin of the IC ferulic acid and αCD was assessed by Monti et 
al [139]. They concluded that the IC prevented the formation of the less active cis-isomer of 
ferulic acid and its degradation by UV light. The αCD/ferulic acid IC presented lower penetration 
on the skin which enlarge the skin protection against UV damages, since the ferulic acid remains 
at the skin surface [139]. The encapsulation of ferulic acid with HPβCD was also studied [183]. 
The IC obtained had lower stability (K 166.3 M -1), and the same stoichiometry of the others IC 
described above. Nerveless, the solubility and protection against decomposition caused by 
irradiation with UV light, was enhanced by the complexation of the ferulic acid with this CD [183]. 
Although, caffeic acid has been described as antibacterial and anti-oxidant phenolic acid, its 
biological activity may be jeopardized by its sensibility to oxidation and lower solubility [136]. 
Thus, some authors had described its encapsulation with CD to overcome these issues. Górnas 
et al [137] and Divakar and Maheswaran [125] complexed this phenolic acid with βCD. In both 
cases, the experimental results suggest a 1:1 IC with K of 270 and 516 M -1, respectively. The 
molecular interaction was described as follows, the OH of the phenolic acid were trapped inside 
the βCD cavity and the carboxyl moiety was projected outwards the CD [125, 137]. Górnas et al 
[137] studied the influence of the pH on the IC formation, and concluded that the K decreased 
with the presence of caffeic acid charged species. The caffeic acid was, also, encapsulate by 
HPβCD to increase solubility [136]. The authors conclude that the IC formation was better in acid 
conditions and the IC ratio was 1:1, also, the caffeic acid solubility increase. The lipophilic 
aromatic ring and ethylene portion of the caffeic acid was entrapped inside the CD cavity and the 
polar groups were outside the HPβCD cavity (Fig 1.7) [136]. 
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Rosmarinic acic, a hydroxycinnamic acid with high anti-oxidant properties and poor solubility, was 
encapsulated with αCD, βCD , HPβCD , HEβCD and MβCD [143] in order to improve both 
properties. By the observation on the UV-Vis spectrum of the rosmarinic acid and the ICs, the 
authors assessed the stoichiometry of all ICs (1:1) and the K. They reported that ability forming 
stables IC was as follows MβCD> HEβCD> HPβCD> βCD> αCD. Additionally, the anti-oxidant 
activity of the ICs was higher than the rosmarinic acid alone [143]. 
 
 
F ig  1.7 Optimised structure of the HPβCD/caffeic acid complex. Caffeic acid is inserted into the apolar cavity of 
HPβCD from its (a) ―top‖ side; (b) ―bottom‖ side. 
 
Resveratrol trans-3,4,5‘-trihydroxystilbene is a polyphenolic with a high level of therapeutic 
potential as anticarcinogenic and anti-oxidant [122]. This stilbene displays a hydrophobic 
behaviour, and is, also, extremely affected by exposure to oxygen, light, and oxidative enzymes, 
reducing its bioactivity. The use of CD to protect resveratrol and to increase it solubility, stability 
and bioactivity was applied in several studies [122, 144, 146–148, 184]. The effect of 3 native 
CDs and MβCD on the thermal stability of the resveratrol was reported by Li et al [144]. Based 
on the thermal analyses made, they assumed that the IC formation was favoured by the 
temperature rise, since all the reactions had negative enthalpy energy. The encapsulation of γCD 
and resveratrol was the most stable owing to the better fit between the phenolic compound the 
CD cavity, since γCD had the biggest cavity [144]. A similar work used the native αCD and βCD 
and 2 derivatives (HPβCD and DMβCD) to increase the concentration of resveratrol on solution 
and it stability. It was observed that the IC with native CD was, only, capable of complex with part 
of the resveratrol molecule and that the HPβCD offered a cavity with a better fit to the bioactive 
molecule [148]. 
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The biological properties of resveratrol (anti-oxidant and anticarcinogenic) were also enhanced by 
its encapsulation. For instances, Lu et al [146] and Li et al [147] used βCD and HPβCD as 
resveratrol carrier agents and described the betterment of the scavenging capacity of the IC, the 
inhibition of the lipid peroxidation activity and the cytotoxicity to cancer cells without harming the 
healthy ones [147]. The results obtained on the two works support the notion that the CD 
derivative form a stronger IC with this stilbene (K βCD 1815M-1 and K HPβCD 6778M-1), related 
to the easier access of the resveratrol to the HPβCD cavity, due to enlargement of the cavity 
opening and the despairing of the intramolecular hydrogen bond network [146, 147]. 
Additionally, the employment of HPβCD for resveratrol encapsulation, also, increases the 
photostability of this natural compound. The host position of the ‗guest‘ molecule inside the CDs 
did increase the resistance to the degradation by UV radiation, without affecting its anti-oxidant 
properties. Therefore, the HPβCD/resveratrol ICs represents a powerful candidate for the 
protection of skin against oxidative stressing episodes [122]. Furthermore, resveratrol 
concentration on aqueous environment was improved by the complexation with βCD and G2βCD 
and, consequently, it anti-oxidant capacity. Besides the solubilisation, both CDs were capable of 
protect the phenolic compound from rapid oxidation, by entrapping it inside their cavities, with 
similar stability (K βCD 4317 M-1 and K G2βCD 5130 M-1) [184].  
The curcumin is a natural phenolic with antitumour activity and effective against HIV-infection, 
cystic fibrosis and immunomodulation agent, but it low stability at acid environment and 
physiological pH and photosensibility limited the use of this coumarin as pharmaceutical agent 
[185]. Therefore, its encapsulation by the 3 native CDs was described by Patro et al [134]. They 
were able to improve the solubility and oral availability with all the 3 ICs. However, the α-CD was 
the one that showed higher K (1124 M -1). Lopez-Tobar et al [133], also, applied βCD and γCD as 
curcumin drug carriers. The large cavity of γCD was more efficient in the IC formation. Moreover, 
both CDs were able to form 2:1 IC with this phenolic compound and the molecular interaction 
proposed was that the aromatic rings and the hydrogen bonds were involved and a change 
occurs from the curcumin planar ketoenol form to non-planar difeto. The chemical stability and 
bioavailability may be upgraded by this conformational alteration [133], The same stoichiometry 
of the IC βCD/curcumin was observed by Tang and co-workers [186] and Rahman et al [127].  
In both situations, the solubility of curcumin was described as well as the same molecular 
interaction, referred above. Dandawate et al [132] used a synthetic form of curcumin but 
accomplished the same stoichiometry and solubility. In this work, the anticarcinogenic, systemic 
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bioavailability and tissue distribution of the IC βCD/synthetic curcumin were compared with the 
synthetic curcumin alone and concluded that they have been improved by the encapsulation 
[132]. 
CD derivatives were also tested as drug carriers of curcumin, in order to overcome the difficulties 
of its application as anticarcinogenic agent. For instance, 2 molecules of HPβCD formed stable 
IC (K 5000 to 62000 M-1) with 1 molecule of curcumin [128, 130, 187]. The transdermal 
capacity of curcumin was raised by the complexation with HPβCD, as well as the decrease of 
skin irritation [128]. Besides, HPβCD, HPαCD and HPγCD were used with the same goal. Mohan 
et al [130] compared the encapsulation of the 3 CD derivatives and reported that the 
encapsulation may occur both in 1:1 and 2:1 stoichiometry, and the HPγCD has a better 
complexion capacity. This IC (HPγCD/curcumin) was capable of reducing cell proliferation  and 
increase the apoptosis of cancer cells by interfering in the protein production [129]. Tonnesen et 
al [135] reported the encapsulation of curcumin with several CD derivatives, namely HPαCD, 
RMβCD, HPβCD, SBEβCD, HTAβCD and HPγCD. The greater positive change on the stability 
and solubility of curcumin was achieved by the complexation with the RMβCD and HPγCD, 
probably due do to the more hydrophobic environment found inside the cavity of the first CD and 
large cavity of the second, leading to a better accommodation of the bioactive molecule  [135]. 
The increase of the curcumin resistance to hydrolysis under alkaline environments when 
encapsulated with these CDs, was also proved [135]. 
The application of CDs as carriers of non-flavonoids is a viable choice to protect them from 
degradation by environment factures, such as UV-light, pH, temperature and oxidation, and also 
to improve their solubility, factors that contribute to increase the biological properties of these 
natural active molecules. However, because this group of molecules is a bit diverse, it is not 
possible to generalize the molecular mechanisms of interaction between CDs and non-flavonoids 
and the efficiency of the encapsulation depends, essentially, on the size of the CD cavity.  
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Conclusion 
 
CDs are capable of forming inclusion complexes with a wide range of bioactive molecules and, 
also, with polymers. CDs can act, simultaneously, as therapeutic agent carriers and as 
enhancers favourable hydrogel properties in biosystems. 
Hydrogels provide major benefits for wound-dressing applications since they can retain a moist 
environment (crucial for wound healing purposes), and are biocompatible. However, with regard 
to drug delivery applications, the trapping of low-to-moderately hydrophobic bioactive molecules is 
not very efficient, and their release is rapid and non-linear with time. 
The use of bioactive molecules from plants has gained a substantial interest during the last 
decade for food, cosmetic and pharmaceutical applications. Polyphenolic agents derived from 
plant sources have aroused much interest, especially in view of their anti-oxidant activity and 
bactericidal and fungicidal actions. Concerning the pharmaceutical applications of these plant-
derived bioactive molecules, the current problems are related to the protection of their properties 
from environmental factors, with their solubility in water and biofluids, and their bioavailability. 
CDs have a relatively unique capacity of improving solubility of bioactive polyphenolic agents in 
aqueous systems; protect them from elevated temperatures, pH values, light or the moisture -
induced degradations phenomena which serve to increase their bioavailability. Furthermore, the 
use of substituted cyclodextrins has been found to improve the physicochemical properties of 
these bioactive molecules. In fact, in the case of flavonoids the CDs‘ derivatives are the better 
choice to achieve an efficient complexation. Otherwise, the selection of the better CD for 
encapsulated non-flavoinoids molecules needs to be based on the dimensions of the molecule 
and the CD‘s cavity. Nerveless, the formation of inclusion complexes between CDs and plant 
polyphenolics serves as a promising pathway for the development of pharmaceutical products 
friendlier to the user. 
Therefore, cyclodextrin-based hydrogels may provide a solution to the achievement of a wound 
dressing material capable of maintaining appropriate conditions for wound healing, in addition to 
improving the healing process itself, via the release of bioactive molecules. 
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Abstract 
 
The present work aims to assess the antibacterial potential of phenolic extracts, recovered from 
North East Portuguese plants, and of their phenolic compounds (ellagic, caffeic and gallic acids, 
quercetin, kaempferol and rutin), against bacteria commonly found on skin infections. The disk 
diffusion and the susceptibility assays were used to identify the most active extracts and phenolic 
compounds. The effect of selected phenolic extracts and compounds on animal cells was 
assessed by determination of cellular metabolic activity. Gallic acid had a higher activity, against 
gram positive (S. epidermidis and S. aureus) and negative bacteria (K. pneumoniae) at lower 
concentrations, when compared with other compounds. The caffeic acid, also, showed good 
antibacterial activity against the 3 bacteria used. At the same concentration, gallic acid inhibited 
the growth of the 3 bacteria without causing harm to the animal cells. Nevertheless, gallic and 
caffeic acid showed a promising applicability as antibacterial agents for the treatment of infected 
wounds. 
 
Keywords:  caffeic acid, fibroblasts, gallic acid, phenolic compounds, skin and soft infections, S. 
aureus. 
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Introduction 
 
Skin, the largest human organ, works as a mechanical barrier against  environment hazards and 
is, also, responsible for self-healing, immune surveillance, sensor detection, thermoregulation 
and fluid homeostasis [1, 2]. Injuries, caused by extreme temperature, trauma, chronic 
ulcerations, pressure or venous stasis, promotes disruption of skin integrity allowing the 
deposition and colonisation of the injury tissue by a wide range of bacteria [3]. Skin and soft 
tissues infections are, typically, associated to staphylococci or streptococci, but virtually any 
microorganism may induce tissue inflammation and immune response [4, 5]. The severity of 
these infections may range from self-limit superficial infections to life-threatening diseases. The 
most common treatment is the use of broad-spectrum antibiotics. Though, the indiscriminate use 
of this kind of drugs affects the normal skin flora and may result in multi-resistant strains [6]. In 
order to overcome this issue it is critical to identify new antimicrobial agents. 
Plants are a viable, unlimited source of bioactive molecules, including antimicrobial agents which 
protect them from microorganism, insects and predators [7–11]. Phenolic compounds belong to 
these bioactive molecules group; their pharmaceutical abilities and benefits for human health 
have been demonstrated in several published studies [7, 8]. Anti-inflammatory, anti-oxidant and 
antimicrobial are some of the properties attributed to those molecules [7, 8]. 
The north-eastern region of Portugal, Trás-os-Montes, gathers a wide range of wild plants used on 
folk pharmacopeia and traditional cuisine. Several ethnobotanical surveys conducted in this 
region by Mountain Research Centre (CIMO) - ESA, Polytechnic Institute of Bragança selected 
some of wild plants as potential source of natural antimicrobial agents.  
The present work aims to select phenolic compounds, identified on extracts of selected wild 
plants from north-eastern region of Portugal, to be applied as antibacterial agents on the 
treatment of infected wounds. The antibacterial activity of 8 phenolic extracts and 6 phenolic 
compounds was tested against Staphylococcus epidermidis, Staphylococcus aureus and 
Klebsiella pneumoniae, usually, isolated from skin and soft tissue infections. The influence of the 
most effective phenolic compounds on human fibroblasts was, also, evaluated.  
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Material and methods 
 
Phenolic  Extracts and Compounds 
The plant samples and their phenolic extracts were obtained as described by Barros et al: 
Asparagus acutifolius (shoots)- Aa and Bryonia dioica (young stems) Bd [12], Cytisus multiflorus 
(flowers)- Cm and Sambucus nigra (flowers)- Sn [13], Rosa micrantha (flowers)– Rm,  Filipendula 
ulmaria (inflorescences)– Fu and Castanea sativa (upright catkins during anthesis)- Cs [14] and 
Cistus ladanifer (leaves)- Cl [15]. The phenolic characterization of the extracts is, also, described 
on the publications mentioned above. Six different phenolic compounds, recovered from those 
plants, were pointed out as the main ones: 3 phenolic acids (caffeic, ellagic and gallic acids) and 
3 flavonoids (kaempferol, quercetin and rutin) [12–15]. 
 
Strains and Growth Conditions 
The antibacterial activity of the phenolic extracts and compounds was tested against 3 bacteria: 
Staphylococcus epidermidis (ATCC 12228), Staphylococcus aureus (ATCC 6538) and Klebsiella 
pneumoniae (ATCC 11296). The bacteria were grown in tryptic soy agar (TSA, Merck, Germany) 
for 24 h at 37 ºC. The cells were inoculated in tryptic soy broth (TSB, Merck, Germany) and 
incubated for 18 h at 37 ºC, under agitation (120 rpm). Subsequently, bacterial concentration of 
each strain was adjusted to 1x106 cells.mL-1, via absorbance readings and the corresponding 
calibration curves. 
 
Disk Dif fusion Assay 
The antibacterial activity of the extracts or compounds against the 3 bacteria was assessed, first, 
by the Disc diffusion method described by the National Committee for Clinical Laboratory 
Standards (NCCLS), M2-A8 document [16], with some modifications. The TSA was the nutritive 
media used. Afterwards, 200 µL of each inoculum (1x106 cells.mL-1) was spread on the solid 
media plates (90 mm Petri dishes). Sterile filter paper disks (“Blanck Discs”, Liofilchem, Roseto, 
Italy, 6 mm in diameter) were placed over the petri dish and impregnated with 20 µL of each 
extract (200 mg.mL-1) or compound (5 mg.mL-1). The plates were incubated at 37 °C for 24 h. 
Thereafter, the size of the halo from the inhibition growth was measured. 
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Susceptibility Assay: Minimal Inhibitory Concentration (MIC) and Minimal Bacter ic id al 
Concentration (MBC) 
MIC and MBC were obtained according to the method described by Wiegand [17], an adaptation 
of the standard methods published by Clinical and Laboratory Standards Institute (CLSI) and the 
European Committee on Antimicrobial Susceptibility Testing (EUCAST) [18], using the broth 
microdilution procedure. Thus, a work solution of 20 mg.mL -1 of each extract and 10 mg.mL -1 of 
each compound were prepared in sterile distilled water. The 96 well plate (Orange Scientific, 
Braine-l’ Alleud, Belgium) were prepared by adding 100 µL of a solution of each 
extract/compound to a final concentration of 10 mg.mL-1 / 5 mg.mL-1 to the first well. Then serial 
dilutions (1:10) were made with MHB (Mueller–Hinton broth, Merck, Germany) in the other wells. 
The extracts concentration tested ranged between 0.02 and 10 mg.mL -1 and the phenolic 
compounds from 0.01 to 5 mg.mL -1. At each well, 50 µL each bacterium were added (S. 
epidermidis, S. aureus and K. pneumoniae). Drug-free and bacteria controls were also included. 
The plates were incubated for 24 h at 37 ºC. 
The MIC value was evaluated by the observation of the concentration that did not show any 
growth, by contrast with the bacteria control. The MBC, number of viable cells, was assessed by 
determination of the number of colony forming units (CFUs). The CFUs were measured by plating 
10 µL of cell suspension from each well onto TSA, and incubated for 24 h at 37 ºC. 
The procedure was made in triplicate for each extract, compound and bacteria combination, in, 
at least, 3 independent assays. 
 
Cytotoxic ity Determination 
Fibroblast 3T3 (CCL 163) from American Type Culture Collection was used in this study. Cells 
were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10 % of foetal 
bovine serum and 1 % penicillin/ streptomycin at 37 ºC, 5% CO2. After achieving the confluence, 
cells were passed at the density of 1×105 cells.mL-1, using trypsin. 
To assess the effect of the extracts or compounds on the cellular viability, the cells were seeded 
at the density of 5×105 cells.mL-1 (24 well plate) in 1 mL of DMEM complete medium. After 24 h, 
the medium was replaced by 500 µL of fresh one, and 500 µL of extracts/compounds, at 
twofold of the desired concentrations dissolved in phosphate buffer solution (PBS). The plates 
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were incubated for 24 h at 37 ºC and 5 % CO2. Afterwards, the medium was removed and a 
mixture of 20 µL of MTS [3-(4,5-carboxymethoxyphenyl)-2-(4-sulfophenyl)- 2H-tetrazolium] 
(Promega) and 980 µL of DMEM without phenol was added to each well. After 1h, the 
absorbance value was measured, at 490 nm, and the results were expressed as percentage of 
viable cells (%), using the number of cells grown on wells without compounds as controls. 
The procedure was made in triplicate each extract/compound in, at least, 3 independent assays. 
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Results and Discussion 
 
The emergence of multi-resistant strains of pathogenic and opportunistic bacteria is correlated 
with the widespread use of broad-spectrum antibiotics, for treatment of skin and soft tissue 
infections. Therefore, the search for new drugs and new sources of antibacterial agents is of 
outmost importance [19]. Natural sources, such as plants, have been explored and gained 
prominence, since they offer many advantages when compared to the synthetic ones. For 
instances, they show high levels of biocompatibility and availability, and low toxicity [7–10]. 
Currently, polyphenolics are one of the major group of interest in view of their anti-inflammatory, 
antimicrobial, antiviral and anti-oxidant properties [20]. 
 
Antimicrobial Activity of the E xtracts 
The antibacterial activity of phenolic extracts from medicinal Portuguese plants, and, also, from 
polyphenolic compounds, identified on those extracts, was assessed by both qualitative and 
quantitative methods. The disk diffusion assay is a qualitative method, which allows a first 
screening of the potential antibacterial agents. However, this method presents some issues 
regarding the active molecules ability to diffuse into the agar, and so, a quantitative method such 
as the MIC and MBC determination should be used in order to obtain more accurate results. The 
MIC is defined as the lowest concentration of the antibacterial agent that inhibits the visible 
bacteria growth, observed with unaided eye, and the MBC is the minimal concentration of the 
antibacterial agent required to destroy most of the viable bacteria (reduce at least 3 log of 
growth) for a given set of conditions [21]. It is important to refer that the extracts and compounds 
present some colouration, which may lead to some misleading of the MIC values. Therefore, the 
MBC determination is crucial for a complementary analysis of the antibacterial properties of the 
phenolic compounds [19]. 
A preliminary assay using phenolic extracts of Portuguese medicinal plants was made, in order to 
identify phenolic compounds from those extracts. The chemical characterization of the phenolic 
extracts was described in previous works [12–15]. Both qualitative and quantitative analysis was 
made to the antibacterial activity of 8 phenolic extracts. From those extracts, only 5 (Cs, Cl, Cm, 
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Fu and Rm) were capable to reduce the growth of the 3 bacteria used (Fig 2.1). These extracts 
were selected as the most promising ones and their MIC and MBC values were assessed. 
As, the disk diffusion assay is based on the measurement of the growth inhibition halo, which is 
dependent on the antibacterial agent ability to diffuse trough agar, leading sometime mislead the 
results, quantitative complementary assays were also performed. 
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F ig  2.1 Values of the halo dimension (disk diffusion assay) for each extract (200 mg.mL -1) for the 3 bacteria. The halo 
size was calculated by deducting the size of the disk (0.6 cm). Aa: A. acutifolius, Bd: B. dioica, CS: C. sativa, Cl: C. 
ladanife, Cm: C. multiflorus, Fu: F. ulmaria, Rm: R. micrantha and Sn: S. nigra. 
 
The MIC and MBC values revelled that the Cs and Cl had a similar effect on the bacteria, being 
more effect against K. pneumoniea and S. epidermidis (MIC and MBC 0.63 mg.mL-1, for both 
species) and less effect against S. aureus (MIC 1.25 and MBC 2.5 mg.mL -1). The Fu and Rm 
extracts, also, showed comparable effect against the bacteria, namely, 2.5 mg.mL -1 was capable 
of reduce completely the 3 bacteria growth when exposed to these 2 extracts. Since, Cm 
phenolic extract had MIC and MBC values higher than 10 mg.mL-1, this extract was not used for 
further analysis. 
 
Extracts Effect on Fibroblast Proliferation 
Besides the antimicrobial activity of the extracts, the knowledge of their effect on the human cells 
is also crucial. Therefore, to predict the influence of the most promising phenolic extracts (Cs, Cl, 
Fu and Rm) on animal cells proliferation, a preliminary assay of cytotoxicity was made. 
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It was observed that the higher concentrations of the extracts (10 and 5 mg.mL -1) reduced the 
number of viable cells, when compared with the fibroblast growth without extracts. The phenolic 
extracts in lower concentration (1.25 mg.mL-1) had the opposite effect on the human cell line 
improving their growth and adhesion. 
A variation on the impact of the phenolic extracts was detected when using 2.5 mg.mL-1. The Cs 
and Cl are still toxic at this concentration, but Rm improved cell growth and the Fu phenolic 
extract show similar number of viable cells, in relation to the control. Thus, the results regarding 
the effect of Cl extract on animal cells in vitro are in accordance with Barrajón-Catalán et al [22] 
and Andrade et al [23]. Both studies show that Cl extract inhibit the proliferation of the cells when 
concentrations higher than 1.25 mg.mL -1 were used. 
Regarding to the cytotoxicity of the Fu extract, it improved the cell growth at 1.25 mg.mL -1. 
However, others authors [24–26] results suggest that this extract inhibit the growth of animal 
cells at lower concentration (between 0.2 a 0.1 mg.mL-1). The cell lines (B16 mouse melanoma 
[24, 25] or human lymphoblastoid cells [26]) and the method for quantify the viable cells (tripan 
blue coloration) used were different from our conditions, justifying the divergence of results. 
To authors’ knowledge, the effect of the Cs and Rm phenolic extracts on animal cells has been 
not described until know. The Rm extract improved the 3T3 fibroblast growth at 2.5 mg.mL -1 and 
CS at 1.25 mg.mL-1. Furthermore, the Rm and FU extracts can be safely used as antibacterial 
agents without causing any harm to the human cells. 
 
Antimicrobial Activity of the Phenolic  Compounds  
Six phenolic compounds identified in the extracts of Cl (ellagic acid, kaempferol and gallic acid), 
Fu (caffeic acid, kaempferol, rutin and gallic acid), Cs (gallic acid and rutin) and Rm (kaempferol) 
were selected for further analysis. Those compounds are all polyphenolics and can be placed into 
two groups: (1) phenolic acids and (2) flavonoids. Caffeic, gallic and ellagic acid belong to the 
first group and the remain compounds (kaempferol, quercetin and rutin) fit into the flavonoids 
group. 
The disk diffusion assay of the phenolic compounds (Fig 2.2) demonstrated that they can inhibit 
the growth of S. epidermidis, being the gallic acid the most efficient and caffeic acid, rutin, and 
quercetin the least. The compounds present a similar halo size against S. aureus, with the 
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exception of ellagic acid that did not change the bacteria growth. Gallic acid and caffeic acid were 
the only phenolic compounds tested capable of inhibit the gram negative bacteria (K. 
pneumoniae) growth. Due to the different and interesting results of the compounds in the 
diffusion assay, it was decided to determine the MIC and MBC of all of them (Table 2.1). 
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F ig  2.2 Values of the halo dimension (disk diffusion assay) for each extract (5 mg.mL -1) for the 3 bacteria. The halo 
size was calculated by deducting the size of the disk (0.6 cm). Ca: Caffeic acid; Ea: ellagic acid; Ga:gallic acid; K: 
kaempferol; Q: quercetin; and R:rutin. 
 
Flavonoids are a group of polyphenolic molecules from plant source with many biological 
properties already studied [27, 28]. The flavonoids antibacterial capacity is based on their ability 
to complex with extracellular and soluble proteins, and to destroy the bacteria cell wall by interact 
with essential enzymes, responsible for maintained the stability of this structure [7, 19]. 
However, in the conditions tested the flavonoids selected (kaempferol, quercetin, and rutin) had 
no effect on the bacteria growth for concentrations under 5 mg.mL-1. 
Our results, similarity to Penna et al [29], suggest that kaempferol has no activity under 5 mg.mL -
1 against S. aureus. Additionally, Fattouch et al [30] showed that kaempferol presented activity 
only at a concentration of 10 mg.mL -1. Regarding quercetin antimicrobial activity, El-Gammal et al 
[31] described that its MIC for S. aureus was 37 µg.mL-1. Fattouch et al [30] achieved a MIC and 
MBC for quercetin of 10 mg.mL -1 for the same bacteria, which corroborates our results. In this 
case, the differences among results can be justified by the methods used. For instance, Fattouch 
et al [30] used the microdilution method, the same procedure used in this work, however El-
Gammal et al [31] used a method dependent on the diffusion capacity of the compounds, which 
justify the differences on the MIC of the quercetin. In the case of rutin, some authors described 
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S. aureus was 0.125 mg.mL-1, and Thiem and Goslinska [36], besides MIC, also, determined the 
MCB of this phenolic acid against the same bacteria and reported the values of 0.63 and 2.5 
mg.mL-1, respectively. 
In literature, the gallic acid and the caffeic acid showed the same antibacterial mechanism, 
related to their similar structure (Table 2.1). These phenolic acids disrupted the bacteria cell by 
hyperacidification of the plasma membrane via proton donation and acidification of the 
intracellular cytosolic; this low pH can inhibit the enzyme H +-ATPase, necessary for the ATP 
production [37–39]. Our results demonstrated that the gallic acid and the caffeic acid had effect 
against the 3 bacteria tested. However, the first phenolic was active against both gram positive 
and negative bacteria with concentration on the range of µg.mL -1 and the caffeic acid activity was 
only detected when concentrations between 0.63 and 5 mg.mL-1 were used. Moreover, the K. 
pneumoniae was the most resilient bacteria to this compound (Table 2.1). 
Most of the published works regarding the antibacterial activity of gallic and caffeic acids use the 
disk diffusion assay method, without any quantitative method for complementary analysis [37, 
40–42], which may lead to misleading results related to the capacity of these molecules to 
diffused into the solid medium. Regarding the caffeic acid activity, Vaquero and Kwon reported 
formation of halo when in contact with gram positive and negative bacteria for 50 mg.mL -1 [37, 
42]. Larrainzar et al [40] obtained a MIC value for S. aureus of 561 µg.mL-1of gallic acid and 
Binutu et al [43] had a MIC of 250 µg.mL-1, 10 and 7 times higher, respectively, than the value 
attained in this work despite of the method used was the same. The differences of the MIC value 
may rely on lower temperature (lower metabolic rate leading lower uptake at 35 ºC when 
compared with 37 ºC) used for the growth of S. aureus by Larrainzar et al [40] or in a misleading 
caused by the colouration of the gallic acid [19].  
The differences find on the results published may be due to the diverse methods applied in each 
work to assess the MIC and MBC and/or interferences on the MIC and MBC procedure, such as, 
variations on the volume and concentration inoculum, source of the polyphenolic (natural or 
commercial), salts formation and precipitation leading to misleading results [19]. 
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Effect of Gallic  and Caffeic  ac id on 3T3 Fibroblast Growth and Adhesion  
Besides the antibacterial activity of natural molecules, the knowledge of their effect on the human 
cells is, also, crucial. Therefore, to predict the effects of the most promising phenolic compounds 
(gallic and caffeic acid) on animal cells, a preliminary assay of cell viability was made (Fig 2.3). 
The gallic acid showed no toxicity to the fibroblast when concentrations between 0.01 and 0.1 
mg.mL-1 were used (Fig 2.3 a). In fact, the lowest concentration induced an increase on the 
number of viable cells measured. However, for concentrations above 0.1 mg.mL -1, gallic acid 
became toxic. 
 
F ig  2.3 The viability of cells after 24 h of contact with gallic acid (a) and caffeic acid (b) dissolved in PBS, measured 
with an MTS assay. All data is expressed as mean + standard deviation (n = 9).The line indicate 70% of cell viability. 
 
The effect of caffeic acid on the viability of cells was dose dependent. The caffeic had no 
significant influence on the cells growth for concentrations between 0.06 and 1.26 mg.mL -1, but a 
reduction greater than 30% of viability was measured when 6.31 mg.mL -1, or higher, were 
applied. 
Both phenolic compounds have been described as potent anti-oxidant, and as consequence they 
exert some chemopreventives effects on animal cells [44, 45]. However, their anti-oxidant activity 
is based on oxidation-reduction reactions that are reversible and dependent on concentration. 
Therefore, these phenolics can act both as anti-oxidant and pro-oxidant, depending on the 
reaction conditions [44, 46]. This explains the fact that for higher concentrations gallic and 
caffeic acid induce major reduction on the cells viability. Additionally, gallic acid was more toxic, 
since that less than 20% of cells were capable of surviving for the concentrations between 0.5 to 
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1 mg.mL-1 (Fig 2.3 a). For the same range of the concentrations, the cells tolerated the caffeic 
acid (Fig 2.3 b). Our findings corroborate the fact that the predisposition to act as pro-oxidant is 
directly proportional to the number of hydroxyl groups (OH) in the molecule, gallic acid has 4 OH 
and caffeic only 3 (Table 2.1). 
Nevertheless, gallic acid can be used as antibacterial agent against the bacteria tested without 
cause any damage to the animal cells, since its MBC was 0.04 mg.mL-1 and, at this range of 
concentrations, the percentage of viable cells measured was higher than 70%, above this limit the 
compounds are safety for humans based on the ISO 10993-5:2006. In the case of caffeic acid, 
the concentration capable of destroy all the bacteria was, also, toxic to the fibroblast, which may 
suggest that the mechanism involved on the antibacterial action is the same of the on that cause 
damage on animal cells. 
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Conclusion  
 
The results presented in this work highlight the potential of phenolic extracts from wild Northeast 
Portuguese plants as antibacterial agents, as well as some of their phenolic compounds. 
Overall, extracts from Cistus ladanifer, Cytisus multiflorus, Castanea sativa, Filipendula ulmaria 
and Rosa micrantha were capable to inhibit the growth of the 3 bacteria commonly isolated from 
skin and soft tissue infections. Moreover, Cistus ladanifer, Castanea sativa, Filipendula ulmaria 
and Rosa micrantha revealed promising antibacterial effects against K. pneumoniae, S. 
epidermidis and S. aureus, in concentrations between 0.625 and 2.5 mg.mL -1. 
From those extracts, 6 phenolic compounds were selected. The flavonoids (kaempferol. quercetin 
and rutin) were capable of inducing halo formation on gram positive bacteria. However, the 
quantitative assay of the flavonoids demonstrated that they were not active for concentrations 
below 5 mg.mL-1. Regarding the phenolic acids, the ellagic acid was only active against S. 
epidermidis, but gallic and caffeic acids showed good antibacterial activity against the 3 bacteria 
at low concentrations. Thus, their effect on fibroblast proliferation was assessed, and revealed 
that caffeic acid has dose-response cytotoxicity and can be considered safe for concentrations 
less than 6.31 mg.mL-1. Regarding gallic acid, at lowest concentration it promoted the 
proliferation of fibroblast, but for concentrations above 0.1 mg.mL -1 it became toxic. Nevertheless, 
conjugating the antibacterial and cytotoxicity results, it could be pointed off that gallic acid can be 
used safely and presenting antibacterial activity against the 3 bacteria. 
The present work pretends to be a starting point to the use of phenolic compounds from North 
Eastern Portugal Plants on the treatment of infected wounds, instead of large-spectrum 
antibiotics. Moreover, gallic and caffeic acid appears to be suitable for incorporation on wound 
dressings to avoid tissue infections. 
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Abstract 
 
The substitution of large spectrum antibiotics for natural bioactive molecules (especially 
polyphenolics) for the treatment of wound infections has gain importance on the pharmaceutical 
industry. However, the use of those molecules depends on their stability in environmental stress 
and ability to reach the action site without losing biological properties. The application of 
cyclodextrins as vehicle for polyphenolics protection has been reported and appears to enhance 
the bioactive molecules properties. 
Therefore, the inclusion of the poor stable antibacterial agent, gallic acid, was investigated in β-
cyclodextrin, hydroxypropyl-β-cyclodextrin and methyl-β-cyclodextrin. Encapsulation by β-
cyclodextrin was confirmed for pH 3 and 5, with similar stability parameters. The hydroxypropyl-
β-cyclodextrin and methyl-β-cyclodextrin interactions with gallic acid were only confirmed at pH 3. 
Among the cyclodextrins, the better parameters of gallic acid encapsulation were obtained for 
hydroxypropyl-β-cyclodextrin, followed by β-cyclodextrin and methyl-β-cyclodextrin. The effect of 
CD encapsulation on the gallic acid antibacterial activity was, also, analysed. The antibacterial 
activity of the inclusion complexes was confirmed here, for the first time. 
Therefore, the encapsulation of gallic acid by hydroxypropyl-β-cyclodextrin seems to be a viable 
option for the treatment of skin and soft tissue infections, since this inclusion complex has good 
stability and antibacterial activity. 
 
Keywords:  Antibacterial activity, Benesi-Hildebrand equation, β-cyclodextrin, gallic acid, 
hydroxypropyl-β-cyclodextrin, methyl-β-cyclodextrin. 
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Introduction 
 
In the last years, the application of cyclodextrins (CD) as functional carriers in the pharmaceutical 
industry has increased. CDs are cyclic oligosaccharides with a truncate cone shape, their 
hydroxyl groups (OH) are oriented to the outer molecular surface and the hydrophobic groups 
turned to the cavity. This creates an micro-heterogeneous environment, which allow the 
formation of inclusion complex (IC) with a wide range of molecules, from straight or branch 
aliphatic chains to polar compounds, changing their chemical, physical or biological properties 
[1, 2]. 
The IC stability is, extremely, dependent on the three-dimensional fit between CD’ cavity and the 
“guest” molecule and, on the specific local interactions between the CDs’ surface groups and the 
“guest” [3]. The complex stability relies on hydrophobic forces, hydrogen bonds, van der Waals 
interactions, and on other factors like the release of ring strain and modifications in solvent 
surface tension. The combinations of these factors render the IC to a more stable energetically 
state [4, 5]. Thermodynamic factors, like enthalpy (ΔH), entropy (ΔS) and Gibbs free energy 
(ΔG), can be used as parameters for the complexation process evaluation, since the temperature 
influences the selectivity of the interaction between CD and the bioactive molecule [6]. In the 
case of organic compounds as guests, additional factors, such as pH and solvents, seems to play 
a major role on the IC formation [7]. 
In nature, CDs exists as α, β and γ differing on the cavity volume and diameter, being βCD the 
most used on the industry due to its capacity to encapsulate with a wide range of molecules. This 
native cyclodextrin has been subjected to chemical alterations on its OH, in order to enhance the 
physiochemical properties [7]. For instances, the 2-hydroxypropyl-β-cyclodextrin (HPβCD) and 
methyl-β-cyclodextrin (MβCD) are more hydrophilic than the βCD. Moreover, these derivatives 
presents higher solubility than the βCD (500 and 750 g.L-1 at room temperature compared to 18 
g.L-1 for βCD), which enhance the complexation with poor water soluble molecules [8].  
Wound infection has been one of the major causes of delay on the healing process or even on 
the scar development. Those infections, often associated to Staphylococcus and Klebsiela 
species, may range from superficial infections to life-threatening in compromised patients. Broad-
spectrum antibiotics has been, indiscriminately, used for the treatment of skin and soft tissue 
infections, changing the normal skin flora and leading to multi-resistant strains [9]. Therefore, the 
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demand for new antibacterial agents has increased in the last years and polyphenolics has been 
one of the major group of compounds study for that propose [7]. 
Gallic acid, also known as 3,4,5-trihydroxybenzoic acid, is a simple phenolic acid common found 
in plants, with several biological activities. For instance, gallic acid has been described as anti-
oxidant, anti-inflammatory, anticarcinogenic and antimicrobial [10–13]. Although, as others 
polyphenolics, gallic acid as reduced pharmacological applicability due to it lower water solubility 
[14, 15] and sensitivity to environmental stress (pH, light, temperature), factors that cause poor 
bioavailability [16–18].Thus, to maintain the gallic structural integrity and allow it to achieve the 
physiological targets, without losing any activity, an encapsulation device is necessary. 
Several authors have reported the phenolic acids encapsulation by CDs, being the native CD the 
most used, as well as the hydroxycinnamic acids (caffeic, chlorogenic, caffeic and rosmarinic 
acid) [8, 19–22]. They all report the IC formation with 1:1 stoichiometry, but the phenolic 
orientation within the CD depends on the phenolic as well as the IC stability. Moreover, the 
utilization of CD derivatives (HPβCD and MβCD) was reported by Çelik et al [8]. The IC obtained 
with rosmaniric acid had better stability than the native CD, suggesting that the substitution 
facilitates the encapsulation [8].  
Therefore, this work aims at evaluating the effect of pH on the stability of the inclusion complex 
formation between gallic acid and 3 CDs (βCD, HPβCD and MβCD). Additionally, the influence of 
gallic acids encapsulation on it antibacterial activity was assessed by the first time. 
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Material and methods 
 
Mater ial 
Gallic acid (3,4,5-trihydroxybenzoic acid) was purchased from Merck, β-cyclodextrin (βCD, 1135 
g.mol-1) and 2-hydroxypropyl-β-cyclodextrin (HPβCD, 1309 g.mol-1) were acquired from 
AppliChem, and the methyl-β-cyclodextrin (MβCD, 1310 g.mol-1) was obtained from Wacker. 
Gallic acid stock solution (2 or 10 mM) was prepared in methanol (MeOH) and kept for 30 min in 
an ultrasonic bath. Stock solutions for each CD (4x10 -2  M) were prepared in distilled water. The 
βCD solution was maintained at 50 ºC and 200 rpm, in order to improve its solubility in water.  
 
Buffer and pH effect  
Gallic acid solutions (1x10 -5 M, 2% MeOH) were prepared in two different buffers (H3PO4/NaOH 
and KH2PO4/K2HPO4) at pH 3, 5, 7 and 8. The buffers were prepared as follows: the desired pH 
(3, 5, 7 and 8) was made by mixing proper amounts of H 3PO4 (1x10-2 M, pH 2.05) and NaOH (1 
M, pH 14) for H3PO4/NaOH buffer and K2HPO4 (5x10-3 M, pH 8.02) and KH2PO4 (5x10-2 M, pH 
2.89) for the buffer KH2PO4/K2HPO4. The solutions were maintained 30 min in ultrasonic bath to 
insure the total solubilisation of gallic acid. The UV-Vis absorbance spectrum of gallic acid was 
recorded between 200-360 nm, for each condition. 
 
Inc lusion Complex Preparation 
In order to determine the stoichiometry and stability constants of the inclusions complexes 
between gallic acid and the 3 CDs, solutions with different concentrations of each CD (between 0 
and 6x10-3 M) were added at the same concentration of gallic acid (1x10 -5 M), for each pH (buffer 
H3PO4/NaOH). The solutions were kept 30 min at ultrasounds bath, after they were maintained 
24 h at 25 ºC, and 50 rpm on dark. Samples of each solution were taken for absorbance 
measurements.  
All the absorption spectra were measured the range 200–360 nm and recorded on a Jasco V560 
spectrometer, using a 1cm quartz cuvette. 
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Stoichiometry, Stability Constant and Thermodynamic Parameters Calculation 
The stoichiometry and stability constant (K) of each complex at the different pH were assessed 
based on the modified Benesi-Hildebrand equation [23] (equations 3.1.1 and 3.1.2). 
(3.1.1) 
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[CD]0 Cyclodextrin initial concentration  
A Absorbance intensities in the presence of cyclodextrin 
A0  Absorbance intensities without cyclodextrin  
A ’ Limiting intensity of absorption 
 
A double reciprocal Benesi-Heldebrand plot was drawn using both equations, i.e. 
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). The better fit (higher r2) of the Benesi-Heldebrand plots 
was used to identify the ICs stoichiometry. The equations were used to define the inclusion 
complexes stoichiometry: equation (3.1.1) represents a 1:1 complex and the equation (3.1.2) 1:2 
complex. The K was obtained from the slope of the graphic.  
The Gibbs free energy (∆G) was calculated using the K and equation 3.1.3. 
(3.1.3) ∆G                 ∆G Gibbs free energy 
R  gas constant  
T temperature (Kelvin) 
K stability constant 
 
BACTERIAL SUSCEPTIBILITY TO GALLIC ACID INCLUSION COMPLEX 
Bacter ial Suspension 
The antibacterial activity of the gallic acid on buffer H 3PO4/NaOH (selected buffer), at different pH 
values, as well as the IC activity, were tested against the bacteria: Staphylococcus epidermidis 
(ATCC 12228), Staphylococcus aureus (ATCC 6538) and Klebsiella pneumoniae (ATCC 11296). 
The bacteria were grown in tryptic soy agar (TSA, Merck, Germany) for 24 h at 37 ºC. The cells 
were inoculated in tryptic soy broth (TSB, Merck, Germany) and incubated for 24 h at 37 ºC, 
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under agitation (120 rpm). Subsequently, bacterial concentration of each strain was adjusted to 
1x106 cells.mL-1, via absorbance readings and determined with the corresponding calibration 
curve. 
 
Susceptibility Assay of Gallic  ac id  
The minimal bactericidal concentration (MBC) was obtained according to the method described 
by Wiegand [24], an adaptation of the standard methods published by Clinical and Laboratory 
Standards Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing 
(EUCAST, 2000), using the broth microdilution procedure. Thus, working solutions of 3.74x10 -3 M 
of gallic acid were prepared at pH 3, 5, 7 and 8 (buffer H 3PO4/NaOH). Serial dilutions of these 
solutions were made with MHB (Mueller–Hinton broth, Merck, Germany) to a final volume of 50 
µL. Afterwards, 50 µL of each bacterium suspension were added to a final concentration of 5x105 
cell.mL-1. Gallic acid- and bacteria-free controls were also included. The plates were incubated for 
24 h at 37˚C. The number of viable cells, was assessed by determination of the number of 
colony forming units (CFUs), by plating 10 µL of cell suspension from each well onto TSA, and 
incubated for 18 h at 37 ºC. 
The procedure was made in triplicate for each pH and bacteria combination in, at least, 3 
independent assays. 
 
Antibacter ial Activity of Inc lusion Complexes 
The ICs capacity to destroy the bacteria was also measured quantitatively. A volume of 50 µL of 
each complex (IC βCD/gallic acid and IC HPβCD/gallic acid) was added to 50 µL of 1x10-6 
cells.mL-1 of each bacterium, on 96 well plate. Bacteria and medium controls were also included. 
The plates were incubated for 24 h at 37 ºC. The antimicrobial activity of each solution was 
assessed by determination of the number of CFUs, as described above. The procedure was 
made in triplicate for each bacterium, at least, in 3 independent assays. Solutions of buffer, gallic 
acid (1 mM), βCD (1 mM) and HPβCD (1mM) were also included, to ensure that none of these 
factors alone could have influence on the antibacterial activity of the ICs. 
All the mathematical analysis was made using the Origin Pro software. 
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Results and Discussion 
 
The biological properties of gallic acid remain active even at low concentrations [18], however 
this phenolic acid is quiet susceptible to degradation under environmental stress (pH, 
temperature, light and oxygen) [25]. Therefore, the gallic acid protection by encapsulation by CD 
was studied. 
 
Inf luence of Buffer and pH on the Gallic  ac id Properties 
The UV-Vis spectra of polyphenols reflects alterations of the electronic energy levels within the 
molecules, caused by electronic transitions between π-type molecular orbitals [26, 27]. The 
nature of the solvent, steric effects, formation of resonance forms, intra- and inter- molecular 
hydrogen-bonding, electron-donating and electron-withdrawing substituents on the benzene ring 
are factors responsible by alterations on polyphenols spectra [25]. 
Therefore, the influence of 2 different buffers on the UV-Vis spectra of gallic acid was analysed, 
as well as the effect of the pH for each buffer (Fig 3.1.1). 
 
 
F ig  3.1.1 Absorbency spectra of gallic acid (1x10-5 M) dissolve in KH2PO4/K2HPO4
 
(a) and H3PO4/NaOH (b) buffers at 
pH3 (black), pH 5 (red), pH7 (blue) and pH8 (green). 
 
The gallic acid UV-Vis spectra usually show 2 bands between 200 and 360, a b-band (lower 
wavelength) near 220 nm and a c-band (higher wavelength) near 270 nm. The buffer effect on 
the gallic acid spectra was notorious. The intensity of the 2 peaks, regardless of the pH, was 
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lower when the phenolic was dissolved in the KH 2PO4/K2HPO4 buffer (Fig 3.1.1 a). At pH8, the 
peaks were not distinct, this peaks dissolution may be the result of a higher oxidation state of the 
phenolic compounds related to its unstable nature on basic environments, more notorious with 
this buffer [25, 28]. 
The H3PO4/NaOH buffer allowed higher intensity of the characteristics peaks, and the changes 
caused by pH were, also, more evident. The gallic acid spectra profile was the same for the pH 
range tested. However, an increase of pH induced a blue shift (a shift of λmax towards shorter 
wavelengths) for both bands, being more notorious for the c -band (pH 3 273nm, pH 5 261 nm, 
and pH 7 and 8 258 nm) and, also, increase of intensity (hyperchromic effect). Therefore, the 
H3PO4/NaOH buffer was chosen for further work, since the effect of pH on the gallic acid UV-Vis 
spectra was more obvious when it was used. 
As referred above, the pH is strongly linked to the stability of the polyphenols and affects their 
UV-Vis spectra [25]. Gallic acid has two ionisable moieties: (1) carboxylic group and (2) OH 
attached to the phenolic ring (Fig 3.1.2). The environmental pH will define the ionization state of 
gallic acid. The phenolic acid will assume a neutral form (Fig 3.1.2 a) at acid pH (<3.4), a 
carboxylic anionic between 4 and 7 and for basic pH appears as both carboxylic and hydroxyl 
anion [28, 29]. The gallic acid chemical alterations with the increase of pH have been attributed 
to the 3 hydroxyl groups (Fig 3.1.2 b). The formation of unstable quinones intermediates and 
other resonance forms has been linked to the reduction of intensity of c -band as the pH increase 
(Fig 3.1.1) [25]. Moreover, for basic pH (>7) gallic acid has been describe as unstable, suffering 
fast autooxidation, leading to the formation of degradation products [25, 28]. The presence of 
those products may justify the alterations observed on the spectra at pH 8, for both buffers. 
 
 
F ig  3.1.2 Chemical structure of neutral gallic acid (a) and gallic acid carboxylic anion (b). 
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The skin and soft tissues infections result from the colonization and proliferation of complex poly-
microbial communities. The infections may be triggered by natural microflora, such as 
Staphylococcus, Micrococcus and Corynebacteriumsp or by not typical resident microflora gram 
negative bacteria (Klebesiella, Capnocytophaga, Bartonella). The proliferation of pathogenic 
bacteria on the wound site has been related with the environmental pH [30, 31].  
In addition, the gallic acid antibacterial ability has been related to its capacity to exchange 
protons with the bacteria and the environment, thus pH-dependent. The antibacterial mechanism 
of gallic acid relays on its affinity to the lipophilic membrane layer, which enable the phenolic 
transport and, consequently, cytoplasm acidification causing protein denaturation. The 
acidification of cell environment leading to variations on the potassium ions efflux, altering the 
electrical potential of the cell and improve it permeability. All these cascade of events takes to 
irreversible alterations on cell and death [32, 33].  
Since the wound infection microflora depends on the environmental pH, as well as the gallic acid 
biological properties [25], the phenolic antibacterial activity at different pH was study (table 
3.1.1). It was used 3 bacteria, usually, isolated from infected skin, two gram positive (S. 
epidermidis and S. aureus ) and one gram negative (K. pneumoniae) [34]. 
 
Table  3.1.1 Minimal bactericidal concentration of gallic acid dissolved on H3PO4/NaOH (pH 3, 5, 7 and 8) against K. 
pneumoniae, S. epidrmidis and S. aureus (5x10-5 cel.mL -1) 
MBC 
(mM) 
K. pneunmoniae S. epidermidis S. aureus 
pH 3 0.47 0.47 0.47 
pH 5 0.23 0.23 0.47 
pH 7 0.23 0.23 0.47 
pH 8 0.12 0.23 0.47 
 
Regarding the gram positive bacteria, the pH had no influence on the MBC obtained for S. aureus 
(0.47 mM) and MBC for S. epidermidis was 0.47 mM, at pH 3 and 0.24 mM for higher pH. It 
was described that S. epidermids growth is enhanced by acid environments [31]. Thus, the lower 
susceptibility of this bacterium at pH 3 may result from higher metabolic activity. This results, 
suggest that all forms of gallic acid (neutral and anionic) are activity against gram positive 
bacteria, on the conditions tested. A relation between the pH and the susceptibility of K. 
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pneumoniae to gallic acid was observed, the MBC obtained decreased with pH basification. The 
optimal growth pH for this gram negative locate near 5 and 6 [35], the pH used to access the 
bacterial susceptibility were beyond that pH range. Bacteria cells have mechanisms responsible 
for controlling the pH variation between the environment and cytoplasm. The maintenance of 
optimal cytoplasmic pH comprises a combination of strategies, such as cytoplasm buffering, 
adaptations on the membrane structure, active ion transportation and metabolic consumption of 
acids and bases [36]. However, in specific situations the pH homeostasis mechanisms can fail, 
leading to significant change on the variation pH and decrease the cell metabolism. One of those 
situations, may occur when the cell increase the uptake of weak acids to equilibrate the 
difference between external and internal pH. The weak acids can freely be transported through 
the bacteria membrane, causing protons release  and consequent cytoplasm acidification [37]. 
In the present work, the addition of different pH buffers to the culture medium triggered those pH 
homeostasis mechanisms. Thus, the pH-dependent MBC obtained for K. pneumoniae may be a 
consequence of rising uptake of gallic acid (weak acid) to keep the pH homeostasis, which result 
on the accumulation of the organic acid on the cytoplasm, hyperacidification and, ultimately, cell 
death [37]. 
 
Impact of pH on the βCD/Gallic  ac id Interaction 
The gallic acid c-band (near 270 nm) was selected for the analysis of the interactions with CD, 
once it is the most use for its characterization (HSDB -Hazardous Substances Data Bank). Fig 
3.1.3 displays the effect of βCD concentration and pH on gallic acid UV-Vis absorbance spectra, 
collected after 24 h of complexation. Regardless the pH, as the CD concentration increase the 
λmax intensity of gallic acid decreased. At higher pH (7 and 8) the alterations caused by βCD on 
the phenolic spectra were subtle, just a slight absorbance variation was detected (Fig 3.1.3). 
The reduction of pH highlighted the effects of CD on the gallic acid spectra. At pH3 and 5, the 
spectra show an isosbestic point near 225 nm and hypsochromic effect (the λmax shift to lower 
wavelength). The isosbestic point states the presence of gallic acid in free form and 
encapsulated. The hypochromic effect observed as CD concentration increase may indicate that 
gallic acid was totally embedded in the cavity [19]. Both alterations support the IC βCD/gallic 
acid formation at this pH range and that the groups involved on the complexation process are 
located near the chromophore [19]. Others authors reported similar effects of βCD on the gallic 
Chapter 3.1| Cyclodextrins modulation of gallic acid in vitro antibacterial activity  
88 
acid spectra [15, 18, 29]; they also confirmed the encapsulation by SEM (scanning electron 
microscope), where the free gallic acid morphology was not detected after molecular inclusion 
[18]. 
 
 
F ig  3.1.3 Gallic acid (1x10-5 M) UV-Vis absorbance spectra in different βCD concentrations (0-6 x10-3M) at pH 3, 5, 7 
and 8 (buffer H3PO4/NaOH). 
 
As referred above, no significantly alterations were observed on UV-Vis gallic acid spectra at pH 7 
and 8 (Fig 3.1.3), probably due to the absence of IC or their lower stability. Thus, the inclusion 
complex formation was only characterized at pH 3 and 5. 
The UV-Vis absorbance spectra enable the confirmation of IC formation between of gallic acid 
and βCD. However, the biding strength and alterations caused by complexation on the guest 
properties lack further analyses. Thus, the stoichiometry, K and ∆G were used to estimate the 
stability of the IC [38]. The stoichiometry and K were calculated based on UV-Vis absorbance 
spectra data transformed by the Benesi-Hildebrand equation (equation 3.1.1) and ∆G was 
determined based on equation 3.1.3. 
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A linear relation (Fig 3.1.4) was obtained for the two pH values (3 and 5), indicating that 1 
molecule of gallic acid complex with 1 molecule of βCD (IC 1:1). 
 
F ig  3.1.4 Benesi-Hildebrand plot for the gallic complexation with βCD, at pH 3 and 5 (buffer H3PO4/NaOH). 
 
The pH range analysed (3 and 5) had lower influence on the K and ∆G, the values obtained were 
similar. The highest values were obtained for pH5 (K 71 M -1 and ∆G -10.4 kJ), however with r2 
0.865. At pH 3, the linear relationship obtained was better (r 2 0.957) but the K and ∆G were 
lower (K 41 M-1, ∆G -9.83 kJ). The ICs formed at pH 3 or 5 were formed spontaneously by an 
exothermic reaction (∆G<0) [39]. The ICs formation involves the replacement of polar water 
molecules, from the hydrophobic CD cavity, by gallic acid. At acids environments, gallic acid is 
present, mainly, has a neutral species (pK 3.4) [28], thus the encapsulation may be enhanced. 
Since, the K and ∆G for both pH were very similar, the pH  3 was considered the best condition 
for the βCD/gallic acid complexation due to it higher r2. 
From authors knowledge, there are just a few publications regarding gallic acid interaction with 
βCD [15, 18, 29]. Those works obtained similar parameters values for the IC characterization 
and, also, described analogues mechanisms of encapsulation. They all stated that the gallic acid 
was completely inside the βCD cavity, the carboxylic group towards to the small CD opening and 
3 OH were placed near wider entrance (Fig 3.1.5). In the present work, the major interactions 
between the gallic acid and βCD were hydrophobic, since the βCD was not charged at the pH 
range describe. Therefore, the ICs stability were maintained by hydrophobic bonds between gallic 
acid and the cavity, as well as hydrogen bonds established between the gallic acid and the CD 
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OH groups [18, 29]. Thus, the gallic acid neutral species (pH 3) may be capable of deeper 
location on the CD cavity than it ionisable form (pH >3.4) (Fig 3.1.5). This fact justify the lower 
stability observed for the IC formed at pH5 and the lack of encapsulation at higher pH. Based on 
our results and on the referred works, the stability of IC βCD/gallic acid may be enhanced by 
acid environment (pH lower than 3.4). 
 
 
F ig  3.1.5 Schematic representation of gallic acid location inside βCD molecule at different pH. 
 
Gallic  ac id Encapsulation by HPβCD and MβCD 
The encapsulation of polyphenolics by modified cyclodextrins has been described as more stable 
than the ones obtained with native cyclodextrins [8, 40]. In the present work, 2 βCD derivatives 
(HPβCD or MβCD) were chosen based on their improved solubility and, also, because the 
substitutions enlarged the cavity opening, reducing the strong intramolecular hydrogen bond 
network. These characteristics facilitate the access of the guest molecule (in this case gallic acid) 
to the cavity, leading to the formation of a complex with higher stability. From author’s 
knowledge, the inclusion of gallic acid by HPβCD or MβCD was analysed by the first time, on the 
present work.  
The effect of pH (3, 5, 7 and 8) on the gallic acid interaction with HPβCD and MβCD was 
studied. The variations on phenolic UV-Vis spectra induced by those CDs at pH 5, 7 and 8 were 
not detected on the conditions tested (data not show). Additionally, the gallic acid encapsulation 
with the native CD (βCD) was more efficient at pH 3. Hence, this pH value was chosen to study 
the effect of the βCD modifications on the complexation with gallic acid (Fig 3.1.6). 
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Fig  3.1.6 Gallic acid concentration detected on the solutions (based on the absorbency measured at the λmax) after 24 
h of complexation with different concentrations of cyclodextrins (0 to 6 mM) and at pH 3 (buffer H 3PO4/NaOH). 
 
The gallic acid behaviour was similar within the presence of the 3 CDs. A reduction of the gallic 
acid concentration on solution with the increased of CDs concentration was observed. These 
values were obtained from the UV-Vis spectra, where it was observed hypochromic effect 
(reduction of λmax intensity) with the increase of CDs concentration. This ef fect may result from the 
interference with molecular groups, responsible for the UV-Vis absorbance, induced by 
encapsulation [19]. The same behaviour was reported above for the native CD. 
Fig 3.1.6 suggests that the IC formed by the 3 CDs were similar, but additional characterization 
(stoichiometry, K and ∆G) of the complexes indicates differences among the CDs. The ICs 
obtained (HPβCD/gallic acid and MβCD/gallic acid) had a 1:1 stoichiometry, concordant results 
with the native CD. Though, the stability and thermodynamic parameters were different for these 
2 CDs. The HPβCD K (90 M-1) was higher than the βCD, and showed a lower ∆G (-11.0 kJ). 
These point out to the higher ability HPβCD to complex with gallic acid, when compared with the 
native CD. The size of HPβCD molecular cavity is similar to the βCD (7 glucopyranose units). 
Thus, the higher K obtained for the HPβCD suggest that the hydroxypropyl groups play a major 
rule on the IC process, these groups maintain the gallic acid molecules may be trapped inside 
the cavity [41]. The opposite was observed for the MβCD, since lower stability parameters were 
obtained (K 37 M-1 and ∆G -8.8 kJ). This CD was less favourable for the complexation of gallic 
acid, when compared with the native and the HPβCD. 
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Based on the results present above and as expected, the pH plays a major rule on the 
encapsulation of gallic acid by cyclodextrins. The pH 3 provide the best environment for the IC 
formation with the 3 CDs, and the pH 5 created conditions to the complexation between gallic 
acid and the native CD, with similar parameters achieved at pH 3. 
 
Antibacter ial E ff icacy of CD/Gallic  ac id Complexes  
The cyclodextrins encapsulation, usually, improve the guest molecule physicochemical and 
biological properties. Zhao [21] proved that the anti-oxidant and antibacterial activity of 
chlorogenic acid was not affect by its encapsulation by βCD. The antibacterial activity of the IC 
βCD/gallic acid and HPβCD/gallic acid was assessed by quantitative method. In order to ensure 
that gallic acid will be capable of killing all the bacteria cells on an infected wound, the 
environmental condition less favourable to its action (pH 3) was used for this analysis. Moreover, 
this pH allowed the best complexation process between gallic acid and βCD or HPβCD. 
The IC complexes were prepared with equimolar solutions (1 mM, two folds the MBC pH 3) of 
CD and gallic acid, considering the stoichiometry determinate above (1:1). As expected, the 
controls (buffer, βCD and HPβCD) and no influence on the bacteria growth.  
Fig 3.1.7 displays the susceptibility of the 3 bacteria when exposed to the ICs. Both ICs 
(βCD/gallic acid and HPβCD/gallic acid) were capable of reducing the 3 bacteria growth, but 
their antibacterial activity was constrained by the bacteria used. Against the gram negative 
bacteria (K. pneumoniae), the ICs had the same effect of the free gallic acid, completely growth 
inhibition. Regarding the gram positive bacteria (S. epidermidis and S. aureus), the antibacterial 
activity of gallic acid was reduce by βCD encapsulation, still the number of CFU detect was less 
than 3 log when compared with the control. The other IC (HPβCD/gallic acid) retained the gallic 
acid activity against S.epidermis, but allowed the growth of 1 log of S. aureus. 
The gram positive and negative bacteria differ in their cell wall and, consequently, on their 
susceptibility to antimicrobial agents. The gram positive bacteria have a continuous cell wall of a 
thick layer of peptidoglycan, while gram negative bacteria have a non-continuous cell envelope 
formed by a thin layer of peptidoglycan covered by an outer membrane. Hence, it is expec ted 
that gram negative bacteria are more susceptible to antimicrobial agents than gram positive ones 
[42]. Therefore, the higher susceptibility of the gram negative bacterium (K. pneumoniae) to the 
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ICs activity suggest that the ICs were capable of reach the cell surface more efficiently and 
consequently, higher uptake, when compared to the other bacteria. 
 
 
F ig  3.1.7 Quantitative analysis of the βCD/gallic acid and HPβCD/gallic acid inclusion complexes against K. 
pneumonia, S. epidermidis and S. aureus (5x105 cel.mL -1). The inclusion complexes were prepared at pH 3 (buffer 
H3PO4/NaOH) with gallic acid and CDs at the same molecular proportion (1 mM). All data is expressed as mean + 
standard deviation (n = 9). 
 
The reduction on the antibacterial activity of gallic acid regarding the ICs in contact with the gram 
positive bacteria may relay on the phenolic lower availability to interact with bacterial cel ls. As 
referred above, the antibacterial mechanism reported for gallic acid involves the interaction with 
cell surface, altering it electrochemical potential, reducing the membrane integrity, and 
hyperacidification of cytoplasm via proton donation that interfere with crucial metabolic pathways. 
Thus, assuming that gallic acid was complete inside the cyclodextrins and within a stable 
complex, as described above, the proton exchange was, probably, lower than free gallic acid. The 
HPβCD allowed a better interaction of gallic acid - bacteria, since the IC with this CD were 
capable of preserve gallic acid acidity against 2 bacteria, and the growth of S. aureus obtained 
was minimal. 
Nevertheless, the encapsulation of gallic acid by the βCD and HPβCD may be viable option for 
the application as antibacterial agent.  
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Conclusion  
 
The role of the solvent and pH on gallic acid properties was confirmed in this work. The intensity 
of phenolic acid peaks was modified by the buffer. The H 3PO4/NaoH buffer allowed a better 
detection of the pH effect on the UV-Vis spectra. 
The encapsulation of gallic acid by βCD was study at pH 3, 5, 7 and 8, and it was observed that 
the basic environment (pH 7 and 8) were less suitable for encapsulation. At pH 3 and pH 5, the 
ICs obtained had similar stability (K and ∆G values alike), though the linear relation was better at 
acid pH. Regarding the βCD derivatives, the encapsulation was, only, detected at pH 3. 
Therefore, the gallic acid neutral form appears to enhance its ability to form IC with HPβCD and 
MβCD. All the complexes obtained had 1:1 stoichiometry regardless the CD, but the IC stability 
parameters were higher for HPβCD and lower MβCD. 
Moreover, the IC βCD/gallic acid and HPβCD/gallic acid antimicrobial activity was also analysed 
and the phenolic activity was retained by the ICs. Nevertheless, the HPβCD IC had better 
efficiency against the 3 bacteria and, also, had the better stability parameters.  
Consequently, HPβCD/gallic acid may be a viable option for the improvement of gallic acid 
applicability as antibacterial agent for the treatment of skin and soft tissue infections.  
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Abstract 
 
Caffeic acid has been described as antibacterial but this bioactive molecule has some issues 
regarding solubility and stability to environmental stress. Thus, encapsulation devices are 
required. This work goal was to study the effect of the caffeic acid encapsulation, by 
cyclodextrins, on the phenolic antibacterial activity. 
The interactions between the caffeic acid and 3 cyclodextrins (βCD, HPβCD and MβCD) were 
study. The pH effect on the inclusion mechanism was, also, analysed. The formation of an 
aqueous soluble inclusion complex was confirmed for both βCD and HPβCD with a 1:1 
stoichiometry. The βCD/caffeic acid complex showed higher stability than HPβCD. Regarding the 
environmental conditions; pH 5 was the most suitable for the inclusion complex formation. The 
antibacterial activity of caffeic acid was similar at pH 3 and pH 5 against 3 bacteria (K. 
pneumoniae, S. epidermidis and S. aureus), being S. epidermidis the most susceptible bacterium 
to this phenol. The antibacterial activity of the inclusion complexes was described here for the 
first time, and it was shown that the caffeic acid activity was remarkably enhanced by the 
cyclodextrins encapsulation. 
 
Keywords:  Antibacterial activity, Benesi-Hildebrand equation, caffeic acid, cyclodextrin, inclusion 
complex. 
 
  
 
Chapter 3.2| Evaluation of antibacterial activity of caffeic acid encapsulated by β-cyclodextrins 
101 
Introduction 
 
Wounds allow the microorganism deposition and growth, causing skin and soft tissues infections 
and, consequently, a delay on the healing process. Over the years, antibiotics have been 
indiscriminately used for the treatment those infections, and aggravated by extended therapies, 
leading to the development of microbial resistance [1]. Thus, antibiotics had been losing their 
capacity against pathogens, and new therapies against multi-resistant bacteria are hard to find. 
Therefore, natural antibacterial agents have become an alternative to overcome this issue [2]. 
Caffeic acid (3,4-dihydroxycinnamic acid) is a simple phenolic acid derived from the 
hydroxycinnamic acid, with some interesting biological properties, such as anti-oxidant, 
antibacterial and fungicide, being the latter the most studied [3–7].The biological activities of this 
phenolic acid have been related to its electrical charge. In solution, the caffeic acid, as well as the 
other phenolic compounds, lies in equilibrium between the protonated and deprotonated form, 
according to the environmental pH. At lower pH (2-3.5) the molecule is neutral and at higher pH 
the caffeic acid assumes a charge form (Fig 3.2.1) [7]. Some authors [8, 9] reported that the 
antibacterial activity of this phenolic increase as the pH decrease (pH range: 4.5 -7). This 
biological active of caffeic acid can be compromised by the sensibility to oxidation and acidic 
environments, as well by its poor solubility in water [10]. 
 
 
F ig  3.2.1 Caffeic acid equilibrium in aqueous solution. 
 
The improvement of physical, chemical and biological properties of natural bioactive molecules 
can be accomplished by their encapsulation within cyclodextrins (CD). Moreover, CDs has been 
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described as safe to humans and approved by FDA (Food and Drug Administration) [11].These 
cyclic oligosaccharides present a hydrophilic external surface and hydrophobic cavity, which 
make them capable of complex with both hydrophilic and hydrophobic molecules. CDs interact 
with the bioactive molecules forming an inclusion complex (IC), the complex’s stability results 
from the perfect physical fit between the CDs cavity and the molecule and, also, from the 
interaction established between the 2 molecules [12]. All these factors contribute to a favourable 
thermodynamic system, which can be characterized by the enthalpy (ΔH), entropy (ΔS) and 
Gibbs free energy (ΔG) [13]. Moreover, the pH and the solvents are, also, crucial for the 
efficiency of the complexation process between organic compounds and CDs [11, 14, 15]. In 
nature, it is possible to find 3 native CDs (α, β and γ), but a wide range of modifications have 
been carried out on native CDs to improve their properties. βCD has been the most applied in 
industry, as well as its derivatives [11]. In the present work, two derivatives were chosen, 
hydroxypropyl-β-cyclodextrin (HPβCD) and methyl-β-cyclodextrin (MβCD), since both CDs has 
higher solubility than the βCD (500 and 750 g.L-1 at room temperature compared to 18 g.L -1 for 
βCD), which enhance the complexation with poor water soluble molecules [16]. 
Therefore, the present work aims to study the effect of the pH on the formation of the IC between 
the caffeic acid and 3 CDs (βCD, HPβCD and MβCD), characterized by UV-Vis spectrometry. 
Moreover, the effect of the encapsulation of caffeic acid by the cyclodextrin on its antibacterial 
activity was, also, studied.  
  
Chapter 3.2| Evaluation of antibacterial activity of caffeic acid encapsulated by β-cyclodextrins 
103 
Material and methods 
 
Mater ial 
Caffeic acid (3,4-dihydroxycinnamic acid) was purchased from Sigma, β-cyclodextrin (βCD, 1135 
g.mol-1) and 2-hydroxypropyl-β-cyclodextrin (HPβCD, 1309 g.mol-1) were acquired from 
AppliChem, and the methyl-β-cyclodextrin (MβCD, 1310 g.mol-1) was obtained from Wacker. 
Caffeic acid stock solution (1x10 -3 M or 2.3x10-1 M) was prepared in ethanol and maintained 30 
min at 50 ºC and 200 rpm. Stock solutions of each CD (4x10 -2M) were prepared in distilled 
water, βCD solution was maintained at 50 ºC and 200 rpm, during 30 min in order to improve it 
solubility in water. Buffers were prepared by mixing proper amounts of both H 3PO4 (1x10-2 M, pH 
2.05) and NaOH (1 M, pH 14), until the desired pH (3 and 5). 
 
INCLUSION COMPLEX PREPARATION 
In order to determine the stoichiometry and stability constants of the 3 ICs, solutions with 
different concentrations of each CD (between 0 and 6x10 -3 M) were added to the same 
concentration of caffeic acid (1x10 -5 M), at each pH (buffer H3PO4/NaOH). The solutions were 
placed in ultrasounds bath during 30 min, and, after, they were maintained 24 h at 25 ºC and 
50 rpm, on dark. Samples of each solution were taken (0 and 24 h) for absorbance 
measurements.  
The absorption spectra of each solution were recorded on a Jasco V560 spectrometer in the 
range 200–360 nm, using a 1cm quartz cuvette. 
 
ANTIBACTERIAL ACTIVITY ASSESSMENT 
Bacter ial Suspension 
The antibacterial activity of caffeic acid on buffer H 3PO4/NaOH at each pH (3 and 5), as well as 
the ICs (prepared according with the conditions described above and with equimolar 
concentrations, 2.3x10-3 M, of caffeic acid and CDs, at pH5) was tested against 3 bacteria: 
Staphylococcus epidermidis (ATCC 12228), Staphylococcus aureus (ATCC 6538) and Klebsiella 
pneumoniae (ATCC 11296). The bacteria were grown in tryptic Soy Agar (TSA, Merck, Germany) 
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for 24 h at 37 ºC. The cells were inoculated in tryptic soy broth (TSB, Merck, Germany) and 
incubated for 18 h at 37 ºC under agitation (120 rpm). Subsequently, bacterial concentration of 
each strain was adjusted to 1x106 cells.mL-1, via absorbance readings, using the correspondent 
calibration curve. 
 
Susceptibility of Caffeic  Ac id 
The MBC was obtained according to the method described by Wiegand et al. [17], an adaptation 
of the standard methods published by Clinical and Laboratory Standards Institute (CLSI) and the 
European Committee on Antimicrobial Susceptibility Testing (EUCAST, 2000), using the broth 
microdilution procedure. Thus, working solutions of 0.28 M of caffeic acid were prepared at pH 3 
and pH 5 (buffer H3PO4/NaOH). Serial dilutions of these solutions were made with Mueller–
Hinton broth (MHB, Merck, Germany) to a final volume of 50 µL. Afterwards, 50 µL of each 
bacterium suspension were added to a final concentration of 5x105 cell.mL-1. Caffeic acid- and 
bacteria-free controls were also included. The plates were incubated for 24 h at 37 ºC. The 
number of viable cells, was assessed by determination of the number of CFUs, by plating 10 µL 
of cell suspension from each well onto TSA, and incubated for 24 h at 37 ºC. 
The procedure was made in triplicate for each pH and bacteria combination in, at least , 3 
independent assays. 
 
Antibacter ial Activity of I nc lusion Complexes 
The antibacterial activity of the ICs against the 3 bacteria was firstly assessed by the Disc 
diffusion method described by the National Committee for Clinical Laboratory Standards 
(NCCLS), M2-A8 document [18], with some modifications. The TSA was the nutritive media used, 
and 200 µL of each inoculum (1x106 cells.mL-1) was spread on these media plates. Sterile filter 
paper disks (“Blanck Discs”, Liofilchem, Roseto, Italy, 6 mm in diameter) were placed over the 
petri dish, and impregnated with 20 µL of each IC. The plates were incubated at 37 °C for 24 h. 
Thereafter, the size of the inhibition halo was measured. 
The ICs capacity to destroy the bacteria was also measured quantitatively. A volume of 50 µL of 
each complex (IC βCD/caffeic acid and IC HPβCD/caffeic acid) was added to 50 µL of 1x10 -6 
cells.mL-1 of each bacterium, on 96 well plate. Bacteria and medium controls were also included. 
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The plates were incubated for 24 h at 37 ºC. The antimicrobial activity of each solution was 
assessed by determination of the number of CFUs, as described above. The procedure was 
made in triplicate for each bacterium at least in 3 independent assays. Solutions of buffer at pH 
5, caffeic acid (2.3x10-2 M), βCD (2.3x10-2 M) and HPβCD (2.3x10-2 M) were also included, to 
ensure that none of these factors, alone, could have influence on the antibacterial activity of the 
ICs. 
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Results and Discussion 
 
CAFFEIC ACID  
pH Effect on the UV-Vis Absorption Spectrum 
The UV-Vis spectroscopy analyses the alterations of the electronic energy levels within the 
molecules, as a result of the electrons transference to different orbitals [19]. In the case of 
polyphenols, their spectra result from electronic transitions between π-type molecular orbitals 
[20]. The caffeic acid spectra, usually, shows 3 peaks: one at 217nm which is associated with 
the π-π transition of the phenyl group; the peak near 290 nm attributed to the π-π transition of 
the phenolic group; and the last one (320 nm) is, normally, associated to the double-bond π-π 
transition [21]. 
Since the pH can change the UV-Vis spectra of polyphenols [22], the caffeic acid spectra were 
recorded between 200 and 360nm for solutions of pH 3 and 5 (Fig 3.2.2). Regarding the peaks 
associated to the π-π transition of the double bound (near 320 nm), and the phenolic group (near 
288 nm), the pH increase induced a reduction of their intensity and had a hypsochromic effect 
(shift of the peak towards shorter wavelength). A bathochromic effect (shift of the peak towards 
longer wavelength), and increased intensity was observed for the peak attributed to the π-π 
transition of the phenyl group, when the pH was increased.  
 
 
F ig  3.2.2 Absorbency spectrum of caffeic acid (1x10-5 M) dissolve in H3PO4/NaOH buffers at pH 3 (black) and pH 5 
(grey). 
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The alterations caused by the pH on the caffeic acid UV-Vis spectra have been attributed to the 
two adjacent hydroxyl groups (OH) linked to the benzene ring (Fig 3.2.1). Those changes may 
result from the chemical alteration of the molecule, for instance the blue shift of the 220 nm 
peak with pH 5 may be a consequence of the formation of unstable quinone intermediates or 
other resonance forms [19, 22].  
 
Antibacter ial Activity: pH I nf luence 
The biological properties of the phenolic compounds strongly depend on the environmental pH 
[22]. Therefore, the effect of pH on the antibacterial activity of caffeic acid against 3 of the most 
common bacteria isolated from wound infections, was assessed. The range of pH tested had no 
visible influence on the caffeic acid activity. The MBC was the same for pH 3 and 5 for the 3 
bacteria. Being the S. epidermidis the most susceptible bacteria to caffeic acid (0.018 M) and the 
other 2 bacteria had the same behaviour when exposed this phenol, 0.07 M was need to 
destroys all their cells.  
The antibacterial ability of caffeic acid has been related to its capacity to cause hyperacidification 
of the environment. The acidification of the plasma membrane, via proton donation, result on 
disruption of the bacteria cell and the same effect on the intracellular cytosolic , leads to inhibition 
of the enzyme H+-ATPase necessary for the ATP production [23–25]. Also, caffeic acid can 
change the electric potential of the bacterial membrane by quench free electrons fr om the 
electron transport chain or by interfering with the proton efflux by dehydrogenases inactivation. 
Because of this, the bacteria growth may be reduced or even inhibit, since the oxidative 
phosphorylation reaction cannot occurs [23, 26]. 
According to our results, the antibacterial activity of caffeic acid may be related to the phenolic 
part of the molecule, since the changes observed on the molecule are on the carboxylic group, at 
the pH tested (Fig 3.2.1). Furthermore, this part of caffeic acid (carboxylic group) has the ability 
to donate the protons associated with the acidification of the environment. 
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CAFFEIC ACID INCLUSION COMPLEXES 
Effect of Cyc lodextr ins and pH on the UV-Vis Absorption 
Given the differences obtained above, both pH values were used for the study of the IC formation 
between the phenolic compound and the 3 CDs. The encapsulation process involving CDs 
induces alterations on physical-chemical properties of the guest molecule (caffeic acid). In the 
case of UV-Vis spectrometry, the absorbance intensity of the guest molecule is changed by its 
presence within the CD cavity [27].  
Caffeic acid absorbency was not altered by the increase in MβCD concentration (data not 
shown), so the encapsulation of caffeic acid with this CD was not detectable, at the conditions 
tested. Thus, MβCD was not included on the further analysis. Fig 3.2.3 displays the UV-Vis 
absorption spectra of caffeic acid, in the present of different concentrations of βCD and HPβCD. 
Since the changes on the spectra were more consistent at the peak near 220 nm, this peak was 
used for the absorbance analysis. 
 
 
F ig  3.2.3 Absorbance spectra of caffeic acid (1x10-5 M) in different cyclodextrin concentrations (0-6 x10-3 M) at pH 3 
and 5. 
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Regardless the pH or the type of CD, as CDs concentration increased the intensity of the peak , 
also, increased, and a slightly red-shifted (peak shift to a longer wavelength) was observed. The 
last alteration was more notorious at pH 5. Those changes on caffeic acid spectrum may result 
from the partial protection of the molecule by the CD cavity, as well as the increase of the 
phenolic compound solubility, factors that suggest the IC formation between this phenolic and 
both CDs [28]. 
 
Inclusion Complexes Characteriza t ion 
The complexes were assessed based on the phase-solubility method described by Higuchi and 
Connors [29]. This technique analyses the alterations of the caffeic acid (guest) properties (by of 
UV-Vis absorbency spectrometry), in mixtures with excess of the guest and different 
concentrations of the host (CDs). The ICs were characterized based on the stoichiometry, K 
(stability constant) and ∆G (Table 3.2.1). The first 2 parameters were calculated using the 
modified Benesi-Hildebrand equation [30] (equations 3.2.1 and 3.2.2): 
 
(3.2.1) 
 
    
 
 
     
 
 
        ⌈  ⌉ 
 
(3.2.2) 
 
    
 
 
     
 
 
        ⌈  ⌉ 
  
[CD]0 Cyclodextrin initial concentration  
A Absorbance intensities in the presence of cyclodextrin 
A0 Absorbance intensities without cyclodextrin  
A ’ Limiting intensity of absorption 
 
Base on the equation (3.2.1), a double reciprocal Benesi-Heldebrand plot, i.e. (
 
    
    
 
    
) 
were draw (Fig 3.2.4). Since the better fit was obtained for this plot, the graphics of 
(
 
    
    
 
     
) were not showed.  
Fig 3.4 shows a straight line with good correlation, indicative of 1:1 molecular complex between 
caffeic acid and both CDs. The K (Table 3.2.1) was obtained based on the slope of the line and 
can be used as a measurement of the stability of the complexes [31]. Thus, based on our results, 
Chapter 3.2| Evaluation of antibacterial activity of caffeic acid encapsulated by β-cyclodextrins 
110 
βCD appears to be a most suitable for the complexation of caffeic acid. Moreover, the pH had 
lower influence on the IC formation with these CDs, but the K value was slight superior at pH 5. 
 
 
F ig  3.2.4 Benesi-Hildebrand plot for the caffeic acid complexation with βCD (a) and HPβCD (b), at pH 3 (black) and 
pH5 (grey). 
 
The Gibbs free energy was obtained from the equation (3.2.3). In concordance with K values, the 
pH had lower influence on the thermodynamic parameter assessed (Table 3.2.1). The pH effect 
was more obvious for the HPβCD, where the IC was enhanced by pH 5.  
(3.2.3)             
∆G Gibbs free energy 
R  gas constant  
T temperature (Kelvin) 
K stability constant 
 
The mechanism responsible for the IC formation between CDs and the guest molecule (in our 
case the caffeic acid) involves the substitution of enthalpy- rich water molecules from the central 
cavity by caffeic acid. An exothermic reaction occurs as a result of energy release by the system. 
Thus, the IC were stabilized mainly by van der Waals interactions and hydrogen bonds [11]. 
The native CD (βCD), as well as the HPβCD, at the pH range used are not charged, so 
hydrophobic interactions between the CD cavity and the caffeic acid and hydrogen bonds of the 
caffeic with the OH of the CDs were the mainly forces responsible by the complex stabilization. 
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According to our results and other published works [7, 27, 32], the caffeic acid aromatic part, 
including the double bond, was inside of both CDs cavities and the more polar group (carboxylic 
group) was projected to the water phase. 
 
Table  3.2.1. Parameters for the inclusion complexes characterization. r2: coefficient of determination, K: stability 
constant and ∆G: Gibbs free energy 
 βCD HPβCD 
 pH 3 pH 5 pH 3 pH 5 
r 2 0.923 0.979 0.548 0.924 
Sto ichiometry 1:1 1:1 1:1 1:1 
K (M-1) 133 178 10 37 
∆G (kJ) -12 -13 -6 -9 
 
At pH 3, the neutral form of the caffeic acid (Fig 3.2.1) is predominant and at pH 5 caffeic acid 
assumes a monoanionic form, thus the hydrophobicity of the phenolic molecule reduces with the 
increase of pH [7]. Therefore, pH 5 was more suitable for the formation of a IC more stable, as 
also reported by Górnas et al [27]. 
Based on the above results, the βCD appears to be the most suitable CD for the encapsulation of 
caffeic acid. Since, the changes induced on the UV-Vis spectra of caffeic acid by the 
concentration of this CD were more notorious than the ones observed for HPβCD. Additionally, 
the K and the ∆G were, also, higher for the βCD/caffeic acid complexes. The higher efficiency of 
complexation by the βCD may be a result of the better fit of caffeic acid molecule into βCD cavity, 
without the interference of the HPβCD hydroxypropyl groups. 
 
Inc lusion Complexes Antibacter ial Activity  
From author’s knowledge, the effect of CDs on the antibacterial activity of caffeic acid was 
described here for the first time. Since the pH had no significant influence on the caffeic acid 
activity and the pH 5 allowed a formation of a more stable IC for both CDs (Fig 3.2.4 and Table 
3.2.1), this pH was used for the assessment of the antibacterial activity of the IC (βCD/caffeic 
acid and HPβCD/caffeic acid). 
As reported above, the IC formed between caffeic acid and βCD or HPβCD were 1:1, thus, 
solutions with the 2.3x10 -2 M of each intervener on the reaction was used. The concentration of 
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caffeic acid used was lower than the MBC, reported above, for K. pneumoniae and S. aureus., 
since βCD has a solubility limit in water of 2x10-2 M at room temperature [16]. 
The qualitative assessment of the antibacterial activity of the complexes (Fig 3.2.5) exhibited a 
presence of growth inhibition halo for all the IC, higher than the halo obtained for the caffeic acid 
alone. The only exception was the IC HPβCD/caffeic acid when in contact with S. aureus, in this 
case no halo was observed. This type of method has some drawbacks regarding the diffusion of 
the antibacterial agents [33], in this case the complexes. Therefore a complementary quantitative 
analysis was made. 
Fig 3.2.6 display the antibacterial activity of the two ICs (βCD/caffeic acid and HPβCD/caffeic 
acid) as well as the controls (buffer, caffeic acid, βCD and HPβCD). As expected the buffer and 
the CDs alone had no antibacterial activity. The free caffeic acid was only capable of killing all the 
S. epidermidis and induced a slight reduction on the growth of the other two bacteria, since the 
concentration used was six times less (1.15x10-2 M) than MBC (7x10-2 M) for K. pneumoniae and 
S. aureus, as explained above. 
Interestingly, the IC of the caffeic acid with both CDs were capable of destroy all the cells from 
the 3 bacteria (Fig 3.2.6), even if we used less than half of the MBC concentration for the S. 
aureu and K. pneumoniae on the IC preparation. The encapsulation of caffeic acid by the CDs 
enhanced it antibacterial activity against S. aureus and K. pneumoniae. 
The antibacterial activity of caffeic acid appears to be deeply linked with the molecule ability to 
interact with electrons presents on the bacteria surface or inside the cytoplasm [34]. The 
enhanced antibacterial activity of the βCD/caffeic acid and HPβCD/caffeic acid may be a result 
of the improved solubility of the caffeic acid and reduction aggregates formation and, also, by the 
higher availability of the caffeic acid to interact with bacteria, all induced by the CDs 
encapsulation. 
Therefore, the encapsulation of caffeic acid by the βCD and HPβCD appears to be viable option 
for the improvement of this phenolic antibacterial activity, and further application as antibacterial 
agent. 
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Fig  3.2.5 Disk diffusion assay of the βCD/caffeic acid and HPβCD/caffeic acid inclusion complexes against K. 
pneumonia, S. epidermidis and S. aureus (1x106 cel.mL -1). The inclusion complexes were prepared at pH 5 (buffer 
H3PO4/NaOH) with caffeic acid and CDs at the same molecular proportion (2.3x10-2 M). 
 
 
Fig  3.2.6 Quantitative analysis of the antibacterial activity of the complexes βCD/caffeic acid and HPβCD/caffeic 
acid against K. pneumonia, S. epidermidis and S. aureus (5x105cel.mL -1). The inclusion complexes were prepared at 
pH 5 (buffer H3PO4/NaOH) with caffeic acid and CDs at the same molecular proportion (2.3x10 -2 M). All data is 
expressed as mean + standard deviation (n = 9).  
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Conclusion  
 
In the present work, the IC between caffeic acid and the native CD (βCD) and 2 derivatives 
(HPβCD and MβCD) was characterized, based on the changes on UV-Vis absorption spectra of 
the phenolic compound. The results obtained showed that the MβCD was not capable of complex 
with caffeic acid, at the conditions tested. Moreover, the pH (3 and 5) showed lower influence on 
the complexation process with βCD and HPβCD, being the higher pH the most suitable. The 
complexes obtained had 1:1 stoichiometry regardless the CDs, but βCD complexes had higher 
stability parameters. 
The caffeic acid was more effective against S. epidermidis than K. pneumoniae or S. aureus and 
the pH had no influence on its antibacterial capacity. Therefore, the carboxylic group may not be 
involved in the interaction caffeic acid – bacteria. Moreover, the antibacterial activity of the caffeic 
acid was enhanced by the complexation with βCD and HPβCD. 
Although the encapsulation of caffeic acid by both βCD and HPβCD enhanced its antimicrobial 
activity, the IC βCD/caffeic acid appears to be the best option to increase the applicability of this 
phenolic as antibacterial agent against skin infections, due to its greater stability.  
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Abstract 
 
Cyclodextrin-based hydrogels have been described as suitable for the controlled-release of 
bioactive molecules for wound dressing proposes. These materials have major advantages, since 
they present hydrogels properties (high degree of swelling and easy manipulation) in combination 
with the encapsulation ability of cyclodextrins. 
β-cyclodextrin (β) or hydroxypropyl-β-cyclodextrin (HPβ) were cross-linked (1,4-butanediol 
diglycidyl ether) with hydroxypropyl methylcellulose under mild conditions. The hydrogels were 
chemical characterized by swelling degree, FTIR, DSC and contact angle. The gallic acid loading 
and release was also analysed, as well the antibacterial and cytotoxicity of the polymeric 
networks. 
The hydrogels obtained were firm and transparent, with good swelling ability. The gel-HPβ had a 
surface more hydrophilic when compared with the gel-β. Nevertheless, both hydrogels were 
capable to incorporate gallic acid and sustain the release for 48 h. The antibacterial activity of 
gallic acid was maintained after it adsorption within the polymeric matrix as well as it effect on 
fibroblast proliferation. 
Therefore, gel-β and gel-HPβ conjugated with gallic acid were shown to be a viable option for 
antibacterial wound dressing. 
 
Keywords: Antibacterial activity, 1, 4-butanediol diglycidyl ether, cyclodextrin, gallic acid, 
hydrogel, wound dressing. 
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Introduction 
 
Wounds provide suitable environment for the deposition and proliferation of pathogenic 
microorganisms, causing skin and soft tissues infections and triggering the patient immunological 
response [1]. The infections severity may range from self-limit superficial to life-threatening 
diseases. Moreover, skin and soft tissue infections increase the production of wound exudate and 
tissue deterioration, thus higher wound dressing replacement is required, causing pain to the 
patient and amplifying the probability of removing the newly formed skin [2]. Therefore, the 
research on wound dressings field has been focused on newly wound dressings capable of 
mechanical protection and suitable environmental conditions for proper healing and, additionally, 
capable of sustained delivery of antimicrobial agents to prevent wound infections [3]. 
Hydrogels have been, successfully, applied as wound dressings and drug delivery devices. They 
are polymeric networks with hydrophilic character, capable of absorb large amounts of water and 
with suitable physicochemical properties for contact with human tissue without causing injury [3]. 
However, hydrogels have some drawbacks as drug delivery systems, their capacity to load 
hydrophobic drugs is quiet reduced, as well as, the control over the drug release mechanisms 
(the diffusion is normally rapid and non-linear) [4]. So, cyclodextrins (CD) -based hydrogels have 
been synthetized to improve the drug delivery system. These materials benefit from the suitable 
swelling ability of hydrogels and from the encapsulation capacity of CDs [5]. CDs are truncated 
oligosaccharides with the ability to form inclusion complexes (IC) with a wide range of molecules, 
due to their hydrophilic surface and hydrophobic cavity. When use as monomer for hydrogel 
production, CDs can act, simultaneous, as carriers and as enhancers for the hydrogel stability 
[3]. 
Nevertheless, the methods used for the preparation of CD-based hydrogels, usually, involve high 
temperatures, leading to toxic products from undesirable side reactions, decreasing their 
applicability has biomedical devices [6]. Rodriguez-Tenreiro et al [5] developed a method for CD-
based hydrogel synthesis with only 1 step, using condensation with ethylene glycol diglycidyl 
ether (EGDE) to obtained CD networks, under mild environmental conditions and without 
previous modification on the CD structure. CD-based hydrogels synthesized by this method 
showed good swelling and mechanical properties, and enhanced ability to load and release 
bioactive molecules [5–9]. 
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Polyphenolics has been proposed has viable alternatives to broad-spectrum antibiotics normally 
used on wound infections treatment [10, 11]. Previous work, Chapter 2 and 3.1, showed that 
gallic acid (a simple phenolic acid) has good applicability as antibacterial agent against bacteria 
commonly isolated from wound infections. Although, its applicability on the pharmaceutical field 
has been constrained by gallic acid susceptibility to environmental factors and low solubility [12–
14]. 
Therefore, the present work aimed to develop a material capable of forming inclusion complexes 
with gallic acid and kept the molecule’s antibacterial properties, which could able to prevent 
wound infections and enhance the healing process. 
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Material and methods 
 
Mater ial 
Gallic acid (3,4,5-trihydroxybenzoic acid) was provide by Merck, β-cyclodextrin (βCD, 1135 g.mol-
1) and 2-hydroxypropyl-β-cyclodextrin (HPβCD, 1309 g.mol-1) were acquired from AppliChem. 
Hydroxypropyl methylcellulose (HPMC) Methocel® K4M was purchased from VWR Prolab; 1,4-
butanediol diglycidyl ether (BDGE), 50-60% in water was from Acros Organics. Purified water, 
obtained by reverse osmosis (MiliQ®, Mikipore, Madrid, Spain) with a resistivity above 18.2 MΩ 
cm-1, was used.  
 
Hydrogel Synthesis 
The hydrogels were prepared based on the method described by Garcia-Fernandez [9]. Solutions 
of each CD, 2.5 g in 10 mL of NaOH (0.2 M), were prepared and maintained for 5 min, at 25 ºC 
and 200 rpm (mechanical agitation). The HPMC (0.025 g) was added to each solution and the 
solubilisation was improved by mechanical agitation (200 rpm) during 5 min at 25 ºC. The 
solutions (5 ml of each) were transferred to petri dishes and 2 mL of BDGE was added, to each 
one. The petri dishes were sealed with parafilm and maintained for 2 min at 25 ºC and under 
mechanical agitation (200 rpm). To complete the crosslink process, the plates were kept at 50  
ºC for 12 h. At this temperature, the CD and HPMC stability was assured. After cooling, 
hydrogels were immersed in ultrapure water for 12 h and 25 ºC, to allow the swelling. Then, they 
were transferred to a HCl solution (10 mM) for more 12 h, and finally immersed in water for 7 
days. The dry process was performed as followed: the hydrogels were kept at 25 ºC for 24 h and, 
after, were transferred to a desiccator until weight stabilization.  
 
Swelling Determination 
The amount of water absorbed by the hydrogels was calculated based on the difference between 
the weight of fully swollen hydrogel in water (W) and the weight after the dry process (W 0). For 
that, dry hydrogels (30 ± 3 mg) were weighted and immersed in 5 mL of ultrapure water. Their 
weight was recorded in regular time periods, until the weight stabilizes (fully swollen hydrogel), 
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using a Saitouris BL 1205 (d=0.1mg) scale, and after removing the water from the hydrogel 
surface. 
The degree of swelling (Q) was calculated based on equation 4.1.1. 
(4.1.1)    
    
  
     
The swelling profile was obtained from the data recorded previously and plotting the amount of 
water absorbed at time t (Wt)/ amount of water at equilibrium (W ) versus time (min). 
 
Gallic  ac id Loading and Release 
Gallic acid solution (2.3x10 -2 M, in 2% methanol) was dissolved in H3PO4/NaOH buffer (pH 3 ± 
0.5), and kept for 30 min in an ultrasonic bath, to allow the fully solubilisation of gallic acid. Dry 
hydrogel samples (30 ± 3 mg) were immersed in 5 mL of gallic acid solution, 25 ºC and 60 rpm. 
The amount of phenolic acid in the solution was assessed by UV-Vis spectrophotometry, until the 
absorbance values stabilize. The gallic acid loading (%) was calculated based on the variation of 
gallic acid on the initial solution and on the equilibrium. 
The gallic acid release, from hydrogels, was performed using load dry samples. The samples (30 
± 3 mg) were immersed in 5 mL of synthetic sweat solution (SSS, 0.5 g l-histidine 
monohydrochloride monohydrate, 5 g of sodium chloride, 2.2 g of sodium dihydrogen 
orthophosphate dihydrate, pH 5 ± 0.5). The samples were maintained at 25 ºC and the 
absorbance of the release medium was monitored until stabilization. 
The absorption spectra were measured in the range of 200–360 nm and recorded on a Jasco 
V560 spectrometer, using a 1cm quartz cuvette. 
 
HYDROGELS PHYSICOCHEMICAL CHARACTERIZATION  
Fourier Transform Infrared Spectroscopy (FTIR) 
Samples (0.5 ± 0.05 g) of each hydrogel, βCD-co-HPMC (gel-β) and HPβCD-co-HPMC (gel-HPβ) 
with or without gallic acid, were used for FTIR-ATR analysis. The spectra were recorded between 
400 and 4000 cm -1, in Avatar 360 FTIR spectrometer. The spectra of compounds alone (gallic 
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acid, βCD, HPβCD and HPMC) were, also, recorded, using the potassium bromide pellet 
technique. 
 
Thermal Analysis by Dif ferential Scanning Calor imetry (DSC) 
DSC measurements were carried in liquid nitrogen atmosphere using DSC-822e instrument 
(Mettler Toledo). The calibration was made with indium as standard. Samples were weighed (2.5 
± 0.2 mg) and sealed in aluminium pans. Then, they were heated from 25º to 350 ºC, at a 
scanning rate of 10 ºC.min-1. Data were treated using LAB mettler star SW 8.1 software (Mettler-
Toledo International Inc, Swiss). 
 
Contact Angle 
Water contact angles of hydrogels were measured using a contact angle measurement apparatus 
(OCA15 Plus; Dataphysics, Germany). A water drop (3 µL) was placed over the clean hydrogel 
surfaces with an autopipette. All measurements were performed at room temperature. 
All the characterization methods were made in triplicate for each hydrogel (gel -β, gel-β/gallic 
acid, gel-HPβ, gel-HPβ/gallic acid). 
 
IN VITRO ANALYSIS OF HYDROGELS’ BIOLOGICAL PROPERTIES 
Antibacter ial Activity  
The hydrogels’ antibacterial activity was tested against 3 bacteria: Staphylococcus epidermidis 
(ATCC 12228), Staphylococcus aureus (ATCC 6538) and Klebsiella pneumoniae (ATCC 11296). 
The bacteria were grown in tryptic soy agar (TSA, Merck, Germany) for 24 h at 37 ºC. The cells 
were inoculated in tryptic soy broth (TSB, Merck, Germany) and incubated for 18 h at 37 ºC 
under agitation (120 rpm). Subsequently, bacterial concentration of each strain was adjusted to 
1x106 cells.mL-1, via absorbance readings and the corresponding calibration curve. 
The hydrogels activity was measured both qualitatively and quantitatively. For the first analysis, 
the Disc diffusion method described by the National Committee for Clinical Laboratory Standards 
(NCCLS), M2-A8 document [15], was used with some modifications. The TSA was the nutritive 
media used and 200 µL of each inoculum (1x106  cells.mL-1) was spread on the media plates. The 
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hydrogel samples (30 ± 3 mg and with 1 ± 0.2 mm of diameter) were placed over the petri dish. 
The plates were then incubated at 37 °C for 24 h. The size of the inhibition halo was measured.  
For the quantitative assays of the hydrogel antibacterial capacity, the samples (30 ± 3 mg) were 
immersed within 5 mL of 5x10 -5 cells.mL-1 of each bacterium. Bacteria and medium controls were 
also included. The plates were incubated for 24 h at 37 ºC. The number of viable cells, was 
assessed by determination of the number of colony forming units (CFUs), by plating 10 µL of cell 
suspension from each well onto TSA, and incubated for 24 h at 37 ºC. 
Both methods were made in triplicate for each bacterium in, at least, 3 independent assays. 
 
Hydrogels Effect on Fibroblast P roliferation 
The hydrogels in vitro cytotoxicity was carried out based on the method described on ISO 10993-
5:2009 -Biological evaluation of medical devices, part 5: Tests for in vitro cytotoxicity, by indirect 
contact.  
The liquid extracts of the hydrogel were prepared as follows: hydrogels (30 ± 3 mg) were 
immersed within 5 mL of Dulbecco’s modified Eagle’s medium (DMEM), and then they were kept 
24 h at 25 ºC in the dark. 
Fibroblast 3T3 (CCL 163 - from American Type Culture Collection) were used in this study. Cells 
were cultured in DMEM supplemented with 10% of foetal bovine serum and 1% 
penicillin/streptomycin at 37 ºC, 5% CO2. After achieving confluence, cells were passed at the 
density of 1×105 cells.mL-1, using trypsin. Cells were seeded at the density of 5×105 cells.mL-1 
(48well plate) in 300 µL of DMEM complete medium.  
The cytotoxicity was tested by MTS ([3-(4,5-carboxymethoxyphenyl)-2-(4-sulfophenyl)- 2H-
tetrazolium]) assay. The medium was replaced with 300 µL of the liquid extract of hydrogels. The 
cells were incubated at 37 ºC and 5% CO2. After 24 h, the medium was removed and a mixture of 
6 µL of MTS (Promega) and 294 µL of DMEM without phenol was added to each well. After 1 h, 
the absorbance value was measured at 490 nm and the results were expressed as percentage of 
viable cells (%), using the number of cells grown on wells without hydrogel (control +) as 100%. 
All the mathematical analysis was made using the Origin Pro software.  
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Results and Discussion 
 
The gallic acid encapsulation by βCD and HPβCD has been studied previous (Chapter 3.1). The 
ICs obtained showed good stability parameters and the gallic acid ability to destroy bacteria, 
usually isolated from skin and soft tissue infections, was preserved (Fig 3.1.7). Thus, these CDs 
were used for the CD-based hydrogel synthesis using HPMC, cellulose derivative, and cross-
linked with BDGE. The HPMC is a linear polymer constituted by glycopyranose units, similar to 
those found on CDs. HPMC has been used within hydrogels due to its high swellability and 
biocompatibility [16, 17]. Hydrogels were made under alkaline pH and mild temperature as 
described by Lorenzo et al [6].  
Attempts to prepared hydrogels based only on βCD and HPβCD (without HPMC), following the 
same protocol failed. Other authors [5, 7, 8] reported the formation of HPβCD hydrogels using 
EGDE, as cross-linking, agent within similar conditions. In the present work, BDGE was used as 
cross-linking agent instead of EDGE. Both molecules have 2 glycidyl groups, capable of react, 
simultaneous, with the CDs’ hydroxyl, amino or carboxylic group or with cellulose ether group. 
They differ on the size of the chain between the epoxy groups, BDGE has longer chain which 
increase the distance between the CD and cellulose molecules [6]. Thus, it was expected to 
obtain a more flexible hydrogel without losing the non-toxic behaviour of the cross-linking agent 
[18]. However, this characteristic may, also, cause the lack of suitable mechanical properties 
observed on the hydrogels without HPMC. 
The CD-based hydrogels were cross-linked with BDGE in the presence of HPMC and 1:1.25:0.1 
ratio between compounds were maintained, since it was described as the best condition, by 
Rodriguez-Tenreiro et al [7]. The hydrogels obtained with HPMC (gel-β and gel-HPβ) were 
transparent and easily to handle, with smooth and continuous surface. They also had enough 
elasticity, suitable for direct contact with injured skin [6]. Additionally, the gel-β was more 
transparent and with lower elasticity than the gel-HPβ. After immersion in water, both hydrogels 
kept their shape and behaved as superabsorbent systems. All these features point out to the 
formation of a homogenously cross-linked hydrogels [7]. 
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Swelling Ability 
Swelling represents the water holding ability and permeability of hydrogels. The hydrogels 
swelling initiates with the diffusion of water molecules into the network, hydration of polar 
hydrophilic groups and polymer expansion until the free water molecules and the molecules 
within the network reach equilibrium [19, 20]. 
The swelling profiles (Fig 4.1.1) show that both hydrogels had a fast swelling during the first 400 
min and the equilibrium was reached after 700 min. Fig 4.1.1 demonstrated that gel-HPβ was 
capable of taking more quantity of water molecules than the gel-β. In addition, the Q values 
shown that gel-HPβ absorbed 9 times more its weight in water, and the gel-β only 2.5 times. 
Similar swelling profiles have been reported CD- based hydrogels HPMC [5, 7, 21].  
 
 
F ig  4.1.1 Swelling profiles in water of gel-β (●) and gel-HPβ (■) dry hydrogels prepared with 25% CD/ 0.25% HPMC. 
 
Based on the swelling profiles, both hydrogels network are suitable for water and small size 
molecules diffusion. However, the gel-β had lower affinity to water probably related with higher 
degree of cross-linking or with overlapped HPMC chains within the network [6]. Additionally, the 
hydroxypropyl groups of HPβCD increase the network porous size, improving the network ability 
to absorb water molecules. 
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Gallic  ac id Loading 
Hydrogels ability to retain molecules depends on (1) the network degree of cross-linking, (2) the 
water affinity of the polymeric molecules, and (3) interactions between the guest and the network 
components. All these factors regulate the molecule ability to diffuse within the hydrogel [22]. 
Fig 4.1.2 displays the quantity of gallic acid incorporated within hydrogels. The loading was 
performed with gallic acid solution dissolved in H3PO4/NaOH buffer at pH 3, since it was 
described as the best condition for the IC formation between this phenolic and βCD or HPβCD 
(Chapter 3.1). 
 
 
F ig  4.1.2 Gallic acid loading (a) in gel-β (black) and gel-HPβ (grey). The loading was performed during 24 h, 25 ºC 
with gallic acid dissolved on the buffer H3PO4/NaOH (pH 3 ± 0.5). 
 
The hydrogel rate of antibacterial agent incorporation was similar to the swelling profile. The 
equilibrium between the free gallic acid and within the hydrogel was achieved after 6h. 
Nevertheless, the difference between the 2 hydrogels obtained for the swelling was not so 
obvious in the case of gallic acid loading. Both hydrogels showed similar ability to incorporate 
gallic acid (gel-β 2.76 g.ghydrogel-1 and gel-HPβ 3 g.ghydrogel-1 ). 
In the present work, both hydrogels loading capacity was similar, suggesting that the 
encapsulation of gallic acid by βCD and HPβCD was crucial for the hydrogel gallic acid loading. 
βCD and HPβCD were described as suitable for the encapsulation of poor soluble gallic acid with 
1:1 stoichiometry and good stability parameters (K 40 and 90 M -1) (Chapter 3.1). According with 
the K values published, the gel-HPβ kept the ability to form IC with higher stability than the native 
CD, since the gallic acid loaded was higher for this hydrogel. 
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HYDROGEL CHARACTERIZATION  
FTIR Analysis 
The hydrogel cross-linking was characterized based on the FTIR spectra of dried hydrogels and 
powders CDs and HPMC (Fig 4.1.3). As expected, the spectra from both CD were similar as 
result of their truncate shape with one edge lined with primary hydroxyl groups (OH) and the 
other edged with secondary groups. On their spectra, the following peaks were identified 
(βCD/HPβCD): 3416/3447 cm -1 (O-H stretching), 2924 cm -1 (stretching vibrational asymmetric 
of C-H), 1645/1640 cm -1 (hydrogen interactions), 1157 (C-O stretching) and 1029/1034 cm -1 (C-
O-C) [7, 21, 23]. The HPMC spectra showed a profile similar to the CD and the strong intensity 
peaks were identified: 3447 cm -1 (O-H stretching), 2924 cm -1 (stretching vibrational asymmetric of 
C-H), 1640 cm -1 (hydrogen interactions), 1115 and 1063 cm -1 (ether bond) [24, 25].  
 
 
F ig  4.1.3 FTIR spectra CD (blue) and HPMC (red) powders, gel (green). (a) with βCD and (b) with HPβCD. 
 
The hydrogels spectra had similar profile regardless the CD used for the synthesis of the 
polymeric network. However, they display some differences on the peaks intensity and shape 
when compared with the CDs and HPMC spectra. For instances, the peak attributed to the ether 
bonds (between 1200 and 1000 cm -1) became weak and with a broad shape, as result of the 
decrease of those bonds induced by the cross-linking reaction. The intensity of the peaks near 
3400 and 1649 cm -1 decreased due to the reduction of OH and hydrogen bonds, after the cross-
linking [7, 21]. Thus, the majority of the CDs’ OH were efficiently linked to the HPMC by the 
BDGE. Moreover, no peak was detected near 1250 cm -1 meaning that no free BDGE was within 
hydrogels.  
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Thermal Analysis  
The syntheses of hydrogel induced alterations on thermal properties of each molecule (βCD, 
HPβCD and HPMC), as result of the interactions established to form the polymeric network. DSC 
thermograms displays the intermolecular interactions between hydrogels components within the 
network [26]. Fig 4.1.4 shows that gallic acid has a sharp endothermic peak (200 ºC), as well as 
the 2 CDs (2 peaks near 100 ºC and 275 ºC). The HPMC exhibits a smaller and broad peak near 
75ºC. The cross-linking between HPMC and CDs induces obvious alterations on the DSC 
thermograms profiles. The profiles of both hydrogels (gel-βCD and gel-HPβ) have a broad peak, 
confirming the cross-linking between the 2 compounds, and suggesting the presence of an 
amorphous structure, characteristic of the hydrogel materials. Moreover, the gallic acid loaded 
hydrogels thermogram, also, lacks the peak of gallic acid. Thus, the gallic acid may be trapped in 
an amorphous or solid solution state into the polymeric network [27]. 
 
F ig  4.1.4 DSC thermograms of gallic acid (blue), CD (black), HPMC (grey), gel (orange) and gel loaded (purple). (a) 
with βCD and (b) with HPβCD. 
 
Surface Hydrophilic ity Measurement  
The hydrogel wettability or hydrophilicity plays a major rule on biocompatibility, since the polymer 
surface states the interaction between the living system and the medical device [28]. This 
property can be determined by the measurement of the contact angle formed between water and 
the hydrogel. The values obtained with gel-β and gel-HPβ with or without gallic acid are on Table 
4.1.1. 
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Table  4.1.1 Contact angle obtained with water when in contact with the hydrogels superficies 
Contact angle (º) Ge l-β Ge l-HPβ 
Without gallic acid 85.68±1.33 97.37±1.63 
With gallic acid 73.83±1.27 106.82±2.86 
 
Regarding gel-β, the contact angle measured was lower than 90º, thus this network has a lower 
hydrophilic surface [29]. Moreover, the contact angle of gel-β decreased after the gallic acid 
loading. An opposite behaviour was detected for the gel-HPβ. This hydrogel displayed a higher 
contact angle than the hydrogel with the native CD, and the gallic acid loading increased the 
hydrophobicity of its surface.  
The hydrogel major characteristic is the ability to absorbed large amount of water, so it should be 
expected to obtained low contact angles, due to hydrogel hydrophilic surface. However, the 
macromolecules within the networks hold high mobility to rearrange their orientation according to 
the environment. Thus, in the specific case of hydrogels, the contact angle value reflects the 
degree of freedom of the network molecules, to move as response to the environment change 
[30]. 
According to the swelling and gallic acid loading results (Fig 4.1.1 and 4.1.2), it was predictable 
that the gel-HPβ had a lower contact angle. The apparent hydrophobicity observed for this 
hydrogel surface may be caused by the less freedom of the network to rearranged their 
macromolecules, due to the hydroxypropyl groups [31]. These groups increase the molecules 
size which enlarge the mesh size (higher swelling), but decrease the molecules mobility within 
the network (low hydrophilic surface). Moreover, the HPβCD has the ability to establish an IC with 
gallic acid with higher stability parameters than the βCD (Chapter 3.1). Thus, the gallic acid 
interaction with this cyclodextrin will be stronger, contributing to the minor interaction of the 
phenolic with water, and consequently the degree on hydrophilicity of gel-HPβ network. 
 
Gallic  ac id Release from Hydrogels 
Fig 4.1.5 displays the gallic acid release profiles in SSS; this solution was chosen in order to 
simulate the behaviour of the hydrogels in contact with the skin. Both hydrogels were capable of 
control the release for 2 days, time at which the equilibrium between the gallic acid within the 
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network and on solution was achieved. Additionally, the release profiles were also analogous for 
the 2 networks, there was a burst release during the first 6h, as result of gallic acid migration 
from the hydrogels surface to the solution. The slower release, after 6h, can be asc ribed to the 
phenolic compound dissociation from the CDs, followed by its diffusion through the network. 
Moreover, the amount of gallic acid released was higher for the gel-HPβ, as result of the greater 
swelling capacity of this network, as referred above. 
 
 
F ig  4.1.5 Gallic acid release from gel-β (black) and gel-HPβ (grey) hydrogels, it was performed during 48 h, 25 ºC 
within synthetic sweat solution (pH 5 ± 0.1). 
 
BIOLOGICAL ACTIVITY OF HYDROGELS 
Antibacter ial Activity  
Gallic acid antibacterial activity has been attributed to its interaction with cells’ surfaces 
(enhanced by gallic acid affinity to the lipophilic membrane layer), which induce alterations on 
the cell electrochemical potential, and reduce the membrane integrity. The gallic acid uptake 
induce a hyperacidification of cytoplasm, via proton donation, interfering with crucial metabolic 
pathways [32]. Previous research reported that gallic acid antibacterial activity was conserved 
after encapsulation by βCD and HPβCD (Chapter 3.1). 
The main goal of the present work was to developed a hydrogel capable of prevent wound 
infections. Hence, the antibacterial activity of the polymeric networks was evaluated by qualitative 
and quantitative methods. Fig 4.1.6 shows the growth inhibition halos obtained for the gallic acid 
loaded hydrogels. The gallic acid maintained its ability to reduce the bacteria growth (halos 
between 3.5 and 2.7 mm). 
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Fig  4.1.6 Qualitative analysis of the gallic acid load hydrogels antibacterial activity against 3 bacteria (K. 
pneumoniae, S. epidermidis and S. aureus, 1x106 cel.mL -1). 
 
The quantification of the hydrogels’ antibacterial activity, against the 3 bacteria (Fig 4.1.7), was 
consistent with the previous analysis (Fig 4.1.6). The gel-β and gel-HPβ were capable of destroy 
all the bacterial cells, with the exception of the gel-HPβ when in contact with S. aureus. Although, 
in this case the growth observed was minimum (only 1 log).  
 
 
F ig  4.1.7 Quantitative analysis antibacterial activity of the gallic acid load hydrogels by direct contact against 3 
bacteria (K. pneumoniae, S. epidermidis and S. aureus, 5x105 cel.mL -1). All data is expressed as mean + standard 
deviation (n = 9). 
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Therefore, it was verified that the gallic acid antibacterial activity was preserved after 
incorporation within the hydrogels. Considering that the hydrogels samples had 30 mg, and the 
gallic acid release (gel-β 7.4 mg.ghydrogel-1 and gel-HPβ 9.4 mg.ghydrogel-1, Fig 4.1.5), the concentration 
of gallic acid in contact with bacteria would be, at least, 0.26 mM for gel -β and for gel-HPβ 
0.33mM. These values are lower than MBC reported (0.47 mM) (Chapter 2 and 3.1). Despite 
that, both networks were capable significantly decreased the 3 bacteria growth. Thus, 
antibacterial activity of hydrogels was based, not only on the amount of phenolic capable of 
migrate from the hydrogel to the solution, but also on the gallic acid tramped inside the 
hydrogels. 
Therefore, the gallic acid was successfully loaded into the polymeric network produced, and its 
release was sustained for 48 h. Moreover, the loaded gel-β and gel-HPβ were capable of destroy 
all the bacteria cells preserving the gallic acid antibacterial activity. 
 
Effect of Hydrogels on Fibroblast Proliferation 
The successfully utilization of gel-β and gel-HPβ as wound dressing, also, depends on their 
biocompatibility. Biocompatibility reflects the interaction between the artificial material and 
tissues, and it can be evaluated by in vitro cytotoxicity [28]. In the present study, MTS test was 
used to evaluate the cytotoxicity effect of the new developed hydrogels. The MTS assay allowed 
the measurement of the cellular viability, due to cell capacity to uptake MTS and its subsequent 
reduction by the mitochondria, leading to alterations on MTS colour. 
The percentage of viable cells (Fig 4.1.8) measured after contact with the extracts from gel-β and 
gel-HPβ were similar to the percentage of the normal conditions of growth (control +). Thus, both 
hydrogels do not release any kind of substance that could be potentially hazardous for fibroblast. 
The gallic acid induces a reduction on the viable cells (Fig 4.1.8). It was previously shown that 
gallic acid can enhance fibroblasts proliferation when applied at low concentrations, and induces 
a reduction on viable cells for concentrations above 0.6 mM (Chapter 2). Assuming that, at least, 
0.26 or 0.33 mM of gallic acid were released to the medium used for contact with fibroblast, the 
gallic acid effect on fibroblast proliferation was similar to the one described for the free gallic 
acid. 
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Fig  4.1.8 Viability of fibroblast 3T3 after 24 h of contact with liquid extracts from hydrogels (24 h within DMEM), 
measured with MTS assay. The control + allowed the perfect growth of the cells. All data is expressed as mean + 
standard deviation (n = 9).The line indicate 70% of cell viability. 
 
Thus, the phenolic incorporation within both hydrogels did not changes the gallic acid biological 
properties. Moreover, the percentage of viable cells, for both hydrogels, was above the limit 
described as safety for humans (70%), based on ISO 10993-5:2006.  
Therefore, gel-β and gel-HPβ conjugated with gallic acid may be a viable option for wound 
dressing without causing any damage to the surrounding tissue. 
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Conclusion  
 
The CD-based hydrogels obtained from the cross-linking between βCD or HPβCD and HPMC 
were developed in order to be applied as wound dressing capable of preventing wound infections. 
To best of authors’ knowledge, loading and release of gallic acid (as antibacterial agent) into 
hydrophilic networks of CD, HPMC and BDGE (as cross-linking), and its release for control wound 
infections, have not been evaluated until know. 
The hydrogels obtained after successful cross-linking with BDGE, under mild conditions were 
transparent, easy to handle and soft, thus suitable for the contacts with injury sk in. Gel-β and gel-
HPβ behaved as superabsorbent hydrogels, being the last network capable of higher swelling. 
The swelling and gallic acid loading profiles were similar. The results obtained (DSC, FTIR and 
loading) suggested that gallic acid may be inside the cyclodextrins cavity and, also, trapped in the 
polymeric network. The gel-HPβ has a less hydrophilic surface when compared with the gel-β, as 
result of the lower mobility of their network. Regarding the biological properties of both hydrogels, 
the gallic acid antibacterial activity was preserved after its incorporation within the hydrogels. In 
addition, all the hydrogels, with or without gallic acid, enabled the fibroblast proliferation.  
In conclusion, the gallic acid was successfully loaded into the polymeric network produced, and 
its release was sustained for 48 h. Moreover, the load gel-β and gel-HPβ were capable of 
destroying bacterial cells preserving the gallic acid antibacterial activity. Based on the results 
from the present work, the gel-HPβ appears to be the network with more suitable properties for 
the incorporation of gallic acid and utilization as antibacterial wound dressing, without causing 
any damage to the surrounding tissue. 
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Abstract 
 
Caffeic acid, a natural phenolic compound, has been described has active against bacteria 
common isolated from wound infections. However, its low stability under environmental stress 
and poor solubility reduced caffeic acid applicability as pharmaceutical product. However, these 
parameters can be enhanced by complexation with cyclodextrin. So, the main goal of the present 
work was to incorporate caffeic acid on cyclodextrin-based hydrogels capable of control delivery in 
order to be used as antibacterial wound dressing. 
Cyclodextrins-based hydrogels were prepared by direct cross-linking of β-cyclodextrin (gel-β) or 
hydroxypropyl-β-cyclodextrin (gel-HPβ) with 1,4-butanediol diglycidyl ether (BDGE) in the presence 
of hydroxypropyl methylcellulose (HPMC). The polymeric networks were transparent and 
viscoelastic. Both hydrogels were capable of load and release caffeic acid. However, gel -β 
showed better loading capacity and lower release, as expected due to β-cyclodextrin higher 
affinity to form inclusion complexes with caffeic acid. 
The caffeic acid loaded hydrogels were effective against Klebsiela pneumoniae, Staphylococcus 
epidermidis and Staphylococcus aureus. Moreover, the hydrogel interaction with fibroblasts was 
better for the gel-β. 
The hydrogels obtained combine good physicochemical properties (viscoelasticity, 
superabsorbency and high ability to retain and deliver caffeic acid) with the preservation of caffeic 
acid antibacterial activity, being the gel-β the most suitable. Thus, this hydrogels could be useful 
as caffeic acid delivery system’s device for the treatment of wound infections. 
 
Keywords:  Antibacterial activity, caffeic acid, cellulose, cyclodextrin, hydrogel, wound dressing. 
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Introduction 
 
Hydrogels have been successfully applied as medical devices, special for wound healing 
purposes [1]. Wound dressing hydrogels are polymeric networks with a three-dimensional 
structure capable of absorbing high amounts of water. These materials, besides mechanical 
protection, may enhance the healing process by promoting gas exchange, and reduce the body 
fluids loss. The biological properties of hydrogels can be improved by the absorption of bioactive 
molecules on their network, such as growth factors to accelerate the healing process or 
antimicrobial agents to prevent infections [2]. However, hydrogels have poor properties regarding 
the controlled release of those bioactive molecules. Thus, cyclodextrins (CD), a truncated 
oligosaccharide with ability to complex with a wide range of molecules, have been used to 
enhance the hydrogels drug delivery ability. CD-based hydrogels retained the suitable properties 
of polymeric networks (swelling, softness and mechanical properties) and, additionally, the 
capacity of CD to complex and sustainably release bioactive molecules [3]. 
Polyphenolics are extensive distributed among plant kingdom, imposing plant odours, 
pigmentation and flavour or/and acting as plant defence mechanism, against tissue infections or 
injuries [4, 5]. These plants’ metabolites are present in human diet, and a wide range of 
biological effects have been attribute to them, like anti-oxidant, anti-inflammatory, antimicrobial 
and antiviral [6–8]. Polyphenolics, the term applied for the set of molecules that share a 
common chemical skeleton (one or more aromatic ring with at least one hydroxyl group (OH) 
attached), but with different structures and functions [9]. 
Caffeic acid (3,4-dihydroxycinnamic acid) is a simple phenolic acid, and has been reported as 
anti-oxidant, antibacterial and fungicide [10–12]. This phenolic acid, as well as other 
polyphenolics, have been used as food preservative and proposed as antimicrobial agent for the 
pharmaceutical field. Though, caffeic acid exhibits poor solubility and stability under 
environmental stress, reducing its applicability as antibacterial agent on pharmaceutical field. 
Thus, encapsulation devices, such as cyclodextrins, have been suggested to ensure caffeic acid 
stability and improved its utilization as antibacterial agent (Chapter 3.2). 
The main goal of the present work was to develop a hydrogel wound dressing based on cellulose 
and cyclodextrins, with the ability to retain and sustain the release of caffeic acid, for wound 
dressing proposes.  
Chapter 4.2| Caffeic acid loading wound dressing: physicochemical and biological characterization 
148 
Material and methods 
 
Mater ial 
Caffeic acid (3,4-dihydroxycinnamic acid) was purchased from Sigma, β-cyclodextrin (βCD, 1135 
g.mol-1) and 2-hydroxypropyl-β-cyclodextrin (HPβCD, 1309 g.mol-1) were acquired from 
AppliChem. Hydroxypropyl methylcellulose (HPMC) Methocel® K4M was purchased from VWR 
Prolab and 1,4-butanediol diglycidyl ether (BDGE), 50-60% in water, was purchased from Acros 
Organics. All solutions were prepared with purified water, obtained by reverse osmosis (MiliQ®, 
Mikipore, Madrid, Spain) with a resistivity above 18.2 MΩ.cm -1. 
 
Synthesis of gel -β and gel-HPβ 
Hydrogels were synthesized through the method described by Lorenzo et al [13]. Briefly, 2.5 g of 
each CD (βCD or HPβCD) was dissolved in 10 mL of NaOH (0.2 M). The solutions were 
maintained for 5 min, at 25 ºC and under mechanical agitation (200 rpm). After, 0.025 g of 
HPMC was added to each solution, and the solubilisation was improved by mechanical agitation 
(200 rpm) during 5 min, at 25 ºC. The cross-linking agent (BDGE, 2 mL) was added to 5 mL 
portions of each solution within petri dishes. The petri dishes were sealed with parafilm and kept 
for 2 min at 25 ºC, and under mechanical agitation (200 rpm). To complete the cross-linking 
process, the plates were preserved at 50 ºC for 12 h. At this temperature, the CD and HPMC 
stability was assured. After cooling, hydrogel were immersed in ultrapure water for 12 h and 25 
ºC, to allow their swelling. Then, the hydrogels were transferred for HCl solution (10 mM) for 
more 12 h, and finally immersed in water for 7 days. 
The dry process was performed as followed: the hydrogels were kept at 25 ºC for 24 h and, after, 
were transferred to a desiccator until the weight stabilizing. 
At the end two hydrogels were obtained: βCD-co-HPMC (gel-β) and HPβCD-co-HPMC (gel-HPβ). 
 
Preparation and Character ization of Caffeic  ac id L oad 
For the hydrogels loading, a caffeic acid solution (2.3x10 -2 M, 2% ethanol) was prepared using 
H3PO4/NaOH buffer (pH 5 ± 0.5). To assurance that the caffeic acid was completely dissolved, 
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the solution was maintained at 50 ºC, 200 rpm for 30 min. Dry hydrogels samples (90 ± 3 mg) 
were immersed in 5 mL of caffeic acid solution, 25 ºC and 60 rpm. The amount of phenolic acid 
in the solution was assessed by UV-Vis spectrophotometry, until the absorbance values stabilized. 
The caffeic loading was calculated based on the variation of the phenolic acid on the initial 
solution and on the equilibrium. The absorption spectra were measured in the range 200–360 
nm and recorded on a Jasco V560 spectrometer, using a 1cm quartz cuvette. 
The hydrogels with and without caffeic acid were characterized by differential scanning 
calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR) and contact angle.  
DSC measurements were carried in liquid nitrogen atmosphere using DSC-822e instrument 
(Mettler Toledo). The calibration was made with indium as standard. Samples were weighed (2.5 
± 0.2 mg) and sealed in aluminium pans. Then, they were heated from 25 to 350 ºC at a 
scanning rate of 10 ºC.min-1. Data were treated using LAB mettler star SW 8.1 software (Mettler -
Toledo International Inc, Swiss).  
The FTIR-ATR analysis was performed as follows: samples (0.5 ± 0.05 g) of each hydrogel were 
used. The IR spectra were recorded between 400 and 4000 cm -1, in Avatar 360 FTIR 
spectrometer. The spectra of compounds alone (caffeic acid, βCD, HPβCD and HPMC) were, 
also, recorded, using the potassium bromide pellet technique. 
Surface contact angles of hydrogels in contact with ultrapure water were measured using a 
contact angle measurement apparatus (OCA15 Plus; Dataphysics, Germany). A 3 µL water drop 
was placed over clean hydrogel surface with an autopipette. All measurements were performed at 
room temperature. 
Hydrogels characterization was made in triplicate for each hydrogel (gel-β, gel-β/caffeic acid, gel-
HPβ, gel-HPβ/caffeic acid). 
 
In vitro Caffeic  ac id Release 
Dry load hydrogels (90 ± 3 mg) were immersed in 5 mL of synthetic sweat solution (SSS, 0.5 g l-
histidine monohydrochloride monohydrate, 5 g of sodium chloride, 2.2 g of sodium dihydrogen 
orthophosphate dihydrate, pH 5 ± 0.5), at 25 ºC. At predetermined time points, samples were 
taken until equilibrium was achieved. The amount of caffeic acid release was measured by the 
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UV-Vis spectrophotometry, within a range 200–360 nm and recorded on a Jasco V560 
spectrometer, using a 1cm quartz cuvette. 
 
Antibacter ial Assessment 
The hydrogels antibacterial activity was tested against 3 bacteria: Staphylococcus epidermidis 
(ATCC 12228), Staphylococcus aureus (ATCC 6538) and Klebsiella pneumoniae (ATCC 11296). 
The bacteria were grown in tryptic soy agar (TSA, Merck, Germany) for 24 h at 37 ºC. Then, the 
cells were inoculated in tryptic soy broth (TSB, Merck, Germany) and incubated for 18 h at 37 ºC 
under agitation (120 rpm). Subsequently, bacterial concentration of each strain was adjusted to 
5x105 cells.mL-1, via absorbance readings and corresponding calibration curve. 
For the quantitative assess of hydrogel antibacterial capacity, samples with 90 ± 3 mg were 
immersed within 5 mL of 5x105 cells.mL-1 of each bacterium. Bacteria and medium controls 
were, also, included. The hydrogels and the bacteria were incubated for 24 h at 37 ºC. The 
number of viable cells was assessed by determination of the number of colony forming units 
(CFUs), plating 10 µL of cell suspension from each replicates onto TSA, and incubated for 24 h 
at 37 ºC. 
The assays were made in triplicate for each bacterium and hydrogel combination, at least in 3 
independent assays. 
 
Cytotoxic ity Assay 
The hydrogels in vitro cytotoxicity was carried out based on the method described on ISO 10993-
5:2009 -Biological evaluation of medical devices, part 5: Tests for in vitro cytotoxicity, by indirect 
contact. The liquid extracts of the hydrogel were prepared as follows: hydrogels (90 ± 3 mg) were 
immersed within 5 mL of Dulbecco’s modified Eagle’s medium (DMEM), and then they were kept 
24 h at 25 ºC, on dark. 
Fibroblast 3T3 (CCL 163), from American Type Culture Collection, were used in this study. Cells 
were cultured in DMEM supplemented with 10% of foetal bovine serum and 1% penic illin/ 
streptomycin at 37 ºC, 5% CO2. After achieving confluence, cells were passed at the density of 
1×105 cells.mL-1, using trypsin. Then, cells were seeded at the density of 5×105 cells.mL-1 (48 well 
plate) in 300 µL of DMEM complete medium. The 48 well plates were incubated for 24 h, 37 ºC 
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and 5% CO2 and after, the medium was replaced for 300 µL of each hydrogels extract and 
incubated for more 24 h. 
The cytotoxicity was tested by MTS ([3-(4,5-carboxymethoxyphenyl)-2-(4-sulfophenyl)- 2H-
tetrazolium]) assay. This assay measured the cells viability by their capacity to uptake MTS and 
subsequent reduction by mitochondria, leading to the coloration of MTS. Thus, the liquid extract 
of hydrogels was removed, and a mixture of 6 µL of MTS (Promega) and 294 µL of DMEM, 
without phenol, was added to each well. After 1 h, the absorbance value was measured, at 490 
nm, and the results were expressed as percentage of viable cells (%), using the number of cells 
grown on wells without hydrogel (control +) as 100%. 
 
Statist ical Analysis 
Statistical analysis was performed with OriginPro 8 SR0 (V8.70724, OriginLab Corporation). The 
differences between groups were evaluated using the 2-way ANOVA variation test and the results 
were considered statistically significant for p values < 0.0001. 
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Results 
Caffeic  ac id Loaded gel-β and gel-HPβ 
Fig 4.2.1 displays the caffeic acid loading profiles of gel-β and gel-HPβ. The hydrogels obtained 
were capable of absorbing caffeic acid and achieving the equilibrium after 360 min. Interestingly, 
gel-β was capable of load a higher amount of caffeic acid (0.6 g.g hydrogel-1) when compared with the 
gel-HPβ (0.37 g.ghydrogel-1). 
 
 
F ig  4.2.1 Caffeic acid loading (a) in gel-β (black) and gel-HPβ (grey). The loading was performed during 24 h, 25 ºC 
with caffeic acid dissolved on the buffer H3PO4/NaOH (pH 5 ± 0.1, 2% ethanol). 
 
Physicochemical Character ization of gel -β and gel-HPβ 
The hydrogels with or without caffeic acid were characterized by DSC, FTIR and surface 
hydrophilicity. 
The DSC thermograms of various products are shown in Fig 4.2.2. The DSC curve of caffeic acid 
display a single sharp endothermic peak near 225 ºC, corresponding to its melting point. The CD 
(βCD and HPβCD), also, showed 2 defined peaks each, near 100 ºC and 275 ºC. In the case of 
HPMC, owing to its amorphous nature, a broad endothermic peak was observed at about 75 ºC. 
The hydrogels formation and cross-linking could be confirmed by the lack of obvious peak on 
their thermograms (orange line). Moreover, a nonobvious peak was obtained for loaded 
hydrogels. 
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Fig  4.2.2 DSC thermograms of caffeic acid (blue), CD (black), HPMC (grey), gel (orange) and gel loaded (purple). (a) 
with βCD and (b) with HPβCD. 
 
Fig 4.2.3 present the FTIR spectra obtained from the gel-β and gel-HPβ with and without caffeic 
acid, and also, the network components alone (βCD, HPβCD, HPMC and caffeic acid). Both CD 
spectra shows higher intensity on the following peaks (βCD/HPβCD): 3416/3447 cm -1 (O-H 
stretching), 2924 cm -1 (asymmetric vibrational stretching of C-H), 1645/1640 cm -1 (hydrogen 
interactions), 1157 cm-1 (C-O stretching) and 1029/1034 cm -1 (C-O-C) [3, 14, 15]. The HPMC 
spectrum showed a profile similar to the CD and the strong intensity peaks were identified: 3447 
cm-1 (O-H stretching), 2924 cm -1 (asymmetric vibrational stretching of C-H), 1640 cm -1 (hydrogen 
interactions), 1115 and 1063 cm -1 (ether bond) [16, 17]. 
 
 
F ig  4.2.3 FTIR spectra of caffeic acid (blue), CD (green), HPMC (grey), gel (pink) and gel loaded (purple). (a) with 
βCD and (b) with HPβCD. 
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The hydrogels spectra had similar profile regardless the CD used for the synthesis of the 
polymeric network. However, they display some differences on the peaks intensity and shape 
when compared with the CDs and HPMC spectra. The changes observed in the region of ether 
bond signals (between 1200 to 1000 cm -1), and the decrease of peaks intensity at 3400 and 
1649 cm-1 confirms that cross-linking occurred during the process. 
The spectra obtained for the load gel-HPβ was similar to the gel without caffeic acid. However, 
the phenolic incorporation within the gel-β induced some changes on the spectra, more obvious 
between 2000 and 800 cm -1. In this range, the caffeic acid peaks were present on the load gel-β 
spectra, making it more alike to the phenolic spectra than to the hydrogel. 
The hydrophilicity of the hydrogels surface was assessed by the contact angle formed after a 
water drop was released on the materials surface. The gel-β had a contact angle of 85.68 ± 1.33 
and the gel-HPβ 97.37 ± 1.63. So, both surfaces can be considered hydrophilic, being the gel-β 
more suitable for contact with water [18]. The caffeic acid loading slightly reduced the 
hydrophilicity of the gel-β (78.73 ± 1.69), and had no influence on the surface properties of the 
gel-HPβ (97.82 ± 1.68). 
 
In vitro Caffeic  ac id Release 
Both polymeric networks were capable of sustain the caffeic acid release for 48 h (Fig 4.2.4), 
with a burst at the first 60 min and a slower release until the equilibrium (360 min). After 2 days, 
the gel-HPβ released 1.2 mg.ghydrogel-1 of caffeic acid and the gel-β near half of that amount (0.77 
mg.ghydrogel-1). 
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Fig  4.2.4 Caffeic acid released from gel-β (black) and gel-HPβ (grey) hydrogels; it was performed during 48 h, 25 ºC 
within synthetic sweat solution (pH 5 ± 0.1). 
 
Antibacter ial Activity of gel -β and gel-HPβ 
The hydrogels antibacterial activity evaluation revelled that both networks has comparable effects 
on 3 bacteria growth (Fig 4.2.5). The gel-β and gel-HPβ without caffeic acid allowed the normal 
growth of the cells (near 6 log), and the hydrogels with caffeic acid caused a reduction of more 
than 3 log on the number of viable cells, when compared with the control. Apparently the S. 
epidermidis was more susceptible to the antibacterial activity of both materials. 
 
 
F ig  4.2.5 Antibacterial assessment of caffeic acid load hydrogels (90 ± 3 mg) by direct contact with the 3 bacteria 
(K. pneumoniae, S. epidermidis and S. aureus, 5x105 cel.mL -1). The control + allowed the perfect growth of the cells. 
All data is expressed as mean + standard deviation (n = 9). *statistically different from the control +, p< 0.0001. 
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Effect of Load Hydrogels on Fibroblasts Proliferation 
Fig 4.2.6 shows the hydrogels effect on the proliferation of 3T3 fibroblast. The gel-β and gel-HPβ 
allowed the perfect proliferation of the fibroblast. However, the caffeic acid loading induced a 
reduction on the viable of cells, gel-β/caffeic acid showed a decrease of 26% on viable cells and, 
only, 40% of viable cells were detected regarding the loaded gel-HPβ. 
 
 
F ig  4.2.6 The viability of fibroblast 3T3 after 24 h of contact with liquid extracts from hydrogels (24 h within DMEM), 
measured with MTS assay. The control + allowed the perfect growth of the cells. All data is expressed as mean + 
standard deviation (n = 9).The line indicate 70% of cell viability. 
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Discussion  
Physicochemical Character ization of gel -β and gel-HPβ 
Previous work demonstrated that hydrogels could be obtained from the cross-linking of HPMC 
and βCD or HPβCD, using BDGE. The hydrogel formation occurred after 12h when a ratio of 1 
CD: 1.25 BDGE: 0.01 HPMC was used (Chapter 4.1). The CD-based hydrogels obtained showed 
suitable characteristics for contact with injury skin. They were resistance but viscoelastic and with 
a smooth and continues surface. Moreover, both polymeric networks behaved as superabsorbent 
hydrogels and kept their shape after swelling (Chapter 4.1). Thus, the same conditions were used 
in the present work. 
The hydrogels loading properties result from the combination of several factors, such as network 
cross-linking degree, water affinity to the components (swelling) and interactions between guest 
and the network [19]. Additionally, CD-based hydrogels ability to retain the guest molecule is, 
also, regulated by the formation of inclusion complexes (IC) between the CDs and bioactive 
molecules. Thus, the guest molecule will be present trapped in the polymeric network , and inside 
the CDs cavity [14, 20]. 
The caffeic acid loading capacity was dependent on the CD used for the hydrogel synthesis. 
Taking in account the swelling results (gel-HPβ > gel-β (Chapter 4.1)) it was expectable that gel-
HPβ was capable of retaining higher amount of caffeic acid in the aqueous phase. However, the 
gel-β absorbed more than 2 fold of caffeic acid, when compared to gel-HPβ. The interaction 
between caffeic acid and βCD or HPβCD was analysed in a previous work. The native CD was 
reported to be the most suitable for the complexation with caffeic acid, at pH 5 (Chapter 3.2). 
Thus, the loading results and the inclusion complexes stability (caffeic acid had higher affinity to 
βCD than HPβCD) suggests that CDs play a major role on the hydrogels ability to load caffeic 
acid, and the βCD capacity to encapsulate caffeic acid was preserved after hydrogel synthesis 
(Fig 4.2.1). 
The loading of larger molecules (diclofenac, ciprofloxacin, 3-methylbenzoic and estradiol) by 
similar hydrogels has been reported. All works stated that the inclusion complex , between the 
guest and the CDs, had a major contribution for the retention ability of CD-based hydrogels, 
which are in agreement with our results. Although, interactions between the guest molecule and 
HPMC were also referred, but with lower influence on the loading mechanism [3, 15, 20–22]. 
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The cross-linking between CDs and HPMC, as well as the presence of caffeic acid on the 
hydrogels network were confirmed by the DSC and the FTIR analysis. The thermograms profiles 
of both hydrogels (gel-βCD and gel-HPβ) have a broad peak, as result of the cross-linking 
between the CD and HPMC. This suggested the presence of an amorphous structure, 
characteristics of hydrogels materials (Fig 4.2.2). Moreover, no significantly differences were 
detected between gel-βCD and gel-HPβ thermograms, thus the cross-linking process was similar 
regardless the CD. The thermograms of the load hydrogels (gel-β and gel-HPβ) lack the 
characteristic peak of caffeic acid (Fig 4.2.2). Therefore, the phenolic may be trapped in an 
amorphous or solid solution state into the polymeric network [23]. 
Regarding the FTIR spectra (Fig 4.2.3), the alterations on the peaks intensity and shape, 
indicating that the polymeric network had less OH and hydrogen bonds, as consequence of the 
cross-linking reaction [3, 14]. Moreover, the differences between the loaded gel-β and gel-HPβ 
spectra may result from the presence of caffeic acid in different state on the polymeric networks. 
In the case of the hydrogel synthetized with HPβCD, the caffeic acid is probably adsorbed in the 
surface, since the spectra from gel-HPβ and gel-HPβ/caffeic acid had similar profile. In 
opposition, the profile of gel-β and caffeic acid/gel-β had visible alterations indicating that the 
phenolic compound may be within the network, and interacting with the HPMC and/or βCD 
molecules. 
Based on the results obtained, a reaction mechanism is proposed and illustrated on Fig 4.2.7. 
The BDGE has 2 epoxide groups able to react with the OH from CDs and HPMC, at alkaline pH 
(condition used), leading to the formation of stable ethers bonds. Thus, the decrease of the OH 
detected, on the FTIR results, were a consequence of their consumption for cross-linking 
reaction. 
Furthermore, the physicochemical differences detected between the 2 hydrogels synthetize (gel-β 
and gel-HPβ) may arise from the CD’ OH group involved in the reaction with BDGE. The 
cyclodextrins have a truncated cone shape (Fig 4.2.8) with 21 OH on the case of βCD, and 
HPβCD has 21 hydroxypropyl and/or OH. These groups have different reactivity, as 
demonstrated on Fig 4.2.8. Regarding βCD, the OH-2 and OH-3 (located on the wider side of the 
rim) are less reactive than the OH-6 (placed on the narrower side and directed away of the 
cavity), and the reactivity of the later is improved by alkaline conditions. Moreover, the HPβCD 
has OH on their substituents with the same reactivity than the OH-6 [3].  
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Fig  4.2.7 Schematic representation of the reaction mechanism between the cyclodextrins (βCD or HPβCD) and 
HPMC using BDGE, as cross-linking agent. The caffeic acid position within the cyclodextrins cavities and adsorbed on 
the polymeric network were also represented. 
 
 
Fig  4.2.8 Position of the hydroxyl groups on the truncate shape of each cyclodextrin. 
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Therefore, the gel-β was formed by the interaction of βCD’ OH-6 and the epoxy group of BDGE, 
resulting in a network with lower mobility (Fig 4.2.7). In the case of gel-HPβ (Fig 4.2.7), CD may 
be linked to the polymeric structure by the OH-6 and/or by the OH on the hydroxylpropyl groups, 
providing more flexibility to the polymeric network and, consequently, more viscoelastic and 
greater swelling.  
 
Biological Properties of gel-β and gel-HPβ 
Wound dressing are expected to be biocompatible and, therefore, suitable for contact with injury 
skin without causing any harm to the user. The hydrogels surface stated the interaction between 
the wound dressing and the skin. Those interactions can be predicted by the angle formed 
between the hydrogels surface and water or other solvents [24]. 
Hydrogels polymeric networks implies the ability of these materials to absorb large amounts of 
water, so it should be expected to obtained low contact angles, due to hydrogel hydrophilic 
nature [25]. According to the swelling results (Chaper 4.1), gel-HPβ should have low contact 
angle than the gel-β, but the opposite was observed. The contact angle value reflects the degree 
of freedom of the molecules network to move, as response to the environment change [25]. 
Therefore, the gel-HPβ showed reduced the mobility of their macromolecules, decreasing their 
surface hydrophilicity (Chapter 4.1). Moreover, the enhanced of gel-β hydrophilic surface after 
the caffeic acid loading can be a result of interactions between the caffeic acid and water. At pH 
5, the caffeic acid is charged, and able to interact with the water molecules [26]. Also, on the IC, 
the caffeic acid carboxylic group (charge group) is project out of the βCD cavity, establishing 
interactions with the water molecules (Chapter 3.2). Thus, the gel-β surface hydrophilicity was 
increased by the interaction of caffeic acid with water. 
Gel-β and gel-HPβ were able to sustain the caffeic acid release for 2 days with similar profiles 
(Fig 4.2.4). An initial burst was detected, as result of the transference of the caffeic acid present 
in the network aqueous phase to the solution. The remained delivery was slower, since it 
depends on the dissociation rate between the CDs and the phenolic. At equilibrium, the gel -HPβ 
allows higher release of caffeic acid, almost twice the amount observed for gel-β. At this point 2 
processes are involved on the controlled release by CD-based hydrogels: (1) the swelling degree 
and (2) inclusion complex stability. The gel-HPβ had higher swelling capacity which enhanced the 
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caffeic acid mobility through the network. Additionally, the low gel-β release was a result of 
hampered caffeic acid dissociation from the CD cavity, since the complex formed with this CD 
was more stable than HPβCD (Chapter 3.2). This suggests that the sustained release was 
dependent on the CD ability to retain the caffeic acid in the network, as previously reported for 
cyclodextrin-based hydrogels load with hydrophobic molecules [3, 15, 20–22].  
The antibacterial properties of the produced hydrogels are directly linked to the materials ability 
to deliver the caffeic acid. Based on the caffeic acid release results (0.77 mg. ghydrogel-1  for gel-β and 
1.2 mg. ghydrogel-1 for gel-HPβ), the concentration of caffeic acid in contact with bacteria was, at least, 
77 or 120 mM. Gel-β and gel-HPβ were able to induce meaningful reduction on the bacteria 
growth regardless the bacteria (Fig 4.2.5)  
The antibacterial activity of caffeic acid appears to be deeply linked with the phenolic ability to 
reach the bacteria surface [27]. Thus, the caffeic acid loading into the polymeric networks 
allowed the caffeic acid interaction with electrons on the bacteria surface leading to cascade of 
events. That interaction induced a change on bacterial electric potential and on the cytoplasmic 
pH. The proton donation causes destabilization and disruption the cell membrane and, also, 
hyperacidification of cytoplasm [27]. Important enzymatic pathways can be disrupt leading to 
decrease of bacteria growth or even total inhibition [12, 28]. 
As stated above, hydrogels for wound dressing applications have to be friendly to the injury 
tissue, thus their cytotoxicity evaluation is crucial. Preliminary cytotoxicity assays of gel -β and gel-
HPβ were performed based on the membrane integrity of the fibroblast cell, by MTS assay. This 
method has been often use for in vitro cytotoxicity evaluation of polymeric materials, and 
correlates the mitochondrial status with cell proliferation [2]. The caffeic acid effect on 3T3 
fibroblast was described as dose-dependent, being safety for concentrations under 7mM (Chapter 
2). Gel-HPβ allows only, 40% of the cells to survive as reflect of its higher ability to deliver caffeic 
acid (120 mM after 48 h). However, gel-β showed reasonable interactions with fibroblasts (viable 
cells above 70%), though the amount of caffeic acid release was 10 times the limit described for 
free phenolic compound. Accordingly, the caffeic acid loading into gel-β, apparently, reduced its 
cytotoxicity (Fig 4.2.6).  
In conclusion, caffeic acid was successfully loaded into the CD-based hydrogels, and its release 
was kept for 2 days. Moreover, the loaded gel-β and gel-HPβ were capable of destroy most of the 
bacteria cells preserving the caffeic acid antibacterial activity. Nevertheless, gel-β appeared to be 
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more suitable for healing wounds, since it was friendly to fibroblasts. Thus, the developed 
cellulosic CD-based hydrogels, specially the gel-β, have a great potential as efficient carrier of 
caffeic acid, to be used as wound dressing. 
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Final Remarks 
 
The deposition and growth of bacteria on injury skin leads to infections, which increase the 
production of exudate, maceration of the tissue, and delay on the healing process. Hydrogels, 
(polymeric networks with the ability to swell after immersion in a liquid) have been, successfully, 
used as wound dressing, since they can retain the moist environment and absorb the exudate. 
The syntheses of hydrogels with cyclodextrins (CDs) allow the improvement of drug delivery 
ability of these networks. Then, CDs can form complexes with a wide range of molecules, altering 
their physiochemical and biological properties. 
Nowadays, the demand for natural and friendly products has increased, as well as the source of 
new antibacterial agents (as consequence of the decrease of wide-spectra antibiotics activity 
against multi-resistant bacteria). Plants offer an immensity of bioactive molecules, being the 
poliphenolics one of the most studied groups. These molecules have been described as anti-
inflammatory, anti-oxidant, bactericidal and fungicidal. However, polyphenolics applicability as 
therapeutics agents has been restricted by their lower stability to environmental factors, solubility 
in water or biofluids, and bioavailability. Moreover, cyclodextrins are known to enhance the 
solubility of polyphenolics in aqueous systems, protecting them from elevated temperatures, pH 
alterations, light or the moisture-induced degradations phenomena, and leading to the 
improvement of their bioavailability. β-cyclodextrin’ (βCD) derivatives allow the formation of more 
stable inclusion complexes (IC) with flavonoids, when compared with native βCD. In the case of 
non-flavonoids, the three-dimensional fit between the bioactive molecules and the cavity of the 
cyclodextrins played a major rule on the inclusion complex stability. Nevertheless, CD-based 
hydrogels combined with polyphenolics gathers suitable properties for the wound healing. Thus, 
the development of a wound dressing with these features was the aim of this study. 
First of all, a screening of antibacterial potential of phenolic extracts from wild Northeast 
Portuguese plants, as well as some of their phenolic compounds was made. From the extracts 
selected, the ones collected from Cistus ladanifer, Castanea sativa, Filipendula ulmaria and Rosa 
micrantha were effective in controlling the growth of bacteria commonly isolated from skin and 
soft tissue infections, in concentrations between 0.625 and 2.5 mg.mL-1. Moreover, the 
Filipendula ulmaria and Rosa micrantha extracts can be safely used as antibacterial agents 
without causing any harm to the human cells. From the above extracts, 6 phenolic compounds 
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were selected: 3 flavonoids (kaempferol, quercetin and rutin) and 3 phenolic acids (ellagic, 
caffeic and gallic acids). Although, the flavonoids showed a growth inhibition halo against the 
gram positive bacteria, they were not active for concentrations below 5 mg.mL-1. The phenolic 
acids were capable of control and inhibit the growth of 3 bacteria, with the exception of the 
ellagic acid. Thus, the caffeic and gallic acids were selected for the further work, as result of their 
antibacterial activity at reduced concentration. Regarding the effect on fibroblast growth and 
proliferation, caffeic acid had dose-response cytotoxicity, and can be used securely in 
concentrations below 6.31 mg.mL-1. Gallic acid promoted the proliferation of fibroblasts for the 
lower concentration, but for concentrations above 0.1 mg.mL-1 it became toxic. In the same range 
of concentration, the gallic acid was more toxic than the caffeic acid, probably because gallic acid 
is more acid (lower pKa). Therefore, Chapter 2 results reinforced the potential of phenolic 
compounds from North Eastern Portugal plants as antibacterial agents, for the treatment of 
infected wounds, instead of large-spectrum antibiotics. Based on the antibacterial and cytotoxicity 
results, the gallic and caffeic acid were chosen for incorporation on wound dressings, to avoid 
tissue infections. 
As referred above, phenolic acids (as others polyphenolics) are susceptible to environmental 
conditions, such as pH and solvent. The effect of both factors on gallic acid UV-Vis spectra was 
analysed. Alterations on the gallic acid spectra were observed, the buffer modified the intensity of 
the peaks, and the pH interfered with the peaks position. Moreover, gallic acid became unstable 
at pH 8, as result of autoxidation. Additionally, gallic acid antibacterial properties were, also, 
affected by the pH, became less efficient at acid pH. Thus, the neutral form of gallic acid had 
lower ability to interact with bacteria. 
In order to improve the gallic and caffeic acids’ stabilization and solubilisation, their 
encapsulation by βCD and derivatives was studied. For the first phenolic, pH 3 was the most 
suitable condition for the formation of inclusion complexes with the 3 cyclodextrins, and all had a 
1:1 stoichiometry. However, the stability parameters varied with the CD used, increasing in the 
following order methyl-β-cyclodextrin (MβCD), βCD and hydroxypropyl-β-cyclodextrin (HPβCD). 
The last 2 CDs were selected, based on higher stability parameters, for the antibacterial 
assessment of inclusion complexes activity. The gallic acid was still capable to reach the bacteria 
surface, and to inhibit their growth despite of being inside the CD cavity. In the case of caffeic 
acid, the pH 5 was the most suitable condition for the inclusion complex formation with βCD and 
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HPβCD. The complexes obtained, also, had 1:1 stoichiometry regardless the CDs, but βCD 
complexes had higher stability parameters. The encapsulation of caffeic acid by the βCD and 
HPβCD improved the phenolic antibacterial properties, probably caused by the improvement of 
caffeic acid solubilisation and reduction of aggregates formation. 
Nevertheless, HPβCD/gallic acid and βCD/caffeic acid show the most suitable properties for 
their utilization as antibacterial agent, to be applied on the treatment of skin and soft tissue 
infections. 
Since gallic and caffeic acids are effective against bacteria, commonly isolated from infected 
wounds, and their encapsulation for cyclodextrins enhanced phenolics properties, CD-based 
hydrogels were prepared to be applied as vehicles for the drug delivery of both phenolic acids, 
with favourable properties for the prevention and/or treatment of wound infections. The βCD and 
HPβCD were cross-linked with hydroxypropylmethyl cellulose (HPMC), using 1 4-butanediol 
diglycidyl ether (BDGE), since these CDs were able to form stable IC with both acids. The 
hydrogels showed suitable mechanical characteristics for contact with injured skin, such as 
viscoelasticity, smooth surface and superabsorbance. A mechanism of reaction for the hydrogel 
formation was proposed based on the analysis of swelling, DSC, FTIR and contact angle results. 
It was postulated that, the epoxy groups from BDGE react with the hydroxyl groups (OH) from the 
CDs and HPMC. In the case of gel-β, the OH-6 present on the narrower side of the CD had higher 
reactivity and, because of that, this was probably the group intervener on the reaction. The OH 
groups of the hydroxypropyl from the HPβCD substitutions had similar reactive to the OH-6 of 
βCD. Thus, this CD may be linked to the polymeric structure by the OH-6 and/or by the OH on 
the hydroxypropyl groups, providing more flexibility to the polymeric network and, consequently, 
more viscoelasticity and greater swelling.  
Regarding the phenolics, the hydrogels were capable of successfully load the gallic and caffeic 
acids, and their controlled release occur for 48 h. However, it was observed that the load and 
release, of these phenolic acids, were intimately related to the CD within the network. Hence, the 
gel-HPβ was the network with best properties for the incorporation of gallic acid, and the gel-β 
was more suitable for caffeic acid. Nevertheless, the results obtained suggested that gallic and 
caffeic acids may be inside the cyclodextrins cavity and, also, trapped in the polymeric network. 
Regarding the biological properties of the hydrogels, the gallic and caffeic acid antibacterial ability 
was preserved after incorporation, as well as their interaction with fibroblast. 
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It is important to highlight that, to best of authors’ knowledge, the loading and release of gallic 
and caffeic acids (as antibacterial agents) into hydrophilic networks of CD, HPMC and BDGE (as 
cross-linking), and its release for control wound infections, have not been evaluated until now. 
In conclusion, the present thesis point out the applicability of natural antibacterial agents for the 
prevention and/or control of infected wounds, which can be enhanced by their incorporation on 
hydrogels wound dressing. The polymeric networks were synthetized using natural compounds 
and were friendly to fibroblast proliferation. Thus, the developed cellulosic CD-based hydrogel 
have a great potential as efficient carrier of gallic and caffeic acid, and can be used as wound 
dressing. 
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Future Perspectives 
 
The work within this thesis highlights the potential of natural molecules as antibacterial agents, 
especially phenolic acids, and their incorporation within CD-based hydrogels. However, new 
information regarding the interaction of the phenolic compounds with the bacteria and animal 
cells will facilitate the optimization of wound dressings, and improve their ability to delivery those 
agents. 
The phenolic acid interaction with bacteria has been general described. Thus, new insights 
regarding mechanism of action will bring valuable information about the molecules and/or 
chemical reactions responsible for the antibacterial properties of these phenolics. It will, also, 
clarify if the mechanism responsible for destroying bacteria is related to the one observed for the 
interaction with animal cells. 
Another interesting study might be the antibacterial activity of gallic and caffeic acid on poly-
microbial populations and biofilms. Wounds, are, usually colonized by complex microbial 
communities comprising a wide range of bacteria species. Thus, the effect of gallic and caffeic 
acids on other strains of K. pneumoniae, S. epidermis and S. aureus, and other bacteria species 
isolated from infected wounds, for example Escherichia coli, Pseudomonas aeruginosa or Proteus 
sp, could clarify the mechanism involved on the phenolics action and enhance the applicability of 
those molecules as antibacterial agents. Moreover, wounds colonizing bacteria can establish and 
proliferate, giving rise to biofilm formation. Biofilms interfere with the human immune system, 
facilitating the establishment of further bacteria communities and inflammation, and delay the 
healing process. Additionally, biofilms show higher tolerance to antibiotics than planktonic cells. 
Therefore, the study of gallic and caffeic acid antibacterial activity on these structures should be 
an asset on the natural antibacterial agents field. The gallic and caffeic acid should be capable of 
control biofilm proliferation, since they are small molecules with improved ability to diffuse to the 
interior of the biofilm structure. 
In the present work, it was demonstrated that the developed hydrogels had suitable properties for 
their use as antibacterial wound dressings. However, in order to their commercialization, 
hydrogels should be subject to more specific evaluation regarding the interaction with human 
cells. Hence, the hydrogels effect on epithelial and keratinocytes cells lines should be evaluated, 
as well as, their effect on skin tissue models. The interaction hydrogel-cells could be assessed by 
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gather information from survival, metabolic, genotoxicity and irritation assays. Moreover, the 
evaluation of the hydrogels antibacterial active on infected skin tissue should, also, brings 
interesting insights to the hydrogels-cells-bacteria interaction. Untimely, the hydrogels should be 
evaluated regarding their in vivo healing ability using animal models. 
As referred during the present thesis, CD-based hydrogels had enhanced ability to load 
hydrophobic bioactive molecules. Thus, it might be interesting to evaluate the versatility of the 
polymeric networks developed, during this work, as platforms for the delivery of other molecules 
(such as growth factors, anti-oxidants or local analgesics) capable of improving the healing 
process, in order to amplify the applicability of this wound dressings. 
Summarizing, the recognition of the specific interactions between the gallic or caffeic acids with 
bacteria and animal cells should bring valuable insights about the mechanism of action of those 
compounds, and help the optimization of the delivery platforms such as the hydrogels developed. 
